10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2022

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-38441

ChampionX Corporation

(Exact name of registrant as specified in its charter)

Delaware		82-3066826
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)
2445 Technology Forest Blvd,	Building 4, 12th Floor
The Woodlands,	Texas	77381
(Address of principal executive offices)		(Zip Code)

(281) 403-5772

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, $0.01 par value	CHX	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑  No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑  No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☑	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

The registrant had 199,359,754 shares of common stock, $0.01 par value, outstanding as of October 20, 2022.

CHAMPIONX CORPORATION

TABLE OF CONTENTS

PART I — FINANCIAL INFORMATION		Page
Item 1.	Financial Statements (unaudited)
	Condensed Consolidated Statements of Income	1
	Condensed Consolidated Statements of Comprehensive Income	2
	Condensed Consolidated Balance Sheets	3
	Condensed Consolidated Statements of Changes in Stockholders’ Equity	4
	Condensed Consolidated Statements of Cash Flows	6
	Notes to Condensed Consolidated Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	24
	Executive Overview and Business Outlook	24
	Consolidated Results of Operations	25
	Segment Results of Operations	27
	Capital Resources and Liquidity	29
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	31
Item 4.	Controls and Procedures	31
PART II — OTHER INFORMATION
Item 1.	Legal Proceedings	32
Item 1A.	Risk Factors	32
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	34
Item 3.	Defaults Upon Senior Securities	34
Item 4.	Mine Safety Disclosures	34
Item 5.	Other Information	34
Item 6.	Exhibits	35
SIGNATURES		36

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, contained in this report are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements usually relate to future events and anticipated revenues, earnings, cash flows or other aspects of our operations or operating results. Forward-looking statements are often identified by the words “believe,” “anticipate,” “expect,” “may,” “intend,” “foresee,” “guidance,” “estimate,” “potential,” “outlook,” “plan,” “should,” “would,” “could,” “target,” “forecast” and similar expressions, including the negative thereof. The absence of these words, however, does not mean that the statements are not forward-looking statements. Forward-looking statements are based on our current expectations, beliefs and assumptions concerning future developments and business conditions and their potential effect on us. While management believes that these forward-looking statements are reasonable as and when made, there can be no assurance that future developments affecting us will be those that we anticipate.

All of our forward-looking statements involve risks, uncertainties (some of which are significant or beyond our control) and assumptions that could cause actual results to materially differ from our historical experience and our present expectations or projections. Known material factors that could cause actual results to materially differ from those contemplated in the forward-looking statements are those set forth in Part I, Item 1A, “Risk Factors,” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and in Part II, Item 1A, “Risk Factors,” in this Quarterly Report on Form 10-Q, including the following:

•Demand for, and profitability of our products and services, is affected by changes in the price of, and demand for, crude oil and natural gas in domestic and international markets;

•Cost inflation and availability of raw materials;

•The impact of inflation in wholesale product costs, labor rates and transportation costs

•Our ability to successfully compete with other companies in our industry;

•Our ability to develop and implement or introduce new technologies, products, and services, as well as our ability to protect and maintain critical intellectual property assets;

•Our ability to successfully execute potential acquisitions;

•Potential liabilities arising out of the installation or use of our products or from a chemical spill or release;

•Continuing consolidation within our customers’ industry;

•Credit risks related to our customer base or the loss of significant customers;

•A failure of our information technology infrastructure or any significant breach of security;

•Risks relating to our existing international operations and expansion into new geographical markets;

•Risks relating to improper conduct by any of our employees, agents or business partners;

•Global economic conditions, inflation, geopolitical issues, supply chain disruptions, and availability and cost of credit, and its impact on our operations and those of our customers and suppliers;

•Failure to attract, retain and develop personnel;

•Our ability to protect or obtain intellectual property rights;

•The impact of natural disasters and other unusual weather conditions on our business;

•The impact of the novel coronavirus (“COVID-19”) and related economic disruptions;

•Investor sentiment towards climate change, fossil fuels and other environmental, social and governance matters;

•Changes in domestic and foreign governmental public policies, risks associated with entry into emerging markets, changes in statutory tax rates and unanticipated outcomes with respect to tax audits;

•Disruptions in the political, regulatory, economic and social conditions of the countries in which we conduct business;

•Fluctuations in currency markets worldwide and disruptions in capital and credit markets;

•The impact of our indebtedness on our financial position and operating flexibility;

•Our ability to realize the benefits of the acquisition of our Chemical Technologies business, and certain limitations in our ability to engage in certain activities as a result of that acquisition;

•The impact of war, terrorism and civil unrest;

•Changes in federal, state and local legislation and regulations relating to oil and gas development and the potential for related litigation or restrictions on our customers;

•Changes in environmental and health and safety laws and regulations which may increase our costs, limit the demand for our products and services or restrict our operations; and

•The impact of tariffs and other trade measures on our business.

We wish to caution you not to place undue reliance on any forward-looking statements, which speak only as of the date hereof. We undertake no obligation to publicly update, revise or correct any of our forward-looking statements after the date they are made, whether as a result of new information, future events or otherwise, except to the extent required under the federal securities laws.

PART I — FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

CHAMPIONX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands, except per share data)	2022		2021		2022		2021
Revenue:
Product revenue	$	897,156	$	711,099	$	2,455,377	$	1,945,855
Service revenue	101,598		89,349		299,835		251,198
Lease and other revenue	22,807		18,337		64,881		55,792
Total revenue	1,021,561		818,785		2,820,093		2,252,845
Cost of goods and services	825,018		623,162		2,204,052		1,714,885
Gross profit	196,543		195,623		616,041		537,960
Costs and expenses:
Selling, general and administrative expense	153,736		135,089		445,447		430,908
Interest expense, net	11,454		12,849		33,582		40,884
Other expense (income), net	(6,118)		(36,876)		27,483		(36,561)
Income before income taxes	37,471		84,561		109,529		102,729
Provision for income taxes	14,246		25,910		19,235		32,255
Net income	23,225		58,651		90,294		70,474
Net income attributable to noncontrolling interest	157		1,823		3,182		624
Net income attributable to ChampionX	$	23,068	$	56,828	$	87,112	$	69,850
Earnings per share attributable to ChampionX:
Basic	$	0.11	$	0.28	$	0.43	$	0.35
Diluted	$	0.11	$	0.27	$	0.42	$	0.34
Weighted-average shares outstanding:
Basic	201,421		201,852		202,600		201,329
Diluted	206,522		208,545		208,155		208,173

The accompanying notes are an integral part of the condensed consolidated financial statements.

1

CHAMPIONX CORPORATION 

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2022		2021		2022		2021
Net income	$	23,225	$	58,651	$	90,294	$	70,474
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	(47,067)		(11,737)		(27,463)		(192)
Cash flow hedges	16,310		3,218		11,608		3,354
Defined pension and other post-retirement benefits adjustments, net	68		46		207		6,586
Other comprehensive income	(30,689)		(8,473)		(15,648)		9,748
Comprehensive income	(7,464)		50,178		74,646		80,222
Less: Comprehensive income (loss) attributable to noncontrolling interest	157		1,823		3,182		624
Comprehensive income attributable to ChampionX	$	(7,621)	$	48,355	$	71,464	$	79,598

The accompanying notes are an integral part of the condensed consolidated financial statements.

2

CHAMPIONX CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(in thousands)	September 30, 2022		December 31, 2021
ASSETS
Current Assets:
Cash and cash equivalents	$	187,472	$	251,678
Restricted cash	3,500		3,500
Receivables, net	611,501		584,440
Inventories, net	570,820		542,910
Assets held for sale	33,617		7,217
Prepaid expenses and other current assets	69,920		71,155
Total current assets	1,476,830		1,460,900
Property, plant and equipment, net of accumulated depreciation of $659,094 in 2022 and $618,867 in 2021	722,868		776,813
Goodwill	708,460		702,867
Intangible assets, net	326,156		401,470
Operating lease right-of-use assets	88,736		115,458
Other non-current assets	79,730		77,193
Total assets	$	3,402,780	$	3,534,701
LIABILITIES AND EQUITY
Current Liabilities:
Current portion of long-term debt	$	4,688	$	26,850
Accounts payable	499,371		473,561
Accrued compensation and employee benefits	73,607		93,131
Current portion of operating lease liabilities	28,688		36,389
Accrued distributor fees	59,611		25,621
Liabilities held for sale	9,635		—
Accrued expenses and other current liabilities	121,075		146,773
Total current liabilities	796,675		802,325
Long-term debt	644,029		697,657
Deferred income taxes	100,972		137,971
Operating lease liabilities	55,652		73,521
Other long-term liabilities	110,732		68,920
Total liabilities	1,708,060		1,780,394
Stockholders’ equity:
Common stock (2.5 billion shares authorized, $0.01 par value) 199.3 million shares and 202.9 million shares issued and outstanding in 2022 and 2021, respectively	1,993		2,029
Capital in excess of par value of common stock	2,276,094		2,315,399
Accumulated deficit	(530,128)		(525,158)
Accumulated other comprehensive loss	(37,273)		(21,625)
ChampionX stockholders’ equity	1,710,686		1,770,645
Noncontrolling interest	(15,966)		(16,338)
Total equity	1,694,720		1,754,307
Total liabilities and equity	$	3,402,780	$	3,534,701

The accompanying notes are an integral part of the condensed consolidated financial statements.

3

CHAMPIONX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(Unaudited)

	Common Stock
(in thousands)	Shares	Par Value		Capital in Excess of Par Value		Accum. Deficit		Accum. Other Comp. Loss		Non-controlling Interest		Total
December 31, 2021	202,866	$	2,029	$	2,315,399	$	(525,158)	$	(21,625)	$	(16,338)	$	1,754,307
Net income	—	—		—		36,702		—		1,471		38,173
Other comprehensive loss	—	—		—		—		(2,795)		—		(2,795)
Stock-based compensation	290	3		4,725		—		—		—		4,728
Stock options exercised	189	1		1,054		—		—		—		1,055
Taxes withheld on issuance of stock-based awards	—	—		(2,639)		—		—		—		(2,639)
Dividends declared to common stockholders ($0.075 per share)	—	—		—		(15,465)		—		—		(15,465)
Cumulative translation adjustments	—	—		—		—		—		208		208
March 31, 2022	203,345	$	2,033	$	2,318,539	$	(503,921)	$	(24,420)	$	(14,659)	$	1,777,572
Net income	—	—		—		27,342		—		1,554		28,896
Other comprehensive income	—	—		—		—		17,836		—		17,836
Stock-based compensation	64	1		5,070		—		—		—		5,071
Stock options exercised	312	3		2,087		—		—		—		2,090
Taxes withheld on issuance of stock-based awards	—	—		(739)		—		—		—		(739)
Dividends declared to common stockholders ($0.075 per share)	—	—		—		(15,494)		—		—		(15,494)
Repurchase and cancellation of common stock	(790)	(8)		(8,992)		(11,016)		—		—		(20,016)
Cumulative translation adjustments	—	—		—		—		—		8		8
Distributions to noncontrolling interest	—	—		—		—		—		(2,369)		(2,369)
June 30, 2022	202,931	$	2,029	$	2,315,965	$	(503,089)	$	(6,584)	$	(15,466)	$	1,792,855
Net income	—	—		—		23,068				157		23,225
Other comprehensive loss	—	—		—		—		(30,689)		—		(30,689)
Stock-based compensation	20	—		5,009		—		—		—		5,009
Stock options exercised	87	1		563		—		—		—		564
Taxes withheld on issuance of stock-based awards	—	—		(198)		—		—		—		(198)
Dividends declared to common stockholders ($0.075 per share)	—	—		—		(15,315)		—		—		(15,315)
Repurchase and cancellation of common stock	(3,698)	(37)		(45,245)		(34,792)		—		—		(80,074)
Cumulative translation adjustments	—	—		—		—		—		(10)		(10)
Distributions to noncontrolling interest	—	—		—		—		—		(647)		(647)
September 30, 2022	199,340	$	1,993	$	2,276,094	$	(530,128)	$	(37,273)	$	(15,966)	$	1,694,720

4

	Common Stock
(in thousands)	Shares	Par Value		Capital in Excess of Par Value		Accum. Deficit		Accum. Other Comp. Loss		Non-controlling Interest		Total
December 31, 2020	200,380	$	2,004	$	2,293,179	$	(638,457)	$	(30,755)	$	(13,396)	$	1,612,575
Net income (loss)	—	—		—		5,772		—		(1,735)		4,037
Other comprehensive income	—	—		—		—		3,793		—		3,793
Stock-based compensation	64	—		6,442		—		—		—		6,442
Stock options exercised	577	6		3,341		—		—		—		3,347
Taxes withheld on issuance of stock-based awards	—	—		(556)		—		—		—		(556)
Cumulative translation adjustments	—	—		—		—		—		268		268
Distributions to noncontrolling interest	—	—		—		—		—		(800)		(800)
March 31, 2021	201,021	$	2,010	$	2,302,406	$	(632,685)	$	(26,962)	$	(15,663)	$	1,629,106
Net income	—	—		—		7,250		—		536		7,786
Other comprehensive income	—	—		—		—		14,428		—		14,428
Stock-based compensation	101	—		5,914		—		—		—		5,914
Stock options exercised	578	7		3,155		—		—		—		3,162
Taxes withheld on issuance of stock-based awards	—	—		(1,208)		—		—		—		(1,208)
Cumulative translation adjustments	—	—		—		—		—		(231)		(231)
June 30, 2021	201,700	$	2,017	$	2,310,267	$	(625,435)	$	(12,534)	$	(15,358)	$	1,658,957
Net income	—	—		—		56,828		—		1,823		58,651
Other comprehensive loss	—	—		—		—		(8,473)		—		(8,473)
Stock-based compensation	133	—		5,557		—		—		—		5,557
Stock options exercised	74	2		429		—		—		—		431
Taxes withheld on issuance of stock-based awards	—	—		(1,661)		—		—		—		(1,661)
Distributions to noncontrolling interest	—	—		—		—		—		(1,710)		(1,710)
September 30, 2021	201,907	$	2,019	$	2,314,592	$	(568,607)	$	(21,007)	$	(15,245)	$	1,711,752

The accompanying notes are an integral part of the condensed consolidated financial statements.

5

CHAMPIONX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Nine Months Ended September 30,
(in thousands)	2022		2021
Cash flows from operating activities:
Net income	$	90,294	$	70,474
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization	177,761		178,805
Loss (gain) on disposal group	16,515		(39,876)
Stock-based compensation	14,808		17,913
Provision for inventory obsolescence and write-downs	21,214		5,259
Loss on debt repurchases	4,043		8,707
Deferred income taxes	(37,505)		(10,844)
(Gain) loss on disposal of fixed assets	(4,428)		4,483
Amortization of deferred loan costs and accretion of discount	2,736		2,689
Employee benefit plan expense	1,848		1,853
Other	(587)		(542)
Changes in operating assets and liabilities (net of effects of foreign exchange):
Receivables	(50,075)		(35,435)
Inventories	(72,298)		(74,641)
Prepaid expenses and other current assets	13,737		2,280
Accounts payable	38,600		130,607
Accrued compensation and employee benefits	(20,601)		18,711
Accrued expenses and other liabilities	32,867		(37,361)
Leased assets	(20,947)		(4,496)
Other	10,285		1,214
Net cash flows provided by operating activities	218,267		239,800
Cash flows from investing activities:
Capital expenditures	(74,752)		(67,027)
Proceeds from sale of fixed assets	16,424		4,891
Proceeds from disposal of business	—		68,807
Acquisitions, net of cash acquired	(3,198)		(9,957)
Other	—		(4,874)
Net cash used for investing activities	(61,526)		(8,160)
Cash flows from financing activities:
Proceeds from long-term debt	995,038		—
Repayment of long-term debt	(1,071,386)		(174,392)
Payment of debt issue costs	(8,008)		—
Repurchases of common stock	(100,090)		—
Dividends paid	(30,480)		—
Proceeds from exercise of stock options	3,709		6,940
Payments related to taxes withheld on stock-based compensation	(3,576)		(3,425)
Distributions to noncontrolling interest	(3,016)		(2,510)
Payment of finance lease obligations	(4,503)		(328)
Other	7,111		—
Net cash used for financing activities	(215,201)		(173,715)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	(5,746)		(1,991)
Net increase (decrease) in cash and cash equivalents and restricted cash	(64,206)		55,934
Cash and cash equivalents and restricted cash at beginning of period	255,178		201,421
Cash and cash equivalents and restricted cash at end of period	$	190,972	$	257,355

The accompanying notes are an integral part of the condensed consolidated financial statements.

6

CHAMPIONX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

NOTE 1—BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Description of the Business

ChampionX Corporation is a global leader in chemistry solutions and highly engineered equipment and technologies that help companies drill for and produce oil and gas safely, efficiently and sustainably around the world. Our products provide efficient and safe operations throughout the lifecycle of a well with a focus on the production phase of wells.

Unless the context requires otherwise, references in this report to “we,” “us,” “our,” “the Company,” or “ChampionX” mean ChampionX Corporation, together with our subsidiaries where the context requires.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of ChampionX have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) pertaining to interim financial information. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted. Therefore, these financial statements should be read in conjunction with the audited consolidated financial statements, and notes thereto, which are included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.

The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Although these estimates are based on management’s best knowledge of current events and actions that we may undertake in the future, actual results may differ from our estimates. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments unless otherwise specified) necessary for a fair statement of our financial condition and results of operations as of and for the periods presented. Revenue, expenses, assets and liabilities can vary during each quarter of the year. Therefore, the results and trends in these financial statements may not be representative of the results that may be expected for the year ending December 31, 2022.

Significant Accounting Policies

Please refer to “Note 1–Basis of Presentation and Summary of Significant Accounting Policies” to our consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 for the discussion of our significant accounting policies.

New Accounting Standards Issued

In September 2022, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2022-04, “Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations”, which requires that a buyer in a supplier finance program disclose information about the key terms of the program, outstanding confirmed amounts as of the end of the period, a rollforward of such amounts during each annual period, and a description of where in the financial statements outstanding amounts are presented. The ASU does not affect the recognition, measurement or financial statement presentation of obligations covered by supplier finance programs. The guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023, with early adoption permitted. We are currently assessing the impact that this ASU will have on our disclosures and will adopt the amendments in this update upon the effective dates.

7

NOTE 2—SEGMENT INFORMATION

Our reporting segments are:

•Production Chemical Technologies—provides oil and natural gas production and midstream markets with solutions to manage and control corrosion, oil and water separation, flow assurance, sour gas treatment and a host of water-related issues.

•Production & Automation Technologies—designs, manufactures, markets and services a full range of artificial lift equipment, end-to-end digital automation solutions, as well as other production equipment and asset monitoring technologies. Production & Automation Technologies’ products are sold under a collection of brands including Harbison-Fischer, Norris, Alberta Oil Tool, Oil Lift Technology, PCS Ferguson, Pro-Rod, Upco, Unbridled ESP, Scientific Aviation, Norriseal-Wellmark, Quartzdyne, Spirit, Theta, Timberline, Windrock, and Leak Surveys (“LSI”).

•Drilling Technologies—designs, manufactures and markets polycrystalline diamond cutters and bearings primarily for use in oil and gas drill bits under the US Synthetic brand.

•Reservoir Chemical Technologies—manufactures specialty products that support well stimulation, construction (including drilling and cementing) and well intervention in the oil and natural gas industry.

We refer to our Production Chemical Technologies segment and our Reservoir Chemical Technologies segment collectively as our Chemical Technologies business. Business activities that do not meet the criteria of an operating segment have been combined into Corporate and other. Corporate and other includes (i) corporate and overhead expenses, and (ii) revenue and costs for activities that are not operating segments.

Segment revenue and segment operating profit

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2022		2021		2022		2021
Segment revenue:
Production Chemical Technologies	$	643,604	$	487,670	$	1,710,987	$	1,347,090
Production & Automation Technologies	247,717		204,473		710,465		559,491
Drilling Technologies	60,965		49,415		175,682		121,998
Reservoir Chemical Technologies	35,485		38,192		119,499		101,305
Corporate and other (1)	33,790		39,035		103,460		122,961
Total revenue	$	1,021,561	$	818,785	$	2,820,093	$	2,252,845
Segment operating profit (loss):
Production Chemical Technologies	$	86,649	$	45,696	$	143,518	$	109,924
Production & Automation Technologies	22,485		14,407		70,845		32,061
Drilling Technologies	14,856		11,146		45,119		21,400
Reservoir Chemical Technologies	(61,711)		37,800		(73,327)		31,979
Total segment operating profit	62,279		109,049		186,155		195,364
Corporate and other (1)	13,354		11,639		43,044		51,751
Interest expense, net	11,454		12,849		33,582		40,884
Income before income taxes	$	37,471	$	84,561	$	109,529	$	102,729

_______________________

(1)    Corporate and other includes costs not directly attributable or allocated to our reporting segments such as corporate executive management and other administrative functions, and the results attributable to our noncontrolling interest. Additionally, the sales and expenses related to the Cross Supply and Product Transfer Agreement with Ecolab Inc. (“Ecolab”) are included within Corporate and other.

8

NOTE 3—REVENUE

Our revenue is generated primarily from product sales. Service revenue is generated from providing services to our customers. These services include installation, repair and maintenance, laboratory and logistics services, chemical management services, troubleshooting, reporting, water treatment services, technical advisory assistance, emissions detection and monitoring, and other field services. Lease revenue is derived from rental income of leased production equipment. As our costs are shared across the various revenue categories, cost of goods sold is not tracked separately and is not discretely identifiable.

In certain geographical areas, the Company utilizes joint ventures and independent third-party distributors and sales agents to sell and market products and services. Amounts payable to independent third-party distributors and sales agents may fluctuate based on sales and timing of distributor fee payments. For services rendered by such independent third-party distributors and sales agents, the Company records the consideration received on a net basis within product revenue in our condensed consolidated statements of income. Additionally, amounts owed to distributors and sales agents are reported within accrued distributor fees within our condensed consolidated balance sheets.

Revenue disaggregated by geography was as follows:

	Three Months Ended September 30, 2022
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	228,007	$	192,914	$	47,645	$	19,756	$	19,651	$	507,973
Latin America	184,964		4,963		7		3,283		758		193,975
Middle East & Africa	77,162		15,567		1,562		8,314		1,358		103,963
Canada	75,334		18,922		4,614		334		49		99,253
Europe	50,206		2,776		5,774		1,102		3,584		63,442
Asia-Pacific	8,851		1,528		1,363		767		8,390		20,899
Australia	5,518		10,803		—		30		—		16,351
Other	13,562		244		—		1,899		—		15,705
Total revenue	$	643,604	$	247,717	$	60,965	$	35,485	$	33,790	$	1,021,561
	Three Months Ended September 30, 2021
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	163,184	$	158,534	$	37,716	$	26,332	$	26,890	$	412,656
Latin America	110,592		4,752		—		3,410		1,048		119,802
Middle East & Africa	66,584		14,243		1,582		4,958		1,467		88,834
Canada	68,907		14,922		3,697		662		43		88,231
Europe	47,891		731		4,459		930		3,529		57,540
Asia-Pacific	11,703		1,853		1,945		1,113		6,058		22,672
Australia	8,693		9,393		—		28		—		18,114
Other	10,116		45		16		759		—		10,936
Total revenue	$	487,670	$	204,473	$	49,415	$	38,192	$	39,035	$	818,785

9

	Nine Months Ended September 30, 2022
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	624,370	$	548,698	$	140,312	$	76,015	$	61,544	$	1,450,939
Latin America	409,109		16,324		7		10,094		2,388		437,922
Middle East & Africa	227,234		51,340		4,471		21,596		1,959		306,600
Canada	223,714		55,858		11,032		1,445		112		292,161
Europe	145,116		8,505		14,640		2,973		10,352		181,586
Asia-Pacific	26,852		3,983		5,180		2,721		27,105		65,841
Australia	16,321		25,386		15		229		—		41,951
Other	38,271		371		25		4,426		—		43,093
Total revenue	$	1,710,987	$	710,465	$	175,682	$	119,499	$	103,460	$	2,820,093
	Nine Months Ended September 30, 2021
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	469,900	$	426,246	$	93,515	$	61,530	$	83,132	$	1,134,323
Latin America	275,597		13,924		—		10,016		3,740		303,277
Middle East & Africa	191,167		38,346		3,744		17,554		8,534		259,345
Canada	193,838		42,204		9,510		1,768		325		247,645
Europe	131,545		4,504		9,236		3,420		9,476		158,181
Asia-Pacific	32,757		6,059		4,351		3,626		17,754		64,547
Australia	21,082		28,151		130		112		—		49,475
Other	31,204		57		1,512		3,279		—		36,052
Total revenue	$	1,347,090	$	559,491	$	121,998	$	101,305	$	122,961	$	2,252,845

______________________

(1)    Revenues associated with sales under the Cross Supply and Product Transfer Agreement with Ecolab are included within Corporate and other.

Revenue is attributed to regions based on the location of our direct customer, which in some instances is an intermediary and not necessarily the end user.

Contract Balances

The beginning and ending contract asset and contract liability balances from contracts with customers were as follows:

(in thousands)	September 30, 2022		December 31, 2021
Contract assets	$	—	$	—
Contract liabilities - current	$	13,660	$	15,246

10

NOTE 4—INTANGIBLE ASSETS AND GOODWILL

Intangible Assets

The components of our definite- and indefinite-lived intangible assets were as follows:

	September 30, 2022						December 31, 2021
(in thousands)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Definite-lived intangible assets:
Customer relationships	$	581,504	$	395,810	$	185,694	$	593,242	$	365,773	$	227,469
Unpatented technologies	142,845		51,624		91,221		142,540		37,264		105,276
Favorable supply agreements	57,000		44,290		12,710		59,000		30,546		28,454
Trademarks	59,852		35,095		24,757		59,873		32,270		27,603
Patents	38,025		31,100		6,925		38,735		31,080		7,655
Other	5,242		5,193		49		5,390		5,177		213
	884,468		563,112		321,356		898,780		502,110		396,670
Indefinite-lived intangible assets:
Trademarks	3,600		—		3,600		3,600		—		3,600
In-process research and development	1,200		—		1,200		1,200		—		1,200
	4,800		—		4,800		4,800		—		4,800
Total	$	889,268	$	563,112	$	326,156	$	903,580	$	502,110	$	401,470

Goodwill

The carrying amount of goodwill, including changes therein, by reportable segment is below:

(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Total
December 31, 2021	$	356,638	$	205,467	$	101,136	$	39,626	$	702,867
Acquisition (1)	—		6,345		—		—		6,345
Allocated to disposal group (2)	(3,271)		—		—		—		(3,271)
Foreign currency translation	3,192		(665)		—		(8)		2,519
September 30, 2022	$	356,559	$	211,147	$	101,136	$	39,618	$	708,460

_______________________

(1) See Note 11—Acquisitions and Divestitures for additional information related to the acquisition of LSI completed during the first quarter of 2022.

(2) See Note 11—Acquisitions and Divestitures for additional information on the reclassification of assets and liabilities held for sale as part of the planned divestiture of our operations in Russia.

Goodwill is not subject to amortization but is tested for impairment on an annual basis or more frequently if impairment indicators arise.

11

NOTE 5—DEBT

Long-term debt consisted of the following:

(in thousands)	September 30, 2022		December 31, 2021
2022 Revolving Credit Facility	$	45,000	$	—
2018 Term Loan Facility	—		140,000
2020 Term Loan Facility	—		496,725
2022 Term Loan Facility	625,000		—
6.375% Senior Notes due 2026	—		92,041
Total	670,000		728,766
Net unamortized discounts and issuance costs	(21,283)		(4,259)
Total long-term debt	648,717		724,507
Current portion of long-term debt (1)	(4,688)		(26,850)
Long-term debt, less current portion	$	644,029	$	697,657

_______________________

(1) Represents the mandatory amortization payments due within twelve months related to the 2022 Term Loan Facility as of September 30, 2022 and 2020 Term Loan Facility as of December 31, 2021.

On May 9, 2018, we entered into a credit agreement (“Credit Agreement”) governing the terms of, among other things, a 7-year senior secured term loan B facility that had an initial commitment of $415 million (the “2018 Term Loan Facility”), and on June 3, 2020, ChampionX Holding Inc. entered into a term loan facility for $537.0 million (the “2020 Term Loan Facility”).

On June 7, 2022, we entered into a restated credit agreement (the “Restated Credit Agreement”), which amends and restates the Credit Agreement. The Restated Credit Agreement provides for (i) a $625 million 7-year senior secured term loan B facility (the “2022 Term Loan Facility”) and (ii) a five-year senior secured revolving credit facility in an aggregate principal amount of $700 million, of which $100 million is available for the issuance of letters of credit (the “2022 Revolving Credit Facility,” together with the 2022 Term Loan Facility, the “Senior Secured Credit Facility”). The full amount of the 2022 Term Loan Facility was funded, and $135 million of the 2022 Revolving Credit Facility was drawn, on June 7, 2022, with the aggregate proceeds used to repay outstanding amounts under our Credit Agreement, repay and terminate our 2020 Term Loan Facility, and to redeem all outstanding 6.375% Senior Notes due 2026 (the “Notes”). Proceeds from future borrowings under the 2022 Revolving Credit Facility are expected to be used for working capital and general corporate purposes. The initial amount drawn on the 2022 Revolving Credit Facility has been repaid. As of September 30, 2022, we had $45.0 million outstanding on the 2022 Revolving Credit Facility.

The 2022 Term Loan Facility matures June 7, 2029 and the 2022 Revolving Credit Facility matures June 7, 2027. The 2022 Term Loan Facility is subject to mandatory amortization payments of 1% per annum of the initial commitment paid quarterly, which begins on December 30, 2022. The Senior Secured Credit Facility contains customary representations and warranties, covenants, and events of default for loan facilities of this type. We were in compliance with all covenants as of September 30, 2022.

At the Company’s election, outstanding borrowings under the Senior Secured Credit Facility will accrue interest at a per annum rate of (i) an adjusted SOFR rate plus the applicable spread or (ii) a base rate plus the applicable spread. On June 29, 2022, the Company executed a five-year amortizing floating-to-fixed interest rate swap to hedge our exposure to increases in variable interest rates on the 2022 Term Loan Facility. This interest rate swap agreement is based on a $300 million notional amount for the first three years, reducing to $150 million for years four and five. See Note 13—Derivatives and Hedging Transactions for additional information on interest rate swaps.

In connection with the Restated Credit Agreement, as noted above, we completed the redemption of all of the remaining Notes at 103.188% of the principal amount thereof. We redeemed $92.0 million in aggregate principal amount of the Notes for $95.6 million in cash, including $0.6 million in accrued interest. In connection with these redemptions, we recognized a net loss of approximately $3.9 million for the nine months ended September 30, 2022, inclusive of the write off of the remaining unamortized debt financing costs related to the Notes, which is included in other expense, net in our condensed consolidated statements of income (loss).

12

NOTE 6—COMMITMENTS AND CONTINGENCIES

Guarantees and Indemnifications

We have provided indemnities in connection with sales of certain businesses and assets, including indemnities for environmental health and safety, tax, and employment matters. We do not have any material liabilities recorded for these indemnifications and are not aware of any claims or other information that would give rise to material payments under such indemnities.

In connection with the Company’s separation from Dover Corporation (“Dover”) in 2018, we entered into agreements with Dover that govern the treatment between Dover and us for certain indemnification matters and litigation responsibility. Generally, the separation and distribution agreement provides for cross-indemnities principally designed to place financial responsibility for the obligations and liabilities of our business with us and to place financial responsibility for the obligations and liabilities of Dover’s business with Dover. The separation and distribution agreement also establishes procedures for handling claims subject to indemnification and related matters.

In connection with the acquisition of the Chemical Technologies business from Ecolab in 2020 (the “Merger”), we entered into agreements with Ecolab that govern the treatment between Ecolab and us for certain indemnification matters and litigation responsibility. Generally, the separation and distribution agreement provides for cross-indemnities principally designed to place financial responsibility for the obligations and liabilities of our business with us and to place financial responsibility for the obligations and liabilities of Ecolab’s business with Ecolab. The separation and distribution agreement also establishes procedures for handling claims subject to indemnification and related matters. In addition, pursuant to the tax matters agreement relating to the Merger (the “Tax Matters Agreement”), we have agreed to indemnify Ecolab and its affiliates for (i) all taxes for which ChampionX is responsible as defined within the Tax Matters Agreement, (ii) all taxes resulting from a breach by ChampionX of any of its representations (but only to the extent relating to a breach occurring after the consummation of the Merger) or any of its covenants under the Tax Matters Agreement, (iii) all taxes resulting from an acquisition after the Merger of any of the stock or assets of ChampionX, other than as a result of the Merger or a repayment of the 2018 Credit Facility (as defined in “Note 8–Debt” to our consolidated financial statements in our Annual Report on Form 10-K for the fiscal

year ended December 31, 2021), 2018 Term Loan Facility or 2020 Term Loan Facility and (iv) reasonable costs and expenses (including reasonable attorneys’ fees and expenses) related to the foregoing.

As of September 30, 2022 and December 31, 2021, we had $73.0 million and $80.2 million, respectively, of outstanding letters of credit, surety bonds and guarantees, which expire at various dates through 2039. These financial instruments are primarily maintained as security for insurance, warranty, and other performance obligations. Generally, we would only be liable for the amount of these letters of credit, surety bonds, and guarantees in the event of default in the performance of our obligations, the probability of which we believe is remote.

Litigation and Environmental Matters

The Company is party to various proceedings and claims incidental to its business, including matters arising under provisions relating to the protection of the environment. We review the probable outcome of such proceedings, the costs and expenses reasonably expected to be incurred and accrued to date, and the availability and extent of insurance coverage. We accrue a liability for legal matters that are probable and can be reasonably estimated. If the reasonable estimate of a probable loss is a range, the Company records the most probable estimate of the loss or the minimum amount when no amount within the range is a better estimate than any other amount. While many of these matters involve inherent uncertainty, we believe that the amount of the liability, if any, ultimately incurred with respect to these proceedings and claims will not have a material adverse effect on our consolidated financial position, results of operations or cash flows.

Environmental Matters

The Company is currently participating in environmental assessments and remediation at approximately 11 locations, the majority of which are in the United States (“U.S.”), and environmental liabilities have been accrued reflecting our best estimate of future costs. Potential insurance reimbursements are not anticipated in the Company’s accruals for environmental liabilities. As of September 30, 2022 and December 31, 2021, environmental liability accruals related to these locations were $6.1 million and $6.8 million, respectively.

Prior to the separation from Dover in 2018, groundwater contamination was discovered at the Norris Sucker Rods plant site located in Tulsa, Oklahoma (“Norris”). Initial remedial efforts were undertaken at the time of discovery of the contamination and Norris has since coordinated monitoring and remediation with the Oklahoma Department of Environmental Quality (“ODEQ”). As part of the ongoing long-term remediation process, Norris contracted an engineering and consulting firm to

13

develop a range of possible additional remedial alternatives in order to accelerate the remediation process and associated cost estimates for the work. In October 2019, we received the firm’s preliminary remedial alternatives for consideration. We have submitted our long-term remediation plan and it was approved by ODEQ. We are now in discussion with ODEQ to finalize a consent order. Because we have not yet finalized the consent order for further remediation at the site and discussions with ODEQ remain ongoing, we cannot fully anticipate the timing, outcome or possible impact of such further remedial activities, financial or otherwise. As a result of the recommendations in the report, we accrued liabilities for these remediation efforts of approximately $2.0 million as of December 31, 2019. Liabilities could increase in the future at such time as we ultimately reach agreement with ODEQ on our remediation plan and such liabilities become probable and can be reasonably estimated; however, there have been no changes to our estimated liability as of September 30, 2022.

Matters Related to Deepwater Horizon Incident Response

On April 22, 2010, the deepwater drilling platform, the Deepwater Horizon, operated by a subsidiary of BP plc, sank in the Gulf of Mexico after an explosion and fire, resulting in a massive oil spill. Certain entities that are now subsidiaries of ChampionX as a result of the Merger (collectively the “COREXIT Defendants”) supplied COREXIT™ 9500, an oil dispersant product listed on the U.S. EPA National Contingency Plan Product Schedule, which was used in the response to the spill. In connection with the provision of COREXIT™ 9500, the COREXIT Defendants were named in several lawsuits. Cases arising out of the Deepwater Horizon accident were administratively transferred and consolidated for pre-trial purposes under In Re: Oil Spill by the Oil Rig “Deepwater Horizon” in the Gulf of Mexico, on April 20, 2010, Case No. 10-md-02179 in the United States District Court in the Eastern District of Louisiana (E.D. La.) (“MDL 2179”). Claims related to the response to the oil spill were consolidated in a master complaint captioned the “B3 Master Complaint.” In 2011, Transocean Deepwater Drilling, Inc. and its affiliates (the “Transocean Entities”) named the COREXIT Defendants and other unaffiliated companies as first party defendants (In re the Complaint and Petition of Triton Asset Leasing GmbH, et al, MDL No. 2179, Civil Action 10-2771). In April and May 2011, the Transocean Entities, Cameron International Corporation, Halliburton Energy Services, Inc., M-I L.L.C., Weatherford U.S., L.P. and Weatherford International, Inc. (collectively, the “Cross Claimants”) filed cross claims in MDL 2179 against the COREXIT Defendants and other unaffiliated cross defendants. In April and June 2011, in support of its defense of the claims against it, the COREXIT Defendants filed counterclaims against the Cross Claimants. On May 18, 2012, the COREXIT Defendants filed a motion for summary judgment as to the claims in the B3 Master Complaint. On November 28, 2012, the Court granted the COREXIT Defendants’ motion and dismissed with prejudice the claims in the B3 Master Complaint asserted against the COREXIT Defendants. There currently remain two “B3” cases that had asserted claims against the COREXIT Defendants and that remain pending against other defendants. Because the Court’s decision was not a “final judgment” for purposes of appeal with respect to those claims, under Federal Rule of Appellate Procedure 4(a), plaintiffs will have 30 days after entry of final judgment in each case to appeal the Court’s summary judgment decision.

The Company believes the claims asserted against the COREXIT Defendants are without merit and intends to defend these lawsuits vigorously. The Company also believes that it has rights to contribution and/or indemnification (including legal expenses) from third parties. However, we cannot predict the outcome of these lawsuits, the involvement it might have in these matters in the future, or the potential for future litigation.

14

NOTE 7—RESTRUCTURING AND OTHER RELATED CHARGES

We approved various restructuring plans related to the consolidation of product lines and associated facility closures and workforce reductions during the current and prior periods. During the second quarter of 2022, the restructuring plans included the exit of one of our product lines within the Reservoir Chemical Technologies segment. The exit of this product line was completed during the third quarter of 2022 and as such, we recognized additional restructuring charges primarily related to certain contract termination costs as well as the exit of facilities. Liabilities for these contract termination costs are recognized and measured at fair value in the period in which we cease using the rights conveyed by the existing contracts. The liability will be paid out over the remaining term of the contracts, ranging from approximately 1 – 8 years.

We recognized charges of $69.8 million and $84.9 million during the three and nine months ended September 30, 2022, respectively, consisting primarily of contract termination costs, employee severance and related benefits, disposals of equipment and warehouse closures, partially offset by gains realized on the sale of facilities. During the three and nine months ended September 30, 2021, we recorded restructuring and other charges of $2.1 million and $10.1 million, respectively.

The following table presents the restructuring and other related charges by segment as classified in our condensed consolidated statements of income.

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2022		2021		2022		2021
Segment restructuring charges (income):
Production Chemical Technologies	$	(335)	$	1,031	$	11,637	$	4,822
Production & Automation Technologies	4,282		947		260		4,903
Drilling Technologies	—		—		—		—
Reservoir Chemical Technologies	63,458		65		69,559		307
Corporate and other	2,350		44		3,403		86
Total	$	69,755	$	2,087	$	84,859	$	10,118
Statements of Income classification:
Cost of goods and services	$	66,488	$	802	$	67,496	$	4,708
Selling, general and administrative expense	3,267		1,285		17,363		5,410
Total	$	69,755	$	2,087	$	84,859	$	10,118

Our liability balance for restructuring and other related charges at September 30, 2022 reflects contract termination costs, employee severance and related benefits initiated during the period. Additional programs may be initiated during the remainder of 2022 with related restructuring charges.

The following table details our restructuring accrual activities during the nine months ended September 30, 2022:

(in thousands)	Restructuring Accrual Balance
December 31, 2021	$	3,743
Restructuring charges	84,859
Asset sales	(13,235)
Payments	(13,771)
Other, including foreign currency translation	(66)
September 30, 2022	$	61,530

15

NOTE 8—EQUITY AND CASH INCENTIVE PROGRAMS

Stock-based compensation expense is reported within selling, general and administrative expense in the condensed consolidated statements of income. Stock-based compensation expense relating to all stock-based incentive plans was as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2022		2021		2022		2021
Stock-based compensation expense	$	5,009	$	5,557	$	14,808	$	17,913
Tax benefit	(1,052)		(1,167)		(3,110)		(3,762)
Stock-based compensation expense, net of tax	$	3,957	$	4,390	$	11,698	$	14,151

A summary of activity relating to our share-based awards for the nine months ended September 30, 2022 was as follows:

(in shares)	Stock-Settled Appreciation Rights	Performance Share Awards	Restricted Stock Units	Non-Qualified Stock Options
Outstanding at January 1, 2022	393,523	505,509	2,342,107	5,488,653
Granted	—	347,920	945,616	—
Forfeited / expired	(1,758)	(6,022)	(226,671)	(2,859)
Exercised / vested	—	(72,410)	(466,898)	(586,064)
Outstanding at September 30, 2022	391,765	774,997	2,594,154	4,899,730

NOTE 9—STOCKHOLDERS' EQUITY

Dividends

On February 4, 2022, our Board of Directors (“Board”) approved a plan to initiate a regular quarterly cash dividend of $0.075 per share of the Company’s common stock. Our third quarter cash dividend of $0.075 per share was declared on August 11, 2022, and is payable on October 28, 2022 to stockholders of record on October 7, 2022. As a result, we recorded a dividend payable of $15.8 million on our condensed consolidated balance sheet as of September 30, 2022. Subsequent dividend declarations, if any, including the amounts and timing of future dividends, are subject to approval by the Board and will depend on future business conditions, financial conditions, results of operations and other factors.

Repurchases

On March 7, 2022, the Company announced that our Board authorized the Company to repurchase up to $250 million of its common stock. On October 24, 2022, our Board increased the authorization under this program to $750 million. This program has no time limit and does not obligate the Company to acquire any particular amount of shares of its common stock. During the three months ended September 30, 2022, we repurchased and cancelled 3,698,106 shares of common stock at a volume-weighted average price of $21.63 per share for a total of $80.1 million, including commissions. During the nine months ended September 30, 2022, we repurchased and cancelled 4,487,622 shares of common stock at a volume-weighted average price of $22.28 per share for a total of $100.1 million, including commissions.

16

Accumulated other comprehensive loss

Accumulated other comprehensive loss—Accumulated other comprehensive loss consisted of the following:

(in thousands)	Foreign Currency Translation		Defined Pension and Other Post-Retirement Benefits		Cash Flow Hedges		Accumulated Other Comprehensive Loss
December 31, 2021	$	(19,430)	$	(3,476)	$	1,281	$	(21,625)
Other comprehensive loss before reclassifications, net of tax	(1,565)		—		(1,299)		(2,864)
Reclassification adjustment for net losses included in net income, net of tax	—		69		—		69
Other comprehensive loss, net of tax	(1,565)		69		(1,299)		(2,795)
March 31, 2022	$	(20,995)	$	(3,407)	$	(18)	$	(24,420)
Other comprehensive income before reclassifications, net of tax	21,169		—		(3,403)		17,766
Reclassification adjustment for net losses included in net income, net of tax	—		70		—		70
Other comprehensive income, net of tax	21,169		70		(3,403)		17,836
June 30, 2022	$	174	$	(3,337)	$	(3,421)	$	(6,584)
Other comprehensive income before reclassifications, net of tax	$	(47,067)	$	—	$	16,310	$	(30,757)
Reclassification adjustment for net losses included in net income, net of tax	$	—	$	68	$	—	$	68
Other comprehensive income, net of tax	(47,067)		68		16,310		(30,689)
September 30, 2022	$	(46,893)	$	(3,269)	$	12,889	$	(37,273)

(in thousands)	Foreign Currency Translation		Defined Pension and Other Post-Retirement Benefits		Cash Flow Hedges		Accumulated Other Comprehensive Loss
December 31, 2020	$	(14,965)	$	(13,470)	$	(2,320)	$	(30,755)
Other comprehensive income before reclassifications, net of tax	3,213		—		413		3,626
Reclassification adjustment for net losses included in net income, net of tax	—		167		—		167
Other comprehensive income, net of tax	3,213		167		413		3,793
March 31, 2021	$	(11,752)	$	(13,303)	$	(1,907)	$	(26,962)
Other comprehensive income (loss) before reclassifications, net of tax	8,332		—		(277)		8,055
Reclassification adjustment for net losses included in net income, net of tax	—		6,373		—		6,373
Other comprehensive income (loss), net of tax	8,332		6,373		(277)		14,428
June 30, 2021	$	(3,420)	$	(6,930)	$	(2,184)	$	(12,534)
Other comprehensive income (loss) before reclassifications, net of tax	(11,737)		—		3,218		(8,519)
Reclassification adjustment for net losses included in net income, net of tax	—		46		—		46
Other comprehensive income (loss), net of tax	(11,737)		46		3,218		(8,473)
September 30, 2021	$	(15,157)	$	(6,884)	$	1,034	$	(21,007)

17

Reclassifications from accumulated other comprehensive loss—Reclassification adjustments from accumulated other comprehensive loss to net income (loss) related to defined pension and other post-retirement benefits consisted of the following:

	Three Months Ended September 30,				Nine Months Ended September 30,				Affected line items on the condensed consolidated statements of income (loss)
(in thousands)	2022		2021		2022		2021
Pensions and other post-retirement benefits:
Amortization of actuarial loss and other	$	68	$	46	$	207	$	6,586	Other expense (income), net
Total before tax	68		46		207		6,586		Income before income taxes
Tax benefit	—		—		—		—		Provision for income taxes
Net of tax	$	68	$	46	$	207	$	6,586	Net income

NOTE 10—EARNINGS PER SHARE

A reconciliation of the number of shares used for the basic and diluted earnings per share calculation was as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands, except per share data)	2022		2021		2022		2021
Net income attributable to ChampionX	$	23,068	$	56,828	$	87,112	$	69,850
Weighted-average number of shares outstanding	201,421		201,852		202,600		201,329
Dilutive effect of stock-based compensation	5,101		6,693		5,555		6,844
Total shares and dilutive securities	206,522		208,545		208,155		208,173
Earnings per share attributable to ChampionX:
Basic	$	0.11	$	0.28	$	0.43	$	0.35
Diluted	$	0.11	$	0.27	$	0.42	$	0.34

For all periods presented, the computation of diluted earnings per share excludes awards with an anti-dilutive impact. For the three and nine months ended September 30, 2022, the diluted shares include the dilutive impact of equity awards except for approximately 0.4 million and 0.4 million shares, respectively, that were excluded because their inclusion would be anti-dilutive. For the three and nine months ended September 30, 2021, the diluted shares include the dilutive impact of equity awards except for approximately 0.5 million and 0.6 million shares, respectively, that were excluded because their inclusion would be anti-dilutive.

NOTE 11—ACQUISITIONS AND DIVESTITURES

Acquisitions

On February 23, 2022, we acquired LSI, a leader in optical gas imaging technology that provides aerial and ground-based emissions leak detection to the oil and gas industry. LSI has been included in our Production & Automation Technologies segment. Under the terms of the agreement, we paid an initial amount of $3.2 million, net of cash acquired, with an additional $0.5 million payable on the first anniversary of the closing date. We may also be required to make future payments of up to an additional $2.5 million, contingent on the future performance of the business. As part of our purchase price allocation, we recorded goodwill of $6.3 million. The pro forma effect of this acquisition on revenue and net income has been determined to be immaterial to our financial statements.

18

Divestitures

Given the continued economic pressure and sanctions imposed by the United States, European Union, and United Kingdom, we initiated a plan to dispose of our operations in Russia (the “CT Russia Business”), which is included in our Production Chemical Technologies segment. As a result, the CT Russia Business met the criteria to be classified as held for sale as of June 30, 2022, which required us to present the related assets and liabilities as separate line items in our condensed consolidated balance sheet. We recorded an initial charge of $22.9 million during the second quarter of 2022, in order to properly reflect the carrying value of the disposal group at the lower of its carrying value or fair value less any costs to sell.

We assess the fair value of a long-lived asset or disposal group (less any costs to sell) each reporting period that it remains classified as held for sale and report any subsequent changes as an adjustment to the carrying value of the asset or disposal group, as long as the new carrying value does not exceed the carrying value of the asset at the time it was initially classified as held for sale. During the three months ended September 30, 2022, we recognized a gain of $6.4 million to adjust the carrying value of the disposal group. Upon the ultimate disposition, we will recognize the cumulative translation adjustment balance associated with the CT Russia Business in our condensed consolidated statement of income as part of the gain or loss on the sale.

The following table presents information related to the major classes of assets and liabilities of the CT Russia Business that were held for sale in our condensed consolidated balance sheet:

(in thousands)
Receivables	$	8,330
Inventory	6,638
Prepaid expenses and other current assets	3,078
Property, plant, and equipment	4,721
Goodwill	3,271
Intangible assets	6,927
Operating lease right-of-use assets	2,001
Loss on disposal group	(16,515)
Total assets held for sale	$	18,451
Accounts payable	$	2,168
Other current liabilities	3,933
Other noncurrent liabilities	3,257
Total liabilities held for sale	$	9,358

NOTE 12—FAIR VALUE MEASUREMENTS

Fair value is defined as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. A hierarchy has been established for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs be used when available. The hierarchy is broken down into three levels:

Level 1- Inputs are quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities.

Level 2- Inputs include observable inputs other than quoted prices in active markets.

Level 3- Inputs are unobservable inputs for which there is little or no market data available.

19

The carrying amount and the estimated fair value for assets and liabilities measured on a recurring basis are as follows:

		Carrying Amount
(in thousands)	Measurement Level	September 30, 2022		December 31, 2021
Assets
Foreign currency forward contracts	Level 2	$	17,074	$	4,081
Interest rate swaps	Level 2	8,885		—
Total		$	25,959	$	4,081
Liabilities
Foreign currency forward contracts	Level 2	$	11,989	$	3,773
Interest rate swaps	Level 2	133		—
Total		$	12,122	$	3,773

For purposes of fair value disclosure above, derivative values are presented gross. See Note 13—Derivatives and Hedging Transactions for further discussion of gross versus net presentation of the Company’s derivatives.

The carrying amounts of cash and cash equivalents, trade receivables, accounts payable, as well as amounts included in other current assets and other current liabilities that meet the definition of financial instruments, approximate fair value due to their short-term nature.

The carrying amount and the estimated fair value of long-term debt, including current maturities, held by the Company were:

	September 30, 2022				December 31, 2021
(in thousands)	Carrying Amount		Fair Value		Carrying Amount		Fair Value
2022 Revolving Credit Facility	$	45,000	$	45,000	$	—	$	—
2018 Term Loan Facility	$	—	$	—	$	140,000	$	138,950
2020 Term Loan Facility	$	—	$	—	$	496,725	$	502,313
2022 Term Loan Facility	$	625,000	$	609,375	$	—	$	—
6.375% Senior Notes due 2026	$	—	$	—	$	92,041	$	95,805

The fair value of the Notes is based on Level 1 quoted market prices. The fair value of our term loan facilities are based on Level 2 quoted market prices for the same or similar debt instruments. The fair value of our revolving line of credit approximates carrying value due to the variable interest rates charged on the borrowings, which reprice frequently (Level 2).

NOTE 13—DERIVATIVES AND HEDGING TRANSACTIONS

The Company uses foreign currency forward contracts to manage risks associated with foreign currency exchange rates. The Company also utilizes floating-to-fixed interest rate swap agreements as cash flow hedges on certain debt, to mitigate interest rate risk. The Company does not hold derivative financial instruments of a speculative nature or for trading purposes. Derivative contracts are recorded as assets and liabilities on the balance sheet at fair value. We evaluated the interest rate swap hedge effectiveness and determined it to be perfectly effective. We evaluate foreign currency forward contracts hedge effectiveness at contract inception and thereafter on a quarterly basis. If a derivative is no longer expected to be effective, hedge accounting is discontinued. Changes in fair value are recognized immediately in earnings unless the derivative qualifies and is designated as a hedge. Changes in fair value attributable to changes in spot exchange rates for derivative contracts that have been designated as cash flow hedges are recognized in accumulated other comprehensive income (loss) (“AOCI”) and reclassified into earnings in the same period the hedged transaction affects earnings and are presented in the same income statement line as the earnings effect of the hedged item. The Company accounts for the interest rate swap agreements as a cash flow hedge, thus the effective portion of gains and losses resulting from changes in fair value are recognized in AOCI and are amortized to interest expense over the term of the respective debt. Cash flows from derivatives are classified in the statement of cash flows in the same category as the cash flows from the items subject to designated hedge or undesignated (economic) hedge relationships.

The Company is exposed to credit risk in the event of nonperformance of counterparties for foreign currency forward exchange contracts and interest rate swaps. We monitor our exposure to credit risk by using major global banks and financial institutions as counterparties and monitoring their financial condition and credit profile. The Company does not anticipate nonperformance

20

by any of these counterparties, and therefore, recording a valuation allowance against the Company’s derivative balance is not considered necessary.

Derivative Positions Summary

Certain of the Company’s derivative transactions are subject to master netting arrangements that allow the Company to settle with the same counterparties. These arrangements generally do not call for collateral and as of the applicable dates presented in the following table, no cash collateral had been received or pledged related to the underlying derivatives. We have elected to present our derivative balances on a gross basis on the condensed consolidated balance sheet.

The following table summarizes the gross fair value of the Company’s outstanding derivatives and the lines in which they are presented on the condensed consolidated balance sheet.

	Derivative Assets				Derivative Liabilities
(in thousands)	September 30, 2022		December 31, 2021		September 30, 2022		December 31, 2021
Prepaid expenses and other current assets	$	20,027	$	4,081	$	—	$	—
Other non-current assets	5,932		—		—		—
Accrued expenses and other current liabilities	—		—		12,122		3,773
Other long-term liabilities	—		—		—		—
	$	25,959	$	4,081	$	12,122	$	3,773

The following table summarizes the notional values of the Company’s outstanding derivatives:

(in thousands)	September 30, 2022		December 31, 2021
Notional value of foreign currency forward contracts and interest rate swaps	$	953,246	$	704,190

Cash Flow Hedges

The Company utilizes foreign currency forward contracts to hedge the effect of foreign currency exchange rate fluctuations on forecasted foreign currency transactions, primarily related to inventory purchases. These forward contracts are designated as cash flow hedges. The changes in fair value of these contracts attributable to changes in spot exchange rates are recorded in AOCI until the hedged items affect earnings, at which time the gain or loss is reclassified into the same line item in the condensed consolidated statements of income (loss) as the underlying exposure being hedged. The forward points are marked-to-market monthly and recognized in the same line item in the condensed consolidated statements of income (loss) as the underlying exposure being hedged.

Under interest rate swaps, we agree with other parties to exchange, at specified intervals, the difference between fixed-rate and floating-rate interest amounts calculated by reference to an agreed notional principal amount. Any unrealized gain or loss at the time of settlement will be reclassified to interest expense, where we record the interest expense on the associated debt.

Derivatives Not Designated as Hedging Instruments

The Company also uses foreign currency forward contracts to offset its exposure to the change in value of certain foreign currency denominated assets and liabilities, primarily receivables and payables, which are remeasured at the end of each period. Although the contracts are effective economic hedges, they are not designated as accounting hedges. Therefore, changes in the value of these derivatives are recognized immediately in earnings, thereby offsetting the current earnings effect of the related foreign currency denominated assets and liabilities.

21

Effect of Derivative Instruments on Income

The loss of all derivative instruments recognized is summarized below:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2022		2021		2022		2021
Loss (gain) reclassified from AOCI to income on cash flow hedges:
Cost of goods and services	$	(837)	$	1,447	$	(884)	$	3,219
Interest expense	585		—		585		—
Loss on derivatives not designated as hedging instruments:
Other (income) expense, net	1,167		955		6,578		2,417
Total loss of derivative instruments	$	915	$	2,402	$	6,279	$	5,636

NOTE 14—INVENTORIES

Inventories consisted of the following:

(in thousands)	September 30, 2022		December 31, 2021
Raw materials	$	148,119	$	186,516
Work in progress	20,363		13,615
Finished goods	523,042		421,702
	691,524		621,833
Inventory reserve	(26,927)		(24,646)
LIFO adjustments (1)	(93,777)		(54,277)
Inventories, net	$	570,820	$	542,910

_______________________

(1) Represents the amount by which the current cost of LIFO inventories exceeded their carrying value.

NOTE 15—ACCOUNTS RECEIVABLE FACILITY

On June 28, 2022, we entered into an uncommitted accounts receivable purchase agreement (the “Accounts Receivable Facility”) with JPMorgan Chase Bank, N.A. as the purchaser. Transfers under the Accounts Receivable Facility are accounted for as sales of receivables, resulting in the receivables being derecognized from our consolidated balance sheet. The purchaser assumes the credit risk at the time of sale and has the right at any time to assign or transfer (including as a participation interest) any of its rights under the purchased receivables to another bank or financial institution.

The amount available for sale under the Accounts Receivable Facility fluctuates over time based on the total amount of eligible receivables generated during the normal course of business. A maximum of $160.0 million in receivables may be sold and remain unpaid under the Accounts Receivable Facility at any time.

Accounts receivable sold were $101.2 million for the three and nine months ended September 30, 2022. The accounts receivable sold that remained outstanding as of September 30, 2022 was $60.0 million. During these periods, cash receipts from the purchaser at the time of the sale were classified as operating activities in our condensed consolidated statement of cash flows. The difference between the carrying amount of the accounts receivable sold and the sum of the cash received is recorded as a loss on sale of receivables in other income (expense), net in our condensed consolidated statements of income. The loss on sale of accounts receivable was $0.7 million for the three and nine months ended September 30, 2022.

22

NOTE 16—CASH FLOW INFORMATION

Leased Asset Program

Our electrical submersible pumping (“ESP”) leased asset program is reported in our Production & Automation Technologies segment. At the time of purchase, assets are recorded to inventory and are transferred to property, plant, and equipment when a customer contracts for an asset under our leased asset program. During the nine months ended September 30, 2022 and September 30, 2021, we transferred $32.1 million and $33.9 million, respectively, of inventory into property, plant, and equipment as a result of assets entering our leased asset program.

Expenditures for assets that are placed into our leased asset program expected to be recovered through sale are reported in leased assets in the operating section of our condensed consolidated statements of cash flows. All other capitalizable expenditures for assets that are placed into our leased asset program are classified as capital expenditures in the investing section of our condensed consolidated statements of cash flows.

23

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Management’s discussion and analysis is our analysis of our financial performance, financial condition and significant trends that may affect our future performance. It should be read in conjunction with the condensed consolidated financial statements, and notes thereto, included elsewhere in this report. It contains forward-looking statements including, without limitation, statements relating to ChampionX’s plans, strategies, objectives, expectations and intentions that are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are often identified by the words “believe,” “anticipate,” “expect,” “may,” “intend,” “foresee,” “guidance,” “estimate,” “potential,” “outlook,” “plan,” “should,” “would,” “could,” “target,” “forecast” and similar expressions, including the negative thereof. We undertake no obligation to publicly update, revise or correct any of our forward-looking statements after the date they are made, whether as a result of new information, future events or otherwise, except to the extent required under the federal securities laws. Readers are cautioned that such forward-looking statements should be read in conjunction with the disclosures under the heading “CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS.”

EXECUTIVE OVERVIEW AND BUSINESS OUTLOOK

We are a global leader in chemistry solutions, artificial lift systems, and highly engineered equipment and technologies that help companies drill for and produce oil and gas safely, efficiently, and sustainably around the world. Our expertise, innovative products, and digital technologies provide enhanced oil and gas production, transportation, and real-time emissions monitoring throughout the lifecycle of a well. Our business is organized into four reportable segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies. We refer to the Production Chemical Technologies segment and Reservoir Chemical Technologies segment together as the Chemical Technologies business.

Recent Events

Russia’s invasion of Ukraine and the related sanctions imposed present economic risk to companies that engage in business within, or have economic ties to, Russia. Our Russia operations (the “CT Russia Business”) are fully contained within the country and include a manufacturing plant and related inventory, service operations, an established customer base and local employees, and has the ability to operate as a standalone business under the brand, Master Chemicals. The revenues, net income and total assets of the CT Russia Business represent less than 2% of our consolidated results of operations. Given the continued economic pressure and sanctions imposed by the United States, European Union and United Kingdom, during the second quarter of 2022, we initiated a plan to dispose of the CT Russia Business. As a result, the CT Russia Business met the criteria to be reported as held for sale and, therefore, was reflected in our condensed consolidated balance sheet as of June 30, 2022 at the lower of its carrying value or its fair value less costs to sell (“estimated selling price”). We recorded an initial charge of $22.9 million during the second quarter of 2022, representing the amount by which the carrying amount exceeded the estimated selling price. During the three months ended September 30, 2022, we recognized a gain of $6.4 million to adjust the carrying value of the disposal group. Upon the ultimate disposition, we will recognize the accumulated cumulative translation adjustment balance associated with the CT Russia Business in our condensed consolidated statement of income as part of the gain or loss on the sale.

On June 7, 2022, we entered into a restated credit agreement (the “Restated Credit Agreement”), which amends and restates the Credit Agreement dated as of May 9, 2018 (the “Credit Agreement”). The Restated Credit Agreement provides for (i) a $625 million 7-year senior secured term loan B facility (the “2022 Term Loan Facility”) and (ii) a five-year senior secured revolving credit facility in an aggregate principal amount of $700 million, of which $100 million is available for the issuance of letters of credit (the “2022 Revolving Credit Facility,” together with the 2022 Term Loan Facility, the “Senior Secured Credit Facility”). The full amount of the 2022 Term Loan Facility was funded, and $135 million of the 2022 Revolving Credit Facility was drawn, on June 7, 2022, with the aggregate proceeds used to repay outstanding amounts under our Credit Agreement, repay and terminate the term loan facility we entered into on June 3, 2020, and to redeem all outstanding 6.375% Senior Notes due 2026. Proceeds from future borrowings under the 2022 Revolving Credit Facility are expected to be used for working capital and general corporate purposes. The 2022 Term Loan Facility matures June 7, 2029 and the 2022 Revolving Credit Facility matures June 7, 2027. The 2022 Term Loan Facility is subject to mandatory amortization payments of 1% per annum of the initial commitment paid quarterly, which begins on December 30, 2022.

Business Environment

We monitor macro-economic conditions and industry-specific drivers and key risk factors affecting our business segments as we formulate our strategic plans and make decisions related to allocating capital and human resources. Our business segments provide a broad range of technologies and products to support oil and gas production, exploration and development, and the

24

midstream sector. As a result, we are substantially dependent upon global oil production levels, as well as new investment activity levels in the oil and gas and midstream sectors. Demand for our products, technologies and services is impacted by overall global demand for oil and gas, ongoing depletion rates of existing oil and gas wells, and our customers’ willingness to invest in the exploration for and development of new oil and gas resources. Our customers determine their operating and capital budgets based on current and expected future crude oil and natural gas prices, United States (“U.S.”) and worldwide rig count, U.S. well completions and expectation of industry cost levels, among other factors. Crude oil and natural gas prices are impacted by supply and demand, which are influenced by geopolitical, macroeconomic, and local events, and have historically been subject to substantial volatility and cyclicality. Rig count, footage drilled, and exploration and production (“E&P”) investment by oil and gas operators have often been used as leading indicators for the level of drilling and development activity and future production levels in the oil and gas sector.

Market Conditions and Outlook

Oil prices steadily increased throughout 2021 and into the first half of 2022, reaching a 13-year high, due in part to the global economy reopening following the COVID-19 pandemic and supply side constraints. However, during the third quarter of 2022, oil prices softened due partly in response to slowing global economic growth. At the beginning of October 2022, oil prices began to increase due to the production cuts by OPEC+. Future oil prices remain uncertain due to rising macroeconomic uncertainty and geopolitical tensions, including the Russian invasion of Ukraine, which began in February 2022 and has put upward pressure on oil prices.

Although oil production is still below pre-pandemic levels as many publicly traded oil and gas companies continue to focus on capital return to shareholders rather than increasing output, we have seen a steady increase in U.S. oil and gas rig counts and some uptick in international activity. However, we have also experienced supply chain disruptions, due at least in part to the aftermath of the COVID-19 pandemic worldwide, the invasion of Ukraine, and logistic challenges globally. The U.S. inflation rate is the highest experienced in four decades, primarily as a result of supply chain constraints and partially attributed to the rising oil and natural gas prices, which is a major economic input. The global economy reopening has also contributed to general inflationary pressures. We continue to work diligently to deliver price increases to offset the impact of raw material, labor and logistics-related inflation that we have experienced in our businesses. We expect to continue to face inflationary pressure throughout the remainder of 2022 and the beginning of 2023.

CRITICAL ACCOUNTING ESTIMATES

Refer to our “Critical Accounting Estimates” included in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2021 for a discussion of our critical accounting estimates.

CONSOLIDATED RESULTS OF OPERATIONS

	Three Months Ended
	September 30,		June 30,		Variance
(in thousands)	2022		2022		$
Revenue	$	1,021,561	$	932,572	$	88,989
Cost of goods and services	825,018		720,684		104,334
Gross profit	196,543		211,888		(15,345)
Selling, general and administrative expense	153,736		141,351		12,385
Interest expense, net	11,454		10,765		689
Other (income) expense, net	(6,118)		32,281		(38,399)
Income before income taxes	37,471		27,491		9,980
Provision for (benefit from) income taxes	14,246		(1,405)		15,651
Net income	23,225		28,896		(5,671)
Net income attributable to noncontrolling interest	157		1,554		(1,397)
Net income attributable to ChampionX	$	23,068	$	27,342	$	(4,274)

Revenue. Revenue increased $89.0 million, or 10%, sequentially, primarily due to an increase in our Production Chemical Technologies segment as we benefited from improved global pricing to offset raw material inflation as well as increased volumes. We also experienced growth in our Production & Automation Technologies and Drilling Technologies segments

25

resulting from incremental volumes and pricing, which was offset by a decline in our Reservoir Chemical Technologies segment as we exited certain product lines.

Gross profit. Gross profit decreased $15.3 million, or 7%. Although gross profit was positively impacted by the increase in volume and pricing noted above, this was more than offset by restructuring charges associated with the exit of certain product lines within our Reservoir Chemical Technologies segment and to a lesser extent the impact of inflation on our raw materials and logistic costs.

Selling, general and administrative expense. Selling, general and administrative expense increased $12.4 million, or 9%, sequentially primarily due to an increase in labor costs and employee incentives as activity levels have increased.

Other (income) expense, net. Other (income) expense, net decreased $38.4 million, primarily due to a $22.9 million charge in connection with reclassifying our CT Russia Business to held for sale recognized during the three months ended June 30, 2022 coupled with a $6.4 million gain during the three months ended September 30, 2022 as we remeasured the disposal group to fair value.

Provision for income taxes. Our provision for income taxes reflected effective tax rate (“ETR”) of 38.0% and (5.1)% for the three months ended September 30, 2022 and June 30, 2022, respectively. The increase to the ETR for the period ending September 30, 2022 was primarily driven by an increased annualized ETR due to forecast earnings shift between jurisdictions and a decrease in the discrete benefit recorded in the second quarter of 2022 on our CT Russia Business. The period ending June 30, 2022 was impacted by the release of a valuation allowance on our operations in Angola and favorable discrete items, including a charge incurred on our CT Russia Business upon classifying as held for sale and adjustments relating to prior period tax return filings.

	Nine Months Ended
	September 30,				Variance
(in thousands)	2022		2021		$
Revenue	$	2,820,093	$	2,252,845	$	567,248
Cost of goods and services	2,204,052		1,714,885		489,167
Gross profit	616,041		537,960		78,081
Selling, general and administrative expense	445,447		430,908		14,539
Interest expense, net	33,582		40,884		(7,302)
Other (income) expense, net	27,483		(36,561)		64,044
Income before income taxes	109,529		102,729		6,800
Provision for income taxes	19,235		32,255		(13,020)
Net income	90,294		70,474		19,820
Net income attributable to noncontrolling interest	3,182		624		2,558
Net income attributable to ChampionX	$	87,112	$	69,850	17,262

Revenue. Revenue increased $567.2 million, or 25%, for the nine months ended September 30, 2022 compared to prior year across all operating segments driven by higher volumes in North America and internationally as the global economy has generally rebounded from the COVID-19 pandemic and rig counts and customer activity has increased. This was further supplemented by the realization of price increases initiated to offset raw material and logistic costs inflation.

Gross profit. Gross profit increased $78.1 million, or 15%, for the nine months ended September 30, 2022 compared to prior year, mainly due to the incremental volumes and pricing noted above partially offset by incremental restructuring charges as we exit certain product lines in our Reservoir Chemical Technologies segment.

Selling, general and administrative expense. Selling, general and administrative expense increased $14.5 million, or 3%, for the nine months ended September 30, 2022 compared to prior year, primarily due to an increase in labor costs and employee incentives as activity levels have increased.

Interest expense, net. Interest expense, net decreased $7.3 million, or 18%, for the nine months ended September 30, 2022 compared to prior year primarily due to the redemption of our 6.375% Senior Notes due 2026 in June 2022.

26

Other (income) expense, net. Other (income) expense, net increased $64.0 million, primarily due to a charge of $22.9 million in connection with reclassifying our CT Russia Business to held for sale during the second quarter of 2022 coupled with a $6.4 million gain during the current period as we remeasured the disposal group to fair value.

Provision for (benefit from) income taxes. The ETR for the first nine months of 2022 and 2021 were 17.6% and 31.4%, respectively. The ETR for the first six months of 2022 was positively impacted by the release of the valuation allowance on our operations in Angola, a charge incurred on the CT Russia Business upon classifying to held for sale, and the recognition of adjustments in several foreign jurisdictions relating to income tax return filings that had a positive impact on the rate. The ETR for the first nine months of 2021 was negatively affected primarily due to the impact of withholding taxes.

SEGMENT RESULTS OF OPERATIONS

	Three Months Ended
	September 30,		June 30,		Variance
(in thousands)	2022		2022		$
Segment revenue:
Production Chemical Technologies	$	643,604	$	552,411	$	91,193
Production & Automation Technologies	247,717		242,399		5,318
Drilling Technologies	60,965		57,858		3,107
Reservoir Chemical Technologies	35,485		44,114		(8,629)
Corporate and other	33,790		35,790		(2,000)
Total revenue	$	1,021,561	$	932,572	$	88,989
Segment operating profit (loss):
Production Chemical Technologies	$	86,649	$	25,606	$	61,043
Production & Automation Technologies	22,485		23,650		(1,165)
Drilling Technologies	14,856		15,043		(187)
Reservoir Chemical Technologies	(61,711)		(8,147)		(53,564)
Total segment operating profit	62,279		56,152		6,127
Corporate expense and other	13,354		17,896		(4,542)
Interest expense, net	11,454		10,765		689
Income before income taxes	$	37,471	$	27,491	$	9,980

Production Chemical Technologies

Revenue. Production Chemical Technologies revenue increased $91.2 million, or 17%, sequentially, mainly due to increased global pricing, which was implemented to help offset the increase in costs for raw materials and other inflationary factors, and to a lesser extent higher volumes both in the U.S. and internationally.

Operating profit. Production Chemical Technologies operating profit increased $61.0 million in the third quarter of 2022 compared to the prior quarter primarily due to the incremental revenue noted above, which was partially offset by raw materials pressures. Additionally, the sequential results were impacted by the entries to adjust the carrying value of the CT Russia Business to its estimated fair value. During the three months ended June 30, 2022, we recognized a $22.9 million charge as we classified that business as held for sale during the period and during the three months ended September 30, 2022, we recognized a gain of $6.4 million to adjust the carrying value of the disposal group.

Production & Automation Technologies

Revenue. Production & Automation Technologies revenue increased $5.3 million, or 2%, as compared to the prior quarter, primarily due to price increases to mitigate raw material inflation.

Operating profit. Production & Automation Technologies operating profit decreased $1.2 million, or 5%, in the third quarter of 2022 compared to the prior quarter due to increased global pricing and higher sales volume noted above, partially offset by the impact of material cost inflation and supply chain disruptions. Also impacting this segment were $4.3 million of restructuring charges in the third quarter.

27

Drilling Technologies

Revenue. Drilling Technologies revenue increased $3.1 million, or 5%, in the third quarter of 2022 compared to the prior quarter primarily due to volume as the worldwide rig count increased.

Operating profit. Drilling Technologies operating profit decreased $0.2 million in the third quarter of 2022 compared to the prior quarter primarily due to product mix and costs associated with servicing customers.

Reservoir Chemical Technologies

Revenue. Reservoir Chemical Technologies revenue decreased $8.6 million, or 20%, in the third quarter of 2022 compared to the prior quarter primarily due to the exit of our friction reducer product line.

Operating profit. Reservoir Chemical Technologies operating profit decreased $53.6 million in the third quarter of 2022 compared to the prior quarter. Operating profit was impacted by $63.5 million in restructuring charges incurred during the third quarter of 2022 as we exited certain product lines to improve the overall profitability of this business.

	Nine Months Ended September 30,				Variance
(in thousands)	2022		2021		$
Segment revenue:
Production Chemical Technologies	$	1,710,987	$	1,347,090	$	363,897
Production & Automation Technologies	710,465		559,491		150,974
Drilling Technologies	175,682		121,998		53,684
Reservoir Chemical Technologies	119,499		101,305		18,194
Corporate	103,460		122,961		(19,501)
Total revenue	$	2,820,093	$	2,252,845	$	567,248
Segment operating profit (loss):
Production Chemical Technologies	$	143,518	$	109,924	$	33,594
Production & Automation Technologies	70,845		32,061		38,784
Drilling Technologies	45,119		21,400		23,719
Reservoir Chemical Technologies	(73,327)		31,979		(105,306)
Total segment operating profit	186,155		195,364		(9,209)
Corporate expense and other	43,044		51,751		(8,707)
Interest expense, net	33,582		40,884		(7,302)
Income before income taxes	$	109,529	$	102,729	$	6,800

Production Chemical Technologies

Revenue. Production Chemical Technologies revenue increased $363.9 million, or 27%, as compared to the prior year, mainly due to higher volumes in our international operations, market share expansion and price increases to offset inflation. Additionally, increased global pricing was implemented to help partially offset the increase in costs for raw materials and other inflationary factors.

Operating profit. Operating profit increased $33.6 million compared to the prior year. Although this segment benefited from the higher revenue noted above, the increase was partially offset by a charge of $16.5 million related to the CT Russia Business, and $11.6 million in restructuring charges and the impact of raw materials inflation.

Production & Automation Technologies

Revenue. Revenue increased $151.0 million, or 27%, as compared to the prior year, primarily due to an increase in customer spending as a result of improving market conditions. The increase in customer spending led to higher volumes across our

28

product offerings in North America. The segment also benefited from the implementation of price increases to offset inflationary pressures in raw material and logistic costs.

Operating profit. Operating profit increased $38.8 million compared to the prior year primarily due to higher sales volumes and price as noted above. However, our results were negatively impacted by further material cost inflation and supply chain disruptions.

Drilling Technologies

Revenue. Revenue increased $53.7 million, or 44%, compared to the prior year primarily due to an increase in U.S. land-based rig count and associated increase in customer spending on drilling activities, which positively impacted sales volumes of our diamond cutters and diamond bearings products.

Operating profit. Operating profit increased $23.7 million compared to the prior year as a result of increased revenue.

Reservoir Chemical Technologies

Revenue. Revenue increased $18.2 million, or 18%, compared to the prior year primarily due to an increase in U.S. rig count and the realization of price increases initiated to offset material cost inflation, which more than offset the decline internationally and the impact of the exit of our friction reducer product line.

Operating profit. Operating profit decreased $105.3 million compared to the prior year, mainly driven by approximately $69.6 million in restructuring charges incurred during 2022 due to the exit of certain product lines to improve the overall profitability of this business and a $39.9 million gain recognized in 2021 on the sale of our chemical manufacturing plant in Corsicana.

CAPITAL RESOURCES AND LIQUIDITY

Overview

Our primary source of cash is from operating activities. We have historically generated, and expect to continue to generate, positive cash flow from operations. Cash generated from operations is generally allocated to working capital requirements, investments to support profitable revenue growth and maintain our facilities and systems, acquisitions that create value through add-on capabilities that broaden our existing businesses and deliver our growth strategy, as well as share repurchases, dividend payments to stockholders, and debt repayments to reduce our leverage.

At September 30, 2022, we had cash and cash equivalents of $187.5 million compared to $251.7 million at December 31, 2021, primarily for working capital and operational purposes. At September 30, 2022, we had total liquidity of $810.6 million, comprised of $187.5 million of cash and $623.1 million of available capacity on the 2022 Revolving Credit Facility, which expires in June 2027.

At September 30, 2022, we had a long-term debt balance of $644.0 million, net of the current portion of long-term debt of $4.7 million, primarily consisting of the 2022 Term Loan Facility with a principal amount of $625.0 million and an outstanding balance on the 2022 Revolving Credit Facility of $45.0 million.

Outlook

We expect to generate cash from operations to support business requirements and, if necessary, through the use of the 2022 Revolving Credit Facility. Volatility in credit, equity and commodity markets can create uncertainty for our businesses. However, the Company believes, based on our current financial condition and current expectations of future market conditions, that we will meet our short- and long-term needs with a combination of cash on hand, cash generated from operations, the 2022 Revolving Credit Facility and access to capital markets.

On February 4, 2022, our Board of Directors (“Board”) approved a plan to initiate a regular quarterly cash dividend of $0.075 per share of the Company’s common stock. Our third quarter cash dividend of $0.075 per share was declared on August 11, 2022, and will be paid on October 28, 2022. Subsequent dividend declarations, if any, including the amounts and timing of future dividends, are subject to approval by the Board and will depend on future business conditions, financial conditions, results of operations and other factors.

29

On March 7, 2022, the Company announced that our Board approved a new $250 million share repurchase program (“2022 Share Repurchase Program”). On October 24, 2022, our Board increased the authorization under this program to $750 million. Under the 2022 Share Repurchase Program, shares of the Company’s common stock may be repurchased periodically, including in the open market or privately negotiated transactions. We expect to fund share repurchases from cash generated from operations. As of September 30, 2022, we have repurchased 4,487,622 shares of common stock at a volume-weighted average price of $22.28 per share for a total of $100.1 million. The actual timing, manner, number, and value of shares repurchased under the program will depend on a number of factors, including the availability of excess free cash, the market price of the Company’s common stock, general market and economic conditions, applicable requirements, and other business considerations.

In 2022, we expect to fund our capital expenditures and reduce outstanding debt through earnings and working capital improvements. We project capital expenditures of 3.0% to 3.5% of revenue inclusive of capital investments for our electric submersible pump leased assets.

Information related to guarantees is incorporated herein by reference from Note 6—Commitments and Contingencies to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.

Cash Flows

	Nine Months Ended September 30,
(in thousands)	2022		2021
Cash provided by operating activities	$	218,267	$	239,800
Cash used in investing activities	(61,526)		(8,160)
Cash used in financing activities	(215,201)		(173,715)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	(5,746)		(1,991)
Net increase (decrease) in cash and cash equivalents and restricted cash	$	(64,206)	$	55,934

Operating Activities

Cash provided by operating activities during the nine months ended September 30, 2022 decreased $21.5 million compared to 2021. The decrease in cash provided by operating activities was primarily driven by the use of cash for working capital items. Changes in working capital items used cash of $68.4 million during the nine months ended September 30, 2022 compared to cash generated of $0.9 million during 2021. The change in working capital items primarily related to cash outflows for inventory procurement and an increase in accounts receivable as a result of revenue growth during the period.

Expenditures for assets that are placed into our leased asset program expected to be recovered through sale are reported in leased assets in the operating section of our condensed consolidated statements of cash flows. All other capitalizable expenditures for assets that are placed into our leased asset program are classified as capital expenditures in the investing section of our condensed consolidated statements of cash flows.

Investing Activities

Cash used in investing activities was $61.5 million for the nine months ended September 30, 2022, and was primarily comprised of capital expenditures of $74.8 million and acquisitions, net of cash acquired, of $3.2 million, partially offset by $16.4 million of cash proceeds from the sale of fixed assets primarily due to the sale of facilities within our Production & Automation Technologies segment.

Cash used in investing activities was $8.2 million for the nine months ended September 30, 2021, and was primarily comprised of capital expenditures of $67.0 million, acquisitions, net of cash acquired, of $10.0 million, and purchase of investments of $4.9 million. This was partially offset by $68.8 million of cash proceeds from the sale of our manufacturing plant in Corsicana and $4.9 million of cash proceeds from the sale of fixed assets.

Financing Activities

Cash used in financing activities of $215.2 million for the nine months ended September 30, 2022 was primarily the result of net repayments totaling $76.3 million on long-term debt as part of our refinancing, repurchases of our common stock of $100.1 million, dividends paid of $30.5 million, payment of debt issuance cost of $8.0 million, payments of finance lease obligations of $4.5 million, payments related to taxes withheld on stock-based compensation of $3.6 million, and distributions to non-

30

controlling interests of $3.0 million. This was partially offset by $3.7 million in cash proceeds from the exercise of stock options.

Cash used in financing activities of $173.7 million for the nine months ended September 30, 2021 was primarily the result of repayments totaling $174.4 million on long-term debt, payments related to taxes withheld on stock-based compensation of $3.4 million, a distribution of $2.5 million to one of our non-controlling interests, and payments totaling $0.3 million for finance lease obligations. This was partially offset by $6.9 million in cash proceeds from the exercise of stock options.

Revolving Credit Facility

A summary of the 2022 Revolving Credit Facility at September 30, 2022 was as follows:

(in millions) Description	Amount		Debt Outstanding		Letters of Credit		Unused Capacity		Maturity
Five-year revolving credit facility	$	700.0	$	45.0	$	31.9	$	623.1	June 2027

Additionally, we have letters of credit outside of the 2022 Revolving Credit Facility totaling approximately $1.4 million. As of September 30, 2022, we were in compliance with all restrictive covenants under the 2022 Revolving Credit Facility.

Accounts Receivable Facility

On June 28, 2022, we entered into an uncommitted accounts receivable purchase agreement (the “Accounts Receivable Facility”) with JPMorgan Chase Bank, N.A. as the purchaser. Transfers under the Accounts Receivable Facility are accounted for as sales of receivables.

The amount available for sale under the Accounts Receivable Facility fluctuates over time based on the total amount of eligible receivables generated during the normal course of business. A maximum of $160.0 million in receivables may be sold and remain unpaid under the Accounts Receivable Facility at any time. Accounts receivable sold were $101.2 million for the three and nine months ended September 30, 2022.

RECENTLY ISSUED ACCOUNTING STANDARDS

See Note 1—Basis of Presentation and Summary of Significant Accounting Policies to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We may be exposed to certain market risks arising from the use of financial instruments in the ordinary course of business. For quantitative and qualitative disclosures about market risk, see Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk,” in our Annual Report on Form 10-K for the year ended December 31, 2021. On June 29, 2022, the Company executed a five-year floating-to-fixed interest rate swap to hedge our exposure to increases in variable interest rates on the 2022 Term Loan Facility. See Note 5—Debt and Note 13—Derivatives and Hedging Transactions to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q for additional information. Our exposure to market risk has not materially changed since December 31, 2021.

ITEM 4. CONTROLS AND PROCEDURES

Our management, with the participation of our principal executive officer and principal financial officer, carried out an evaluation, pursuant to Rule 13a-15(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of September 30, 2022.

There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

31

PART II — OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We are involved in various pending or potential legal actions in the ordinary course of our business. Management is unable to predict the ultimate outcome of these actions because of the inherent uncertainty of litigation. However, management believes the most probable, ultimate resolution of these matters will not have a material adverse effect on our condensed consolidated financial position, results of operations or cash flows. See Note 6—Commitments and Contingencies to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.

ITEM 1A. RISK FACTORS

Other than the risk factors set forth below, there have not been material changes from the risk factors previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2021.

We could lose customers or generate lower revenue, operating profits and cash flows if there are significant increases in the cost of raw materials or if we are unable to obtain raw materials.

We purchase raw materials, sub-assemblies and components for use in manufacturing operations, which exposes us to volatility in prices for certain commodities. Significant price increases for these commodities could adversely affect our operating profits. Like others in our industry, in 2021 we faced, and continue to face, unprecedented inflation in raw materials cost. In addition to general inflationary pressures relating to the global economy reopening, adverse weather, such as the severe winter storm in Texas in the early months of 2021, may also result in raw materials supply chain disruptions, that can lead to short-term raw materials cost inflation. International conflicts or other geopolitical events, such as the continuing conflict between Russia and Ukraine, may also cause upward pressure on raw materials costs due to transportation disruptions, higher manufacturing costs, disruptions in supply chains and availability of raw materials, interruptions in manufacturing operation, and heightened inflation. While we will generally attempt to mitigate the impact of increased raw material prices by endeavoring to make strategic purchasing decisions, broadening our supplier base and passing along increased costs to customers, there may be a time delay between the increased raw material prices and the ability to increase the prices of our products. Additionally, we may be unable to increase the prices of products due to the terms of existing contracts, a competitor’s pricing pressure or other factors. The inability to obtain necessary raw materials on acceptable terms could affect our ability to meet customer commitments and satisfy demand for certain products. Certain of our product lines depend on a limited number of third-party suppliers and vendors. The ability of these third parties to deliver raw materials may be affected by events beyond our control. Public health threats, such as COVID-19, severe influenza and other highly communicable viruses or diseases, in addition to international conflicts or other geopolitical events could limit access to vendors and their facilities, or the ability to transport raw materials from our vendors, which would adversely affect our ability to obtain necessary raw materials for certain of our products or increase the costs of such materials. A significant price increase in or the unavailability of raw materials may result in a loss of customers and adversely impact our business, results of operations, financial condition and cash flows, and could result in asset impairments, including an impairment of the carrying value of our goodwill.

We are subject to information technology, cybersecurity and privacy risks.

We depend on various information technologies and other products and services to store and process business information and otherwise support our business activities. We also manufacture and sell hardware and software to provide monitoring, controls and optimization of customer critical assets in oil and gas production and distribution. In addition, certain of our customer offerings include digital components, such as remote monitoring of certain customer operations. We also provide services to maintain these systems. Additionally, our operations rely upon partners, suppliers and other third-party providers of information technology and other products and services. If any of these information technologies, products or services are damaged, cease to properly function, are breached due to employee error, malfeasance, system errors, or other vulnerabilities, or are subject to cybersecurity attacks, such as those involving unauthorized access, malicious software and/or other intrusions, we and our partners, suppliers or other third parties could experience: (i) production downtimes, (ii) operational delays, (iii) the compromising of confidential, proprietary or otherwise protected information, including personal and customer data, (iv) destruction, corruption, or theft of data, (v) security breaches, (vi) other manipulation, disruption, misappropriation or improper use of our systems or networks, (vii) hydrocarbon pollution from loss of containment, (viii) financial losses from remedial actions, (ix) loss of business or potential liability, (x) adverse media coverage, and (xi) legal claims or legal proceedings, including regulatory investigations and actions, and/or damage to our reputation. Increased risks of such attacks and disruptions also exist because of the continuing conflict between Russia and Ukraine. While we have not experienced a material breach of our information technologies and we attempt to mitigate these risks by employing a number of measures, including employee training, technical security controls and maintenance of backup and protective systems, the Company’s and our customers’, partners’, vendors’ and other third- parties’ systems, networks, products and services remain potentially vulnerable to known or unknown cybersecurity attacks and other threats, any of which could have a material adverse effect on our business, results of operations, financial condition and cash flows.

32

While we currently maintain cybersecurity insurance, such insurance may not be sufficient in type or amount to cover us against claims related to cybersecurity breaches or attacks, failures or other data security-related incidents, and we cannot be certain that cyber insurance will continue to be available to us on economically reasonable terms, or at all, or that an insurer will not deny coverage as to any future claim. The successful assertion of one or more large claims against us that exceed available insurance coverage, or the occurrence of changes in our insurance policies, including premium increases or the imposition of large deductible or co-insurance requirements, could materially and adversely affect our results of operations, cash flows, and financial condition.

Our operations could be adversely affected by global market and economic conditions in ways we may not be able to predict or control.

Concerns over global economic conditions, inflation, energy costs, geopolitical issues, supply chain disruptions, the availability and cost of credit, the worldwide COVID-19 pandemic, and the continuing conflict between Russia and Ukraine have contributed to increased economic uncertainty. An expansion or escalation of the Russian-Ukraine conflict or an economic slowdown or recession in the United States or in any other country that significantly affects the supply of or demand for oil or natural gas could negatively impact our operations and therefore adversely affect our results. Global economic conditions have a significant impact on oil and natural gas prices and any stagnation or deterioration in global economic conditions could result in less demand for our services and could cause our customers to reduce their planned spending on drilling and production activity. Adverse global economic conditions may cause our customers, vendors and/or suppliers to lose access to the financing necessary to sustain or increase their current level of operations, fulfill their commitments and/or fund future operations and obligations. Furthermore, challenging economic conditions may result in certain of our customers experiencing bankruptcy or otherwise becoming unable to pay vendors, including us. In the past, global economic conditions, and expectations for future global economic conditions, have sometimes experienced significant deterioration in a relatively short period of time and there can be no assurance that global economic conditions or expectations for future global economic conditions will recover in the near term or not quickly deteriorate again due to one or more factors. These conditions could have a material adverse effect on our business, financial condition and results of operations.

Our reputation, ability to do business and results of operations may be impaired by violations of U.S. and international laws and regulations regarding anti-bribery, trade control, trade sanctions, anti-corruption and similar laws.

Our operations require us to comply with a number of U.S. and international laws and regulations, including those relating to anti-corruption, anti-bribery, fair competition, export and import compliance, money laundering and data privacy. Our international operations are subject to the regulations imposed by the Foreign Corrupt Practices Act and the United Kingdom Bribery Act 2010 as well as anti-bribery and anti-corruption laws of various jurisdictions in which we operate. In response to the conflict between Russia and Ukraine beginning in February 2022, the U.S. and foreign governmental bodies in jurisdictions in which we operate have announced targeted sanctions and export control measures and have threatened additional sanctions and export control measures, which may result in counter-sanctions and other retaliatory measures and actions by Russia against U.S.-based companies and their employees (together “Russian Conflict Sanctions”). While we strive to maintain high ethical standards and robust internal controls, we cannot provide assurance that our internal controls and compliance systems will always protect us from acts committed by our employees, agents or business partners that would violate such U.S. or international laws or regulations. Any such violations of law or improper actions could subject us to civil or criminal investigations in the United States or other jurisdictions, could lead to substantial civil or criminal, monetary and non-monetary penalties and related shareholder lawsuits, could lead to increased costs of compliance and could damage our reputation, business, results of operations, financial condition and cash flows.

Tariffs, sanctions and other trade measures could adversely affect our results of operations, financial position and cash flows.

In 2020, the U.S. government continued to impose tariffs on steel and aluminum and a broad range of other products imported into the United States. In response to the tariffs imposed by the U.S. government, a number of jurisdictions, including the European Union, Canada, Mexico, India and China, announced tariffs on U.S. goods and services. These tariffs have increased our material input costs, and any further trade restrictions, retaliatory trade measures and additional tariffs could result in higher input costs for our products. The Russian Conflict Sanctions have and could in the future result in, among other things, severe or complete restrictions on exports to and other commerce and business dealings involving Russia, certain regions of Ukraine, and/or particular entities and individuals. The potential impact of such sanction programs and export control measures on our business is uncertain at the current time due to the fluid nature of the military conflict as it is unfolding. The potential impacts include supply chain and logistics disruptions, financial impacts including volatility in foreign exchange rates and interest rates, inflationary pressures on raw materials and energy, heightened cybersecurity threats and other restrictions. We may not be able to fully mitigate the impact of these increased costs or pass price increases on to our customers. While tariffs and other

33

retaliatory trade measures imposed by other countries on U.S. goods have not yet had a significant impact on our business or results of operations, we cannot predict further developments, and such existing or future tariffs could have a material adverse effect on our results of operations, financial position and cash flows.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following table contains information about our purchases of our common stock during the three months ended September 30, 2022.

Period	Total Number of Shares Purchased	Average Price Paid Per Share (1)		Total Number of Shares Purchased as Part of a Publicly Announced Program (2)	Maximum Dollar Value of Shares that May Yet Be Purchased Under the Program (2)
July 1-31, 2022	145,740	$	20.58	145,740	$	226,981,300
August 1-31, 2022	2,388,541	$	21.76	2,388,541	$	174,952,560
September 1-30, 2022	1,163,825	$	21.50	1,163,825	$	149,910,262
Total	3,698,106	$	21.63	3,698,106

_______________________

(1)Excluding fees, commissions, and expenses associated with the share repurchases.

(2)On March 7, 2022, the Company announced that our Board authorized the Company to repurchase up to $250 million of its common stock. On October 24, 2022, our Board increased the authorization under this program to $750 million. This program has no time limit and does not obligate the Company to acquire any particular amount of shares of its common stock.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

Iran Threat Reduction and Syria Human Rights Act of 2012

Under the Iran Threat Reduction and Syria Human Rights Act of 2012, which added Section 13(r) of the Exchange Act, the Company is required to disclose in its periodic reports if it or any of its affiliates knowingly engaged in certain activities, transactions or dealings relating to Iran or with entities or individuals designated pursuant to certain Executive Orders. Disclosure is required even where the activities are conducted outside the U.S. by non-U.S. affiliates in compliance with applicable law, and even if the activities are not covered or prohibited by U.S. law.

As authorized by the U.S. Treasury’s Office of Foreign Assets Control (“OFAC”), a non-U.S. subsidiary of the Company which is part of our Chemical Technologies business completed sales of products used for process and water treatment applications in upstream oil and gas production related to the operation of and production from the Rhum gas field off the Scottish coast (“Rhum”) totaling $160,330 during the period from July 1, 2022 to September 30, 2022 and $640,551 during the period from January 1, 2022 to September 30, 2022. The net profit before taxes associated with these sales for each period were nominal. Rhum is jointly owned by Serica Energy plc and Iranian Oil Company (U.K.) Limited. Our non-U.S. subsidiary intends to continue the Rhum-related activities, consistent with a specific license obtained from OFAC by its customers, and such activities may require additional disclosure pursuant to the above mentioned statute.

34

ITEM 6. EXHIBITS

		Incorporated by Reference
Exhibit No.	Exhibit Description	Form	Exhibit No.	Filing Date
3.1	Amended and Restated Certificate of Incorporation of the Company.	8-K	3.1	May 11, 2018
3.2	Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company.	8-K	3.1	June 4, 2020
3.3	Amended and Restated By-Laws of the Company.	8-K	3.2	June 4, 2020
31.1*	Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.
31.2*	Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.
32.1**	Certification of Chief Executive Officer Under Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. 1350.
32.2**	Certification of Chief Financial Officer Under Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. 1350.
101.INS*	XBRL Instance Document
101.SCH*	XBRL Taxonomy Extension Schema Document
101.CAL*	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*	XBRL Taxonomy Extension Label Linkbase Document
101.PRE*	XBRL Taxonomy Extension Presentation Linkbase Document
104*	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
* Filed herewith
** Furnished herewith

35

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

CHAMPIONX CORPORATION
(Registrant)
/s/ ANTOINE MARCOS
Antoine Marcos
Vice President, Corporate Controller and Chief Accounting Officer
(Principal Accounting Officer and a Duly Authorized Officer)
Date:	October 26, 2022

36

EX-31.1

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A)

OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, Sivasankaran Somasundaram, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of ChampionX Corporation (the “registrant”);

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	October 26, 2022	/s/ SIVASANKARAN SOMASUNDARAM
		Sivasankaran Somasundaram
		President and Chief Executive Officer
		(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A)

OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, Kenneth M. Fisher, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of ChampionX Corporation (the “registrant”);

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	October 26, 2022	/s/ KENNETH M. FISHER
		Kenneth M. Fisher
		Executive Vice President and Chief Financial Officer
		(Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

UNDER SECTION 906 OF THE SARBANES-OXLEY

ACT OF 2002, 18 U.S.C. SECTION 1350

I, Sivasankaran Somasundaram, President and Chief Executive Officer of ChampionX Corporation (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(a) The Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2022, as filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(b) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	October 26, 2022	/s/ SIVASANKARAN SOMASUNDARAM
		Sivasankaran Somasundaram
		President and Chief Executive Officer
		(Principal Executive Officer)

EX-32.2

Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

UNDER SECTION 906 OF THE SARBANES-OXLEY

ACT OF 2002, 18 U.S.C. SECTION 1350

I, Kenneth M. Fisher, Executive Vice President and Chief Financial Officer of ChampionX Corporation (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(a) The Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2022, as filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(b) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	October 26, 2022	/s/ KENNETH M. FISHER
		Kenneth M. Fisher
		Executive Vice President and Chief Financial Officer
		(Principal Financial Officer)

XML

Cover Page - shares	9 Months Ended
	Sep. 30, 2022	Oct. 20, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-38441
Entity Registrant Name	ChampionX Corp
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	82-3066826
Entity Address, Address Line One	2445 Technology Forest Blvd,
Entity Address, Address Line Two	Building 4, 12th Floor
Entity Address, City or Town	The Woodlands,
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	77381
City Area Code	(281)
Local Phone Number	403-5772
Security 12b Title	Common stock, $0.01 par value
Trading Symbol	CHX
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		199,359,754
Entity Central Index Key	0001723089
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false

XML

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenue:
Lease and other revenue	$ 22,807	$ 18,337	$ 64,881	$ 55,792
Total revenue	1,021,561	818,785	2,820,093	2,252,845
Cost of goods and services	825,018	623,162	2,204,052	1,714,885
Gross profit	196,543	195,623	616,041	537,960
Costs and expenses:
Selling, general and administrative expense	153,736	135,089	445,447	430,908
Interest expense, net	11,454	12,849	33,582	40,884
Other expense (income), net	(6,118)	(36,876)	27,483	(36,561)
Income before income taxes	37,471	84,561	109,529	102,729
Provision for income taxes	14,246	25,910	19,235	32,255
Net income	23,225	58,651	90,294	70,474
Net income attributable to noncontrolling interest	157	1,823	3,182	624
Net income attributable to ChampionX	$ 23,068	$ 56,828	$ 87,112	$ 69,850
Earnings per share attributable to ChampionX:
Basic (in dollars per share)	$ 0.11	$ 0.28	$ 0.43	$ 0.35
Diluted (in dollars per share)	$ 0.11	$ 0.27	$ 0.42	$ 0.34
Weighted-average shares outstanding:
Weighted-average shares outstanding, basic (in shares)	201,421	201,852	202,600	201,329
Weighted-average shares outstanding, diluted (in shares)	206,522	208,545	208,155	208,173
Product revenue
Revenue:
Revenue	$ 897,156	$ 711,099	$ 2,455,377	$ 1,945,855
Service revenue
Revenue:
Revenue	$ 101,598	$ 89,349	$ 299,835	$ 251,198

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 23,225	$ 58,651	$ 90,294	$ 70,474
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	(47,067)	(11,737)	(27,463)	(192)
Cash flow hedges	16,310	3,218	11,608	3,354
Defined pension and other post-retirement benefits adjustments, net	68	46	207	6,586
Other comprehensive income	(30,689)	(8,473)	(15,648)	9,748
Comprehensive income	(7,464)	50,178	74,646	80,222
Less: Comprehensive income (loss) attributable to noncontrolling interest	157	1,823	3,182	624
Comprehensive income attributable to ChampionX	$ (7,621)	$ 48,355	$ 71,464	$ 79,598

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands, shares in Millions	Sep. 30, 2022	Dec. 31, 2021
Current Assets:
Cash and cash equivalents	$ 187,472	$ 251,678
Restricted cash	3,500	3,500
Receivables, net	611,501	584,440
Inventories, net	570,820	542,910
Assets held for sale	33,617	7,217
Prepaid expenses and other current assets	69,920	71,155
Total current assets	1,476,830	1,460,900
Property, plant and equipment, net of accumulated depreciation of $659,094 in 2022 and $618,867 in 2021	722,868	776,813
Goodwill	708,460	702,867
Intangible assets, net	326,156	401,470
Operating lease right-of-use assets	88,736	115,458
Other non-current assets	79,730	77,193
Total assets	3,402,780	3,534,701
Current Liabilities:
Current portion of long-term debt	4,688	26,850
Accounts payable	499,371	473,561
Accrued compensation and employee benefits	73,607	93,131
Current portion of operating lease liabilities	28,688	36,389
Accrued distributor fees	59,611	25,621
Liabilities held for sale	9,635	0
Accrued expenses and other current liabilities	121,075	146,773
Total current liabilities	796,675	802,325
Long-term debt	644,029	697,657
Deferred income taxes	100,972	137,971
Operating lease liabilities	55,652	73,521
Other long-term liabilities	110,732	68,920
Total liabilities	1,708,060	1,780,394
Stockholders’ equity:
Common stock (2.5 billion shares authorized, $0.01 par value) 199.3 million shares and 202.9 million shares issued and outstanding in 2022 and 2021, respectively	1,993	2,029
Capital in excess of par value of common stock	2,276,094	2,315,399
Accumulated deficit	(530,128)	(525,158)
Accumulated other comprehensive loss	(37,273)	(21,625)
ChampionX stockholders’ equity	1,710,686	1,770,645
Noncontrolling interest	(15,966)	(16,338)
Total equity	1,694,720	1,754,307
Total liabilities and equity	$ 3,402,780	$ 3,534,701
Common stock, shares issued (in shares)	199.3	202.9
Common stock, shares outstanding (in shares)	199.3	202.9

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Accumulated depreciation on property, plant, and equipment	$ 659,094	$ 618,867
Common stock, shares authorized (in shares)	2,500,000,000	2,500,000,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares issued (in shares)	199,300,000	202,900,000
Common stock, shares outstanding (in shares)	199,300,000	202,900,000

XML

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock, Par Value	Common Stock, Capital in Excess of Par Value	Accum. Deficit	Accum. Other Comp. Loss	Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2020		200,380,000
Beginning balance at Dec. 31, 2020	$ 1,612,575	$ 2,004	$ 2,293,179	$ (638,457)	$ (30,755)	$ (13,396)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	4,037			5,772		(1,735)
Other comprehensive income (loss)	3,793				3,793
Stock-based compensation (in shares)		64,000
Stock-based compensation	6,442		6,442
Stock options exercised (in shares)		577,000
Stock options exercised	3,347	$ 6	3,341
Taxes withheld on issuance of stock-based awards	(556)		(556)
Cumulative translation adjustments	268					268
Distributions to noncontrolling interest	(800)					(800)
Ending balance (in shares) at Mar. 31, 2021		201,021,000
Ending balance at Mar. 31, 2021	1,629,106	$ 2,010	2,302,406	(632,685)	(26,962)	(15,663)
Beginning balance (in shares) at Dec. 31, 2020		200,380,000
Beginning balance at Dec. 31, 2020	1,612,575	$ 2,004	2,293,179	(638,457)	(30,755)	(13,396)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	70,474
Other comprehensive income (loss)	9,748
Ending balance (in shares) at Sep. 30, 2021		201,907,000
Ending balance at Sep. 30, 2021	1,711,752	$ 2,019	2,314,592	(568,607)	(21,007)	(15,245)
Beginning balance (in shares) at Mar. 31, 2021		201,021,000
Beginning balance at Mar. 31, 2021	1,629,106	$ 2,010	2,302,406	(632,685)	(26,962)	(15,663)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	7,786			7,250		536
Other comprehensive income (loss)	14,428				14,428
Stock-based compensation (in shares)		101,000
Stock-based compensation	5,914		5,914
Stock options exercised (in shares)		578,000
Stock options exercised	3,162	$ 7	3,155
Taxes withheld on issuance of stock-based awards	(1,208)		(1,208)
Cumulative translation adjustments	(231)					(231)
Ending balance (in shares) at Jun. 30, 2021		201,700,000
Ending balance at Jun. 30, 2021	1,658,957	$ 2,017	2,310,267	(625,435)	(12,534)	(15,358)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	58,651			56,828		1,823
Other comprehensive income (loss)	(8,473)				(8,473)
Stock-based compensation (in shares)		133,000
Stock-based compensation	5,557		5,557
Stock options exercised (in shares)		74,000
Stock options exercised	431	$ 2	429
Taxes withheld on issuance of stock-based awards	(1,661)		(1,661)
Distributions to noncontrolling interest	(1,710)					(1,710)
Ending balance (in shares) at Sep. 30, 2021		201,907,000
Ending balance at Sep. 30, 2021	$ 1,711,752	$ 2,019	2,314,592	(568,607)	(21,007)	(15,245)
Beginning balance (in shares) at Dec. 31, 2021	202,900,000	202,866,000
Beginning balance at Dec. 31, 2021	$ 1,754,307	$ 2,029	2,315,399	(525,158)	(21,625)	(16,338)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	38,173			36,702		1,471
Other comprehensive income (loss)	(2,795)				(2,795)
Stock-based compensation (in shares)		290,000
Stock-based compensation	4,728	$ 3	4,725
Stock options exercised (in shares)		189,000
Stock options exercised	1,055	$ 1	1,054
Taxes withheld on issuance of stock-based awards	(2,639)		(2,639)
Dividends declared to common stockholders ($0.075 per share)	(15,465)			(15,465)
Cumulative translation adjustments	208					208
Ending balance (in shares) at Mar. 31, 2022		203,345,000
Ending balance at Mar. 31, 2022	$ 1,777,572	$ 2,033	2,318,539	(503,921)	(24,420)	(14,659)
Beginning balance (in shares) at Dec. 31, 2021	202,900,000	202,866,000
Beginning balance at Dec. 31, 2021	$ 1,754,307	$ 2,029	2,315,399	(525,158)	(21,625)	(16,338)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	90,294
Other comprehensive income (loss)	$ (15,648)
Repurchase and cancellation of common stock (in shares)	(4,487,622)
Repurchase and cancellation of common stock	$ (100,100)
Ending balance (in shares) at Sep. 30, 2022	199,300,000	199,340,000
Ending balance at Sep. 30, 2022	$ 1,694,720	$ 1,993	2,276,094	(530,128)	(37,273)	(15,966)
Beginning balance (in shares) at Mar. 31, 2022		203,345,000
Beginning balance at Mar. 31, 2022	1,777,572	$ 2,033	2,318,539	(503,921)	(24,420)	(14,659)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	28,896			27,342		1,554
Other comprehensive income (loss)	17,836				17,836
Stock-based compensation (in shares)		64,000
Stock-based compensation	5,071	$ 1	5,070
Stock options exercised (in shares)		312,000
Stock options exercised	2,090	$ 3	2,087
Taxes withheld on issuance of stock-based awards	(739)		(739)
Dividends declared to common stockholders ($0.075 per share)	(15,494)			(15,494)
Repurchase and cancellation of common stock (in shares)		(790,000)
Repurchase and cancellation of common stock	(20,016)	$ (8)	(8,992)	(11,016)
Cumulative translation adjustments	8					8
Distributions to noncontrolling interest	(2,369)					(2,369)
Ending balance (in shares) at Jun. 30, 2022		202,931,000
Ending balance at Jun. 30, 2022	1,792,855	$ 2,029	2,315,965	(503,089)	(6,584)	(15,466)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	23,225			23,068		157
Other comprehensive income (loss)	(30,689)				(30,689)
Stock-based compensation (in shares)		20,000
Stock-based compensation	5,009		5,009
Stock options exercised (in shares)		87,000
Stock options exercised	564	$ 1	563
Taxes withheld on issuance of stock-based awards	(198)		(198)
Dividends declared to common stockholders ($0.075 per share)	$ (15,315)			(15,315)
Repurchase and cancellation of common stock (in shares)	(3,698,106)	(3,698,000)
Repurchase and cancellation of common stock	$ (80,074)	$ (37)	(45,245)	(34,792)
Cumulative translation adjustments	(10)					(10)
Distributions to noncontrolling interest	$ (647)					(647)
Ending balance (in shares) at Sep. 30, 2022	199,300,000	199,340,000
Ending balance at Sep. 30, 2022	$ 1,694,720	$ 1,993	$ 2,276,094	$ (530,128)	$ (37,273)	$ (15,966)

XML

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) (Parenthetical) - $ / shares		3 Months Ended
	Aug. 11, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022
Statement of Stockholders' Equity [Abstract]
Dividends declared to common shareholders (in dollars per share)	$ 0.075	$ 0.075	$ 0.075	$ 0.075

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net income	$ 90,294	$ 70,474
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization	177,761	178,805
Loss (gain) on disposal group	16,515	(39,876)
Stock-based compensation	14,808	17,913
Provision for inventory obsolescence and write-downs	21,214	5,259
Loss on debt repurchases	4,043	8,707
Deferred income taxes	(37,505)	(10,844)
(Gain) loss on disposal of fixed assets	(4,428)	4,483
Amortization of deferred loan costs and accretion of discount	2,736	2,689
Employee benefit plan expense	1,848	1,853
Other	(587)	(542)
Changes in operating assets and liabilities (net of effects of foreign exchange):
Receivables	(50,075)	(35,435)
Inventories	(72,298)	(74,641)
Prepaid expenses and other current assets	13,737	2,280
Accounts payable	38,600	130,607
Accrued compensation and employee benefits	(20,601)	18,711
Accrued expenses and other liabilities	32,867	(37,361)
Leased assets	(20,947)	(4,496)
Other	10,285	1,214
Net cash flows provided by operating activities	218,267	239,800
Cash flows from investing activities:
Capital expenditures	(74,752)	(67,027)
Proceeds from sale of fixed assets	16,424	4,891
Proceeds from disposal of business	0	68,807
Acquisitions, net of cash acquired	(3,198)	(9,957)
Other	0	(4,874)
Net cash used for investing activities	(61,526)	(8,160)
Cash flows from financing activities:
Proceeds from long-term debt	995,038	0
Repayment of long-term debt	(1,071,386)	(174,392)
Payment of debt issue costs	(8,008)	0
Repurchases of common stock	(100,090)	0
Dividends paid	(30,480)	0
Proceeds from exercise of stock options	3,709	6,940
Payments related to taxes withheld on stock-based compensation	(3,576)	(3,425)
Distributions to noncontrolling interest	(3,016)	(2,510)
Payment of finance lease obligations	(4,503)	(328)
Other	7,111	0
Net cash used for financing activities	(215,201)	(173,715)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	(5,746)	(1,991)
Net increase (decrease) in cash and cash equivalents and restricted cash	(64,206)	55,934
Cash and cash equivalents and restricted cash at beginning of period	255,178	201,421
Cash and cash equivalents and restricted cash at end of period	$ 190,972	$ 257,355

XML

Basis of Presentation and Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation and Summary of Significant Accounting Policies

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Description of the Business

ChampionX Corporation is a global leader in chemistry solutions and highly engineered equipment and technologies that help companies drill for and produce oil and gas safely, efficiently and sustainably around the world. Our products provide efficient and safe operations throughout the lifecycle of a well with a focus on the production phase of wells.

Unless the context requires otherwise, references in this report to “we,” “us,” “our,” “the Company,” or “ChampionX” mean ChampionX Corporation, together with our subsidiaries where the context requires.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of ChampionX have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) pertaining to interim financial information. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted. Therefore, these financial statements should be read in conjunction with the audited consolidated financial statements, and notes thereto, which are included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.

The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Although these estimates are based on management’s best knowledge of current events and actions that we may undertake in the future, actual results may differ from our estimates. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments unless otherwise specified) necessary for a fair statement of our financial condition and results of operations as of and for the periods presented. Revenue, expenses, assets and liabilities can vary during each quarter of the year. Therefore, the results and trends in these financial statements may not be representative of the results that may be expected for the year ending December 31, 2022.

Significant Accounting Policies

Please refer to “Note 1–Basis of Presentation and Summary of Significant Accounting Policies” to our consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 for the discussion of our significant accounting policies.

New Accounting Standards Issued

In September 2022, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2022-04, “Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations”, which requires that a buyer in a supplier finance program disclose information about the key terms of the program, outstanding confirmed amounts as of the end of the period, a rollforward of such amounts during each annual period, and a description of where in the financial statements outstanding amounts are presented. The ASU does not affect the recognition, measurement or financial statement presentation of obligations covered by supplier finance programs. The guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023, with early adoption permitted. We are currently assessing the impact that this ASU will have on our disclosures and will adopt the amendments in this update upon the effective dates.

XML

Segment Information

9 Months Ended

Sep. 30, 2022

Segment Reporting [Abstract]

Segment Information

SEGMENT INFORMATION

Our reporting segments are:

•Production Chemical Technologies—provides oil and natural gas production and midstream markets with solutions to manage and control corrosion, oil and water separation, flow assurance, sour gas treatment and a host of water-related issues.

•Production & Automation Technologies—designs, manufactures, markets and services a full range of artificial lift equipment, end-to-end digital automation solutions, as well as other production equipment and asset monitoring technologies. Production & Automation Technologies’ products are sold under a collection of brands including Harbison-Fischer, Norris, Alberta Oil Tool, Oil Lift Technology, PCS Ferguson, Pro-Rod, Upco, Unbridled ESP, Scientific Aviation, Norriseal-Wellmark, Quartzdyne, Spirit, Theta, Timberline, Windrock, and Leak Surveys (“LSI”).

•Drilling Technologies—designs, manufactures and markets polycrystalline diamond cutters and bearings primarily for use in oil and gas drill bits under the US Synthetic brand.

•Reservoir Chemical Technologies—manufactures specialty products that support well stimulation, construction (including drilling and cementing) and well intervention in the oil and natural gas industry.

We refer to our Production Chemical Technologies segment and our Reservoir Chemical Technologies segment collectively as our Chemical Technologies business. Business activities that do not meet the criteria of an operating segment have been combined into Corporate and other. Corporate and other includes (i) corporate and overhead expenses, and (ii) revenue and costs for activities that are not operating segments.

Segment revenue and segment operating profit

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2022		2021		2022		2021
Segment revenue:
Production Chemical Technologies	$	643,604	$	487,670	$	1,710,987	$	1,347,090
Production & Automation Technologies	247,717		204,473		710,465		559,491
Drilling Technologies	60,965		49,415		175,682		121,998
Reservoir Chemical Technologies	35,485		38,192		119,499		101,305
Corporate and other (1)	33,790		39,035		103,460		122,961
Total revenue	$	1,021,561	$	818,785	$	2,820,093	$	2,252,845
Segment operating profit (loss):
Production Chemical Technologies	$	86,649	$	45,696	$	143,518	$	109,924
Production & Automation Technologies	22,485		14,407		70,845		32,061
Drilling Technologies	14,856		11,146		45,119		21,400
Reservoir Chemical Technologies	(61,711)		37,800		(73,327)		31,979
Total segment operating profit	62,279		109,049		186,155		195,364
Corporate and other (1)	13,354		11,639		43,044		51,751
Interest expense, net	11,454		12,849		33,582		40,884
Income before income taxes	$	37,471	$	84,561	$	109,529	$	102,729

_______________________

(1)    Corporate and other includes costs not directly attributable or allocated to our reporting segments such as corporate executive management and other administrative functions, and the results attributable to our noncontrolling interest. Additionally, the sales and expenses related to the Cross Supply and Product Transfer Agreement with Ecolab Inc. (“Ecolab”) are included within Corporate and other.

XML

Revenue

9 Months Ended

Sep. 30, 2022

Revenue from Contract with Customer [Abstract]

Revenue

REVENUE

Our revenue is generated primarily from product sales. Service revenue is generated from providing services to our customers. These services include installation, repair and maintenance, laboratory and logistics services, chemical management services, troubleshooting, reporting, water treatment services, technical advisory assistance, emissions detection and monitoring, and other field services. Lease revenue is derived from rental income of leased production equipment. As our costs are shared across the various revenue categories, cost of goods sold is not tracked separately and is not discretely identifiable.

In certain geographical areas, the Company utilizes joint ventures and independent third-party distributors and sales agents to sell and market products and services. Amounts payable to independent third-party distributors and sales agents may fluctuate based on sales and timing of distributor fee payments. For services rendered by such independent third-party distributors and sales agents, the Company records the consideration received on a net basis within product revenue in our condensed consolidated statements of income. Additionally, amounts owed to distributors and sales agents are reported within accrued distributor fees within our condensed consolidated balance sheets.

Revenue disaggregated by geography was as follows:

	Three Months Ended September 30, 2022
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	228,007	$	192,914	$	47,645	$	19,756	$	19,651	$	507,973
Latin America	184,964		4,963		7		3,283		758		193,975
Middle East & Africa	77,162		15,567		1,562		8,314		1,358		103,963
Canada	75,334		18,922		4,614		334		49		99,253
Europe	50,206		2,776		5,774		1,102		3,584		63,442
Asia-Pacific	8,851		1,528		1,363		767		8,390		20,899
Australia	5,518		10,803		—		30		—		16,351
Other	13,562		244		—		1,899		—		15,705
Total revenue	$	643,604	$	247,717	$	60,965	$	35,485	$	33,790	$	1,021,561
	Three Months Ended September 30, 2021
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	163,184	$	158,534	$	37,716	$	26,332	$	26,890	$	412,656
Latin America	110,592		4,752		—		3,410		1,048		119,802
Middle East & Africa	66,584		14,243		1,582		4,958		1,467		88,834
Canada	68,907		14,922		3,697		662		43		88,231
Europe	47,891		731		4,459		930		3,529		57,540
Asia-Pacific	11,703		1,853		1,945		1,113		6,058		22,672
Australia	8,693		9,393		—		28		—		18,114
Other	10,116		45		16		759		—		10,936
Total revenue	$	487,670	$	204,473	$	49,415	$	38,192	$	39,035	$	818,785

	Nine Months Ended September 30, 2022
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	624,370	$	548,698	$	140,312	$	76,015	$	61,544	$	1,450,939
Latin America	409,109		16,324		7		10,094		2,388		437,922
Middle East & Africa	227,234		51,340		4,471		21,596		1,959		306,600
Canada	223,714		55,858		11,032		1,445		112		292,161
Europe	145,116		8,505		14,640		2,973		10,352		181,586
Asia-Pacific	26,852		3,983		5,180		2,721		27,105		65,841
Australia	16,321		25,386		15		229		—		41,951
Other	38,271		371		25		4,426		—		43,093
Total revenue	$	1,710,987	$	710,465	$	175,682	$	119,499	$	103,460	$	2,820,093
	Nine Months Ended September 30, 2021
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	469,900	$	426,246	$	93,515	$	61,530	$	83,132	$	1,134,323
Latin America	275,597		13,924		—		10,016		3,740		303,277
Middle East & Africa	191,167		38,346		3,744		17,554		8,534		259,345
Canada	193,838		42,204		9,510		1,768		325		247,645
Europe	131,545		4,504		9,236		3,420		9,476		158,181
Asia-Pacific	32,757		6,059		4,351		3,626		17,754		64,547
Australia	21,082		28,151		130		112		—		49,475
Other	31,204		57		1,512		3,279		—		36,052
Total revenue	$	1,347,090	$	559,491	$	121,998	$	101,305	$	122,961	$	2,252,845

______________________

(1)    Revenues associated with sales under the Cross Supply and Product Transfer Agreement with Ecolab are included within Corporate and other.

Revenue is attributed to regions based on the location of our direct customer, which in some instances is an intermediary and not necessarily the end user.

Contract Balances

The beginning and ending contract asset and contract liability balances from contracts with customers were as follows:

(in thousands)	September 30, 2022		December 31, 2021
Contract assets	$	—	$	—
Contract liabilities - current	$	13,660	$	15,246

XML

Intangible Assets and Goodwill

9 Months Ended

Sep. 30, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets and Goodwill

INTANGIBLE ASSETS AND GOODWILL

Intangible Assets

The components of our definite- and indefinite-lived intangible assets were as follows:

	September 30, 2022						December 31, 2021
(in thousands)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Definite-lived intangible assets:
Customer relationships	$	581,504	$	395,810	$	185,694	$	593,242	$	365,773	$	227,469
Unpatented technologies	142,845		51,624		91,221		142,540		37,264		105,276
Favorable supply agreements	57,000		44,290		12,710		59,000		30,546		28,454
Trademarks	59,852		35,095		24,757		59,873		32,270		27,603
Patents	38,025		31,100		6,925		38,735		31,080		7,655
Other	5,242		5,193		49		5,390		5,177		213
	884,468		563,112		321,356		898,780		502,110		396,670
Indefinite-lived intangible assets:
Trademarks	3,600		—		3,600		3,600		—		3,600
In-process research and development	1,200		—		1,200		1,200		—		1,200
	4,800		—		4,800		4,800		—		4,800
Total	$	889,268	$	563,112	$	326,156	$	903,580	$	502,110	$	401,470

Goodwill

The carrying amount of goodwill, including changes therein, by reportable segment is below:

(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Total
December 31, 2021	$	356,638	$	205,467	$	101,136	$	39,626	$	702,867
Acquisition (1)	—		6,345		—		—		6,345
Allocated to disposal group (2)	(3,271)		—		—		—		(3,271)
Foreign currency translation	3,192		(665)		—		(8)		2,519
September 30, 2022	$	356,559	$	211,147	$	101,136	$	39,618	$	708,460

_______________________

(1) See Note 11—Acquisitions and Divestitures for additional information related to the acquisition of LSI completed during the first quarter of 2022.

(2) See Note 11—Acquisitions and Divestitures for additional information on the reclassification of assets and liabilities held for sale as part of the planned divestiture of our operations in Russia.

Goodwill is not subject to amortization but is tested for impairment on an annual basis or more frequently if impairment indicators arise.

XML

Debt

9 Months Ended

Sep. 30, 2022

Debt Disclosure [Abstract]

Debt

DEBT

Long-term debt consisted of the following:

(in thousands)	September 30, 2022		December 31, 2021
2022 Revolving Credit Facility	$	45,000	$	—
2018 Term Loan Facility	—		140,000
2020 Term Loan Facility	—		496,725
2022 Term Loan Facility	625,000		—
6.375% Senior Notes due 2026	—		92,041
Total	670,000		728,766
Net unamortized discounts and issuance costs	(21,283)		(4,259)
Total long-term debt	648,717		724,507
Current portion of long-term debt (1)	(4,688)		(26,850)
Long-term debt, less current portion	$	644,029	$	697,657

_______________________

(1) Represents the mandatory amortization payments due within twelve months related to the 2022 Term Loan Facility as of September 30, 2022 and 2020 Term Loan Facility as of December 31, 2021.

On May 9, 2018, we entered into a credit agreement (“Credit Agreement”) governing the terms of, among other things, a 7-year senior secured term loan B facility that had an initial commitment of $415 million (the “2018 Term Loan Facility”), and on June 3, 2020, ChampionX Holding Inc. entered into a term loan facility for $537.0 million (the “2020 Term Loan Facility”).

On June 7, 2022, we entered into a restated credit agreement (the “Restated Credit Agreement”), which amends and restates the Credit Agreement. The Restated Credit Agreement provides for (i) a $625 million 7-year senior secured term loan B facility (the “2022 Term Loan Facility”) and (ii) a five-year senior secured revolving credit facility in an aggregate principal amount of $700 million, of which $100 million is available for the issuance of letters of credit (the “2022 Revolving Credit Facility,” together with the 2022 Term Loan Facility, the “Senior Secured Credit Facility”). The full amount of the 2022 Term Loan Facility was funded, and $135 million of the 2022 Revolving Credit Facility was drawn, on June 7, 2022, with the aggregate proceeds used to repay outstanding amounts under our Credit Agreement, repay and terminate our 2020 Term Loan Facility, and to redeem all outstanding 6.375% Senior Notes due 2026 (the “Notes”). Proceeds from future borrowings under the 2022 Revolving Credit Facility are expected to be used for working capital and general corporate purposes. The initial amount drawn on the 2022 Revolving Credit Facility has been repaid. As of September 30, 2022, we had $45.0 million outstanding on the 2022 Revolving Credit Facility.

The 2022 Term Loan Facility matures June 7, 2029 and the 2022 Revolving Credit Facility matures June 7, 2027. The 2022 Term Loan Facility is subject to mandatory amortization payments of 1% per annum of the initial commitment paid quarterly, which begins on December 30, 2022. The Senior Secured Credit Facility contains customary representations and warranties, covenants, and events of default for loan facilities of this type. We were in compliance with all covenants as of September 30, 2022.

At the Company’s election, outstanding borrowings under the Senior Secured Credit Facility will accrue interest at a per annum rate of (i) an adjusted SOFR rate plus the applicable spread or (ii) a base rate plus the applicable spread. On June 29, 2022, the Company executed a five-year amortizing floating-to-fixed interest rate swap to hedge our exposure to increases in variable interest rates on the 2022 Term Loan Facility. This interest rate swap agreement is based on a $300 million notional amount for the first three years, reducing to $150 million for years four and five. See Note 13—Derivatives and Hedging Transactions for additional information on interest rate swaps.

In connection with the Restated Credit Agreement, as noted above, we completed the redemption of all of the remaining Notes at 103.188% of the principal amount thereof. We redeemed $92.0 million in aggregate principal amount of the Notes for $95.6 million in cash, including $0.6 million in accrued interest. In connection with these redemptions, we recognized a net loss of approximately $3.9 million for the nine months ended September 30, 2022, inclusive of the write off of the remaining unamortized debt financing costs related to the Notes, which is included in other expense, net in our condensed consolidated statements of income (loss).

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2022

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

COMMITMENTS AND CONTINGENCIES

Guarantees and Indemnifications

We have provided indemnities in connection with sales of certain businesses and assets, including indemnities for environmental health and safety, tax, and employment matters. We do not have any material liabilities recorded for these indemnifications and are not aware of any claims or other information that would give rise to material payments under such indemnities.

In connection with the Company’s separation from Dover Corporation (“Dover”) in 2018, we entered into agreements with Dover that govern the treatment between Dover and us for certain indemnification matters and litigation responsibility. Generally, the separation and distribution agreement provides for cross-indemnities principally designed to place financial responsibility for the obligations and liabilities of our business with us and to place financial responsibility for the obligations and liabilities of Dover’s business with Dover. The separation and distribution agreement also establishes procedures for handling claims subject to indemnification and related matters.

In connection with the acquisition of the Chemical Technologies business from Ecolab in 2020 (the “Merger”), we entered into agreements with Ecolab that govern the treatment between Ecolab and us for certain indemnification matters and litigation responsibility. Generally, the separation and distribution agreement provides for cross-indemnities principally designed to place financial responsibility for the obligations and liabilities of our business with us and to place financial responsibility for the obligations and liabilities of Ecolab’s business with Ecolab. The separation and distribution agreement also establishes procedures for handling claims subject to indemnification and related matters. In addition, pursuant to the tax matters agreement relating to the Merger (the “Tax Matters Agreement”), we have agreed to indemnify Ecolab and its affiliates for (i) all taxes for which ChampionX is responsible as defined within the Tax Matters Agreement, (ii) all taxes resulting from a breach by ChampionX of any of its representations (but only to the extent relating to a breach occurring after the consummation of the Merger) or any of its covenants under the Tax Matters Agreement, (iii) all taxes resulting from an acquisition after the Merger of any of the stock or assets of ChampionX, other than as a result of the Merger or a repayment of the 2018 Credit Facility (as defined in “Note 8–Debt” to our consolidated financial statements in our Annual Report on Form 10-K for the fiscal

year ended December 31, 2021), 2018 Term Loan Facility or 2020 Term Loan Facility and (iv) reasonable costs and expenses (including reasonable attorneys’ fees and expenses) related to the foregoing.

As of September 30, 2022 and December 31, 2021, we had $73.0 million and $80.2 million, respectively, of outstanding letters of credit, surety bonds and guarantees, which expire at various dates through 2039. These financial instruments are primarily maintained as security for insurance, warranty, and other performance obligations. Generally, we would only be liable for the amount of these letters of credit, surety bonds, and guarantees in the event of default in the performance of our obligations, the probability of which we believe is remote.

Litigation and Environmental Matters

The Company is party to various proceedings and claims incidental to its business, including matters arising under provisions relating to the protection of the environment. We review the probable outcome of such proceedings, the costs and expenses reasonably expected to be incurred and accrued to date, and the availability and extent of insurance coverage. We accrue a liability for legal matters that are probable and can be reasonably estimated. If the reasonable estimate of a probable loss is a range, the Company records the most probable estimate of the loss or the minimum amount when no amount within the range is a better estimate than any other amount. While many of these matters involve inherent uncertainty, we believe that the amount of the liability, if any, ultimately incurred with respect to these proceedings and claims will not have a material adverse effect on our consolidated financial position, results of operations or cash flows.

Environmental Matters

The Company is currently participating in environmental assessments and remediation at approximately 11 locations, the majority of which are in the United States (“U.S.”), and environmental liabilities have been accrued reflecting our best estimate of future costs. Potential insurance reimbursements are not anticipated in the Company’s accruals for environmental liabilities. As of September 30, 2022 and December 31, 2021, environmental liability accruals related to these locations were $6.1 million and $6.8 million, respectively.

Prior to the separation from Dover in 2018, groundwater contamination was discovered at the Norris Sucker Rods plant site located in Tulsa, Oklahoma (“Norris”). Initial remedial efforts were undertaken at the time of discovery of the contamination and Norris has since coordinated monitoring and remediation with the Oklahoma Department of Environmental Quality (“ODEQ”). As part of the ongoing long-term remediation process, Norris contracted an engineering and consulting firm to

develop a range of possible additional remedial alternatives in order to accelerate the remediation process and associated cost estimates for the work. In October 2019, we received the firm’s preliminary remedial alternatives for consideration. We have submitted our long-term remediation plan and it was approved by ODEQ. We are now in discussion with ODEQ to finalize a consent order. Because we have not yet finalized the consent order for further remediation at the site and discussions with ODEQ remain ongoing, we cannot fully anticipate the timing, outcome or possible impact of such further remedial activities, financial or otherwise. As a result of the recommendations in the report, we accrued liabilities for these remediation efforts of approximately $2.0 million as of December 31, 2019. Liabilities could increase in the future at such time as we ultimately reach agreement with ODEQ on our remediation plan and such liabilities become probable and can be reasonably estimated; however, there have been no changes to our estimated liability as of September 30, 2022.

Matters Related to Deepwater Horizon Incident Response

On April 22, 2010, the deepwater drilling platform, the Deepwater Horizon, operated by a subsidiary of BP plc, sank in the Gulf of Mexico after an explosion and fire, resulting in a massive oil spill. Certain entities that are now subsidiaries of ChampionX as a result of the Merger (collectively the “COREXIT Defendants”) supplied COREXIT™ 9500, an oil dispersant product listed on the U.S. EPA National Contingency Plan Product Schedule, which was used in the response to the spill. In connection with the provision of COREXIT™ 9500, the COREXIT Defendants were named in several lawsuits. Cases arising out of the Deepwater Horizon accident were administratively transferred and consolidated for pre-trial purposes under In Re: Oil Spill by the Oil Rig “Deepwater Horizon” in the Gulf of Mexico, on April 20, 2010, Case No. 10-md-02179 in the United States District Court in the Eastern District of Louisiana (E.D. La.) (“MDL 2179”). Claims related to the response to the oil spill were consolidated in a master complaint captioned the “B3 Master Complaint.” In 2011, Transocean Deepwater Drilling, Inc. and its affiliates (the “Transocean Entities”) named the COREXIT Defendants and other unaffiliated companies as first party defendants (In re the Complaint and Petition of Triton Asset Leasing GmbH, et al, MDL No. 2179, Civil Action 10-2771). In April and May 2011, the Transocean Entities, Cameron International Corporation, Halliburton Energy Services, Inc., M-I L.L.C., Weatherford U.S., L.P. and Weatherford International, Inc. (collectively, the “Cross Claimants”) filed cross claims in MDL 2179 against the COREXIT Defendants and other unaffiliated cross defendants. In April and June 2011, in support of its defense of the claims against it, the COREXIT Defendants filed counterclaims against the Cross Claimants. On May 18, 2012, the COREXIT Defendants filed a motion for summary judgment as to the claims in the B3 Master Complaint. On November 28, 2012, the Court granted the COREXIT Defendants’ motion and dismissed with prejudice the claims in the B3 Master Complaint asserted against the COREXIT Defendants. There currently remain two “B3” cases that had asserted claims against the COREXIT Defendants and that remain pending against other defendants. Because the Court’s decision was not a “final judgment” for purposes of appeal with respect to those claims, under Federal Rule of Appellate Procedure 4(a), plaintiffs will have 30 days after entry of final judgment in each case to appeal the Court’s summary judgment decision.

The Company believes the claims asserted against the COREXIT Defendants are without merit and intends to defend these lawsuits vigorously. The Company also believes that it has rights to contribution and/or indemnification (including legal expenses) from third parties. However, we cannot predict the outcome of these lawsuits, the involvement it might have in these matters in the future, or the potential for future litigation.

XML

Restructuring and Other Related Charges

9 Months Ended

Sep. 30, 2022

Restructuring and Related Activities [Abstract]

Restructuring and Other Related Charges

RESTRUCTURING AND OTHER RELATED CHARGES

We approved various restructuring plans related to the consolidation of product lines and associated facility closures and workforce reductions during the current and prior periods. During the second quarter of 2022, the restructuring plans included the exit of one of our product lines within the Reservoir Chemical Technologies segment. The exit of this product line was completed during the third quarter of 2022 and as such, we recognized additional restructuring charges primarily related to certain contract termination costs as well as the exit of facilities. Liabilities for these contract termination costs are recognized and measured at fair value in the period in which we cease using the rights conveyed by the existing contracts. The liability will be paid out over the remaining term of the contracts, ranging from approximately 1 – 8 years.

We recognized charges of $69.8 million and $84.9 million during the three and nine months ended September 30, 2022, respectively, consisting primarily of contract termination costs, employee severance and related benefits, disposals of equipment and warehouse closures, partially offset by gains realized on the sale of facilities. During the three and nine months ended September 30, 2021, we recorded restructuring and other charges of $2.1 million and $10.1 million, respectively.

The following table presents the restructuring and other related charges by segment as classified in our condensed consolidated statements of income.

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2022		2021		2022		2021
Segment restructuring charges (income):
Production Chemical Technologies	$	(335)	$	1,031	$	11,637	$	4,822
Production & Automation Technologies	4,282		947		260		4,903
Drilling Technologies	—		—		—		—
Reservoir Chemical Technologies	63,458		65		69,559		307
Corporate and other	2,350		44		3,403		86
Total	$	69,755	$	2,087	$	84,859	$	10,118
Statements of Income classification:
Cost of goods and services	$	66,488	$	802	$	67,496	$	4,708
Selling, general and administrative expense	3,267		1,285		17,363		5,410
Total	$	69,755	$	2,087	$	84,859	$	10,118

Our liability balance for restructuring and other related charges at September 30, 2022 reflects contract termination costs, employee severance and related benefits initiated during the period. Additional programs may be initiated during the remainder of 2022 with related restructuring charges.

The following table details our restructuring accrual activities during the nine months ended September 30, 2022:

(in thousands)	Restructuring Accrual Balance
December 31, 2021	$	3,743
Restructuring charges	84,859
Asset sales	(13,235)
Payments	(13,771)
Other, including foreign currency translation	(66)
September 30, 2022	$	61,530

XML

Equity and Cash Incentive Programs

9 Months Ended

Sep. 30, 2022

Share-Based Payment Arrangement, Noncash Expense [Abstract]

Equity and Cash Incentive Programs

EQUITY AND CASH INCENTIVE PROGRAMS

Stock-based compensation expense is reported within selling, general and administrative expense in the condensed consolidated statements of income. Stock-based compensation expense relating to all stock-based incentive plans was as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2022		2021		2022		2021
Stock-based compensation expense	$	5,009	$	5,557	$	14,808	$	17,913
Tax benefit	(1,052)		(1,167)		(3,110)		(3,762)
Stock-based compensation expense, net of tax	$	3,957	$	4,390	$	11,698	$	14,151

A summary of activity relating to our share-based awards for the nine months ended September 30, 2022 was as follows:

(in shares)	Stock-Settled Appreciation Rights	Performance Share Awards	Restricted Stock Units	Non-Qualified Stock Options
Outstanding at January 1, 2022	393,523	505,509	2,342,107	5,488,653
Granted	—	347,920	945,616	—
Forfeited / expired	(1,758)	(6,022)	(226,671)	(2,859)
Exercised / vested	—	(72,410)	(466,898)	(586,064)
Outstanding at September 30, 2022	391,765	774,997	2,594,154	4,899,730

XML

Stockholders' Equity

9 Months Ended

Sep. 30, 2022

Stockholders' Equity Note [Abstract]

Stockholders' Equity

STOCKHOLDERS' EQUITY

Dividends

On February 4, 2022, our Board of Directors (“Board”) approved a plan to initiate a regular quarterly cash dividend of $0.075 per share of the Company’s common stock. Our third quarter cash dividend of $0.075 per share was declared on August 11, 2022, and is payable on October 28, 2022 to stockholders of record on October 7, 2022. As a result, we recorded a dividend payable of $15.8 million on our condensed consolidated balance sheet as of September 30, 2022. Subsequent dividend declarations, if any, including the amounts and timing of future dividends, are subject to approval by the Board and will depend on future business conditions, financial conditions, results of operations and other factors.

Repurchases

On March 7, 2022, the Company announced that our Board authorized the Company to repurchase up to $250 million of its common stock. On October 24, 2022, our Board increased the authorization under this program to $750 million. This program has no time limit and does not obligate the Company to acquire any particular amount of shares of its common stock. During the three months ended September 30, 2022, we repurchased and cancelled 3,698,106 shares of common stock at a volume-weighted average price of $21.63 per share for a total of $80.1 million, including commissions. During the nine months ended September 30, 2022, we repurchased and cancelled 4,487,622 shares of common stock at a volume-weighted average price of $22.28 per share for a total of $100.1 million, including commissions.

Accumulated other comprehensive loss

Accumulated other comprehensive loss—Accumulated other comprehensive loss consisted of the following:

(in thousands)	Foreign Currency Translation		Defined Pension and Other Post-Retirement Benefits		Cash Flow Hedges		Accumulated Other Comprehensive Loss
December 31, 2021	$	(19,430)	$	(3,476)	$	1,281	$	(21,625)
Other comprehensive loss before reclassifications, net of tax	(1,565)		—		(1,299)		(2,864)
Reclassification adjustment for net losses included in net income, net of tax	—		69		—		69
Other comprehensive loss, net of tax	(1,565)		69		(1,299)		(2,795)
March 31, 2022	$	(20,995)	$	(3,407)	$	(18)	$	(24,420)
Other comprehensive income before reclassifications, net of tax	21,169		—		(3,403)		17,766
Reclassification adjustment for net losses included in net income, net of tax	—		70		—		70
Other comprehensive income, net of tax	21,169		70		(3,403)		17,836
June 30, 2022	$	174	$	(3,337)	$	(3,421)	$	(6,584)
Other comprehensive income before reclassifications, net of tax	$	(47,067)	$	—	$	16,310	$	(30,757)
Reclassification adjustment for net losses included in net income, net of tax	$	—	$	68	$	—	$	68
Other comprehensive income, net of tax	(47,067)		68		16,310		(30,689)
September 30, 2022	$	(46,893)	$	(3,269)	$	12,889	$	(37,273)

(in thousands)	Foreign Currency Translation		Defined Pension and Other Post-Retirement Benefits		Cash Flow Hedges		Accumulated Other Comprehensive Loss
December 31, 2020	$	(14,965)	$	(13,470)	$	(2,320)	$	(30,755)
Other comprehensive income before reclassifications, net of tax	3,213		—		413		3,626
Reclassification adjustment for net losses included in net income, net of tax	—		167		—		167
Other comprehensive income, net of tax	3,213		167		413		3,793
March 31, 2021	$	(11,752)	$	(13,303)	$	(1,907)	$	(26,962)
Other comprehensive income (loss) before reclassifications, net of tax	8,332		—		(277)		8,055
Reclassification adjustment for net losses included in net income, net of tax	—		6,373		—		6,373
Other comprehensive income (loss), net of tax	8,332		6,373		(277)		14,428
June 30, 2021	$	(3,420)	$	(6,930)	$	(2,184)	$	(12,534)
Other comprehensive income (loss) before reclassifications, net of tax	(11,737)		—		3,218		(8,519)
Reclassification adjustment for net losses included in net income, net of tax	—		46		—		46
Other comprehensive income (loss), net of tax	(11,737)		46		3,218		(8,473)
September 30, 2021	$	(15,157)	$	(6,884)	$	1,034	$	(21,007)

Reclassifications from accumulated other comprehensive loss—Reclassification adjustments from accumulated other comprehensive loss to net income (loss) related to defined pension and other post-retirement benefits consisted of the following:

	Three Months Ended September 30,				Nine Months Ended September 30,				Affected line items on the condensed consolidated statements of income (loss)
(in thousands)	2022		2021		2022		2021
Pensions and other post-retirement benefits:
Amortization of actuarial loss and other	$	68	$	46	$	207	$	6,586	Other expense (income), net
Total before tax	68		46		207		6,586		Income before income taxes
Tax benefit	—		—		—		—		Provision for income taxes
Net of tax	$	68	$	46	$	207	$	6,586	Net income

XML

Earnings Per Share

9 Months Ended

Sep. 30, 2022

Earnings Per Share [Abstract]

Earnings Per Share

EARNINGS PER SHARE

A reconciliation of the number of shares used for the basic and diluted earnings per share calculation was as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands, except per share data)	2022		2021		2022		2021
Net income attributable to ChampionX	$	23,068	$	56,828	$	87,112	$	69,850
Weighted-average number of shares outstanding	201,421		201,852		202,600		201,329
Dilutive effect of stock-based compensation	5,101		6,693		5,555		6,844
Total shares and dilutive securities	206,522		208,545		208,155		208,173
Earnings per share attributable to ChampionX:
Basic	$	0.11	$	0.28	$	0.43	$	0.35
Diluted	$	0.11	$	0.27	$	0.42	$	0.34

For all periods presented, the computation of diluted earnings per share excludes awards with an anti-dilutive impact. For the three and nine months ended September 30, 2022, the diluted shares include the dilutive impact of equity awards except for approximately 0.4 million and 0.4 million shares, respectively, that were excluded because their inclusion would be anti-dilutive. For the three and nine months ended September 30, 2021, the diluted shares include the dilutive impact of equity awards except for approximately 0.5 million and 0.6 million shares, respectively, that were excluded because their inclusion would be anti-dilutive.

XML

Acquisitions and Divestitures

9 Months Ended

Sep. 30, 2022

Business Combination and Asset Acquisition [Abstract]

Acquisitions and Divestitures

ACQUISITIONS AND DIVESTITURES

Acquisitions

On February 23, 2022, we acquired LSI, a leader in optical gas imaging technology that provides aerial and ground-based emissions leak detection to the oil and gas industry. LSI has been included in our Production & Automation Technologies segment. Under the terms of the agreement, we paid an initial amount of $3.2 million, net of cash acquired, with an additional $0.5 million payable on the first anniversary of the closing date. We may also be required to make future payments of up to an additional $2.5 million, contingent on the future performance of the business. As part of our purchase price allocation, we recorded goodwill of $6.3 million. The pro forma effect of this acquisition on revenue and net income has been determined to be immaterial to our financial statements.

Divestitures

Given the continued economic pressure and sanctions imposed by the United States, European Union, and United Kingdom, we initiated a plan to dispose of our operations in Russia (the “CT Russia Business”), which is included in our Production Chemical Technologies segment. As a result, the CT Russia Business met the criteria to be classified as held for sale as of June 30, 2022, which required us to present the related assets and liabilities as separate line items in our condensed consolidated balance sheet. We recorded an initial charge of $22.9 million during the second quarter of 2022, in order to properly reflect the carrying value of the disposal group at the lower of its carrying value or fair value less any costs to sell.

We assess the fair value of a long-lived asset or disposal group (less any costs to sell) each reporting period that it remains classified as held for sale and report any subsequent changes as an adjustment to the carrying value of the asset or disposal group, as long as the new carrying value does not exceed the carrying value of the asset at the time it was initially classified as held for sale. During the three months ended September 30, 2022, we recognized a gain of $6.4 million to adjust the carrying value of the disposal group. Upon the ultimate disposition, we will recognize the cumulative translation adjustment balance associated with the CT Russia Business in our condensed consolidated statement of income as part of the gain or loss on the sale.

The following table presents information related to the major classes of assets and liabilities of the CT Russia Business that were held for sale in our condensed consolidated balance sheet:

(in thousands)
Receivables	$	8,330
Inventory	6,638
Prepaid expenses and other current assets	3,078
Property, plant, and equipment	4,721
Goodwill	3,271
Intangible assets	6,927
Operating lease right-of-use assets	2,001
Loss on disposal group	(16,515)
Total assets held for sale	$	18,451
Accounts payable	$	2,168
Other current liabilities	3,933
Other noncurrent liabilities	3,257
Total liabilities held for sale	$	9,358

XML

Fair Value Measurements

9 Months Ended

Sep. 30, 2022

Fair Value Disclosures [Abstract]

Fair Value Measurements

FAIR VALUE MEASUREMENTS

Fair value is defined as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. A hierarchy has been established for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs be used when available. The hierarchy is broken down into three levels:

Level 1- Inputs are quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities.

Level 2- Inputs include observable inputs other than quoted prices in active markets.

Level 3- Inputs are unobservable inputs for which there is little or no market data available.

The carrying amount and the estimated fair value for assets and liabilities measured on a recurring basis are as follows:

		Carrying Amount
(in thousands)	Measurement Level	September 30, 2022		December 31, 2021
Assets
Foreign currency forward contracts	Level 2	$	17,074	$	4,081
Interest rate swaps	Level 2	8,885		—
Total		$	25,959	$	4,081
Liabilities
Foreign currency forward contracts	Level 2	$	11,989	$	3,773
Interest rate swaps	Level 2	133		—
Total		$	12,122	$	3,773

For purposes of fair value disclosure above, derivative values are presented gross. See Note 13—Derivatives and Hedging Transactions for further discussion of gross versus net presentation of the Company’s derivatives.

The carrying amounts of cash and cash equivalents, trade receivables, accounts payable, as well as amounts included in other current assets and other current liabilities that meet the definition of financial instruments, approximate fair value due to their short-term nature.

The carrying amount and the estimated fair value of long-term debt, including current maturities, held by the Company were:

	September 30, 2022				December 31, 2021
(in thousands)	Carrying Amount		Fair Value		Carrying Amount		Fair Value
2022 Revolving Credit Facility	$	45,000	$	45,000	$	—	$	—
2018 Term Loan Facility	$	—	$	—	$	140,000	$	138,950
2020 Term Loan Facility	$	—	$	—	$	496,725	$	502,313
2022 Term Loan Facility	$	625,000	$	609,375	$	—	$	—
6.375% Senior Notes due 2026	$	—	$	—	$	92,041	$	95,805

The fair value of the Notes is based on Level 1 quoted market prices. The fair value of our term loan facilities are based on Level 2 quoted market prices for the same or similar debt instruments. The fair value of our revolving line of credit approximates carrying value due to the variable interest rates charged on the borrowings, which reprice frequently (Level 2).

XML

Derivatives and Hedging Transactions

9 Months Ended

Sep. 30, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivatives and Hedging Transactions

DERIVATIVES AND HEDGING TRANSACTIONS

The Company uses foreign currency forward contracts to manage risks associated with foreign currency exchange rates. The Company also utilizes floating-to-fixed interest rate swap agreements as cash flow hedges on certain debt, to mitigate interest rate risk. The Company does not hold derivative financial instruments of a speculative nature or for trading purposes. Derivative contracts are recorded as assets and liabilities on the balance sheet at fair value. We evaluated the interest rate swap hedge effectiveness and determined it to be perfectly effective. We evaluate foreign currency forward contracts hedge effectiveness at contract inception and thereafter on a quarterly basis. If a derivative is no longer expected to be effective, hedge accounting is discontinued. Changes in fair value are recognized immediately in earnings unless the derivative qualifies and is designated as a hedge. Changes in fair value attributable to changes in spot exchange rates for derivative contracts that have been designated as cash flow hedges are recognized in accumulated other comprehensive income (loss) (“AOCI”) and reclassified into earnings in the same period the hedged transaction affects earnings and are presented in the same income statement line as the earnings effect of the hedged item. The Company accounts for the interest rate swap agreements as a cash flow hedge, thus the effective portion of gains and losses resulting from changes in fair value are recognized in AOCI and are amortized to interest expense over the term of the respective debt. Cash flows from derivatives are classified in the statement of cash flows in the same category as the cash flows from the items subject to designated hedge or undesignated (economic) hedge relationships.

The Company is exposed to credit risk in the event of nonperformance of counterparties for foreign currency forward exchange contracts and interest rate swaps. We monitor our exposure to credit risk by using major global banks and financial institutions as counterparties and monitoring their financial condition and credit profile. The Company does not anticipate nonperformance

by any of these counterparties, and therefore, recording a valuation allowance against the Company’s derivative balance is not considered necessary.

Derivative Positions Summary

Certain of the Company’s derivative transactions are subject to master netting arrangements that allow the Company to settle with the same counterparties. These arrangements generally do not call for collateral and as of the applicable dates presented in the following table, no cash collateral had been received or pledged related to the underlying derivatives. We have elected to present our derivative balances on a gross basis on the condensed consolidated balance sheet.

The following table summarizes the gross fair value of the Company’s outstanding derivatives and the lines in which they are presented on the condensed consolidated balance sheet.

	Derivative Assets				Derivative Liabilities
(in thousands)	September 30, 2022		December 31, 2021		September 30, 2022		December 31, 2021
Prepaid expenses and other current assets	$	20,027	$	4,081	$	—	$	—
Other non-current assets	5,932		—		—		—
Accrued expenses and other current liabilities	—		—		12,122		3,773
Other long-term liabilities	—		—		—		—
	$	25,959	$	4,081	$	12,122	$	3,773

The following table summarizes the notional values of the Company’s outstanding derivatives:

(in thousands)	September 30, 2022		December 31, 2021
Notional value of foreign currency forward contracts and interest rate swaps	$	953,246	$	704,190

Cash Flow Hedges

The Company utilizes foreign currency forward contracts to hedge the effect of foreign currency exchange rate fluctuations on forecasted foreign currency transactions, primarily related to inventory purchases. These forward contracts are designated as cash flow hedges. The changes in fair value of these contracts attributable to changes in spot exchange rates are recorded in AOCI until the hedged items affect earnings, at which time the gain or loss is reclassified into the same line item in the condensed consolidated statements of income (loss) as the underlying exposure being hedged. The forward points are marked-to-market monthly and recognized in the same line item in the condensed consolidated statements of income (loss) as the underlying exposure being hedged.

Under interest rate swaps, we agree with other parties to exchange, at specified intervals, the difference between fixed-rate and floating-rate interest amounts calculated by reference to an agreed notional principal amount. Any unrealized gain or loss at the time of settlement will be reclassified to interest expense, where we record the interest expense on the associated debt.

Derivatives Not Designated as Hedging Instruments

The Company also uses foreign currency forward contracts to offset its exposure to the change in value of certain foreign currency denominated assets and liabilities, primarily receivables and payables, which are remeasured at the end of each period. Although the contracts are effective economic hedges, they are not designated as accounting hedges. Therefore, changes in the value of these derivatives are recognized immediately in earnings, thereby offsetting the current earnings effect of the related foreign currency denominated assets and liabilities.

Effect of Derivative Instruments on Income

The loss of all derivative instruments recognized is summarized below:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2022		2021		2022		2021
Loss (gain) reclassified from AOCI to income on cash flow hedges:
Cost of goods and services	$	(837)	$	1,447	$	(884)	$	3,219
Interest expense	585		—		585		—
Loss on derivatives not designated as hedging instruments:
Other (income) expense, net	1,167		955		6,578		2,417
Total loss of derivative instruments	$	915	$	2,402	$	6,279	$	5,636

XML

Inventories

9 Months Ended

Sep. 30, 2022

Inventory, Net [Abstract]

Inventories

INVENTORIES

Inventories consisted of the following:

(in thousands)	September 30, 2022		December 31, 2021
Raw materials	$	148,119	$	186,516
Work in progress	20,363		13,615
Finished goods	523,042		421,702
	691,524		621,833
Inventory reserve	(26,927)		(24,646)
LIFO adjustments (1)	(93,777)		(54,277)
Inventories, net	$	570,820	$	542,910

_______________________

(1) Represents the amount by which the current cost of LIFO inventories exceeded their carrying value.

XML

Accounts Receivable Facility

9 Months Ended

Sep. 30, 2022

Receivables [Abstract]

Accounts Receivable Facility

ACCOUNTS RECEIVABLE FACILITY

On June 28, 2022, we entered into an uncommitted accounts receivable purchase agreement (the “Accounts Receivable Facility”) with JPMorgan Chase Bank, N.A. as the purchaser. Transfers under the Accounts Receivable Facility are accounted for as sales of receivables, resulting in the receivables being derecognized from our consolidated balance sheet. The purchaser assumes the credit risk at the time of sale and has the right at any time to assign or transfer (including as a participation interest) any of its rights under the purchased receivables to another bank or financial institution.

The amount available for sale under the Accounts Receivable Facility fluctuates over time based on the total amount of eligible receivables generated during the normal course of business. A maximum of $160.0 million in receivables may be sold and remain unpaid under the Accounts Receivable Facility at any time.

Accounts receivable sold were $101.2 million for the three and nine months ended September 30, 2022. The accounts receivable sold that remained outstanding as of September 30, 2022 was $60.0 million. During these periods, cash receipts from the purchaser at the time of the sale were classified as operating activities in our condensed consolidated statement of cash flows. The difference between the carrying amount of the accounts receivable sold and the sum of the cash received is recorded as a loss on sale of receivables in other income (expense), net in our condensed consolidated statements of income. The loss on sale of accounts receivable was $0.7 million for the three and nine months ended September 30, 2022.

XML

Cash Flow Information

9 Months Ended

Sep. 30, 2022

Supplemental Cash Flow Elements [Abstract]

Cash Flow Information

CASH FLOW INFORMATION

Leased Asset Program

Our electrical submersible pumping (“ESP”) leased asset program is reported in our Production & Automation Technologies segment. At the time of purchase, assets are recorded to inventory and are transferred to property, plant, and equipment when a customer contracts for an asset under our leased asset program. During the nine months ended September 30, 2022 and September 30, 2021, we transferred $32.1 million and $33.9 million, respectively, of inventory into property, plant, and equipment as a result of assets entering our leased asset program.

Expenditures for assets that are placed into our leased asset program expected to be recovered through sale are reported in leased assets in the operating section of our condensed consolidated statements of cash flows. All other capitalizable expenditures for assets that are placed into our leased asset program are classified as capital expenditures in the investing section of our condensed consolidated statements of cash flows.

XML

Basis of Presentation and Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of ChampionX have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) pertaining to interim financial information. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted. Therefore, these financial statements should be read in conjunction with the audited consolidated financial statements, and notes thereto, which are included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.

The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Although these estimates are based on management’s best knowledge of current events and actions that we may undertake in the future, actual results may differ from our estimates. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments unless otherwise specified) necessary for a fair statement of our financial condition and results of operations as of and for the periods presented. Revenue, expenses, assets and liabilities can vary during each quarter of the year. Therefore, the results and trends in these financial statements may not be representative of the results that may be expected for the year ending December 31, 2022.

New Accounting Standards Issued

New Accounting Standards Issued

In September 2022, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2022-04, “Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations”, which requires that a buyer in a supplier finance program disclose information about the key terms of the program, outstanding confirmed amounts as of the end of the period, a rollforward of such amounts during each annual period, and a description of where in the financial statements outstanding amounts are presented. The ASU does not affect the recognition, measurement or financial statement presentation of obligations covered by supplier finance programs. The guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023, with early adoption permitted. We are currently assessing the impact that this ASU will have on our disclosures and will adopt the amendments in this update upon the effective dates.

Fair Value Measurements

Fair value is defined as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. A hierarchy has been established for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs be used when available. The hierarchy is broken down into three levels:

Level 1- Inputs are quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities.

Level 2- Inputs include observable inputs other than quoted prices in active markets.

Level 3- Inputs are unobservable inputs for which there is little or no market data available.

XML

Segment Information (Tables)

9 Months Ended

Sep. 30, 2022

Segment Reporting [Abstract]

Schedule of Segment Revenue and Operating Profit

Segment revenue and segment operating profit

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2022		2021		2022		2021
Segment revenue:
Production Chemical Technologies	$	643,604	$	487,670	$	1,710,987	$	1,347,090
Production & Automation Technologies	247,717		204,473		710,465		559,491
Drilling Technologies	60,965		49,415		175,682		121,998
Reservoir Chemical Technologies	35,485		38,192		119,499		101,305
Corporate and other (1)	33,790		39,035		103,460		122,961
Total revenue	$	1,021,561	$	818,785	$	2,820,093	$	2,252,845
Segment operating profit (loss):
Production Chemical Technologies	$	86,649	$	45,696	$	143,518	$	109,924
Production & Automation Technologies	22,485		14,407		70,845		32,061
Drilling Technologies	14,856		11,146		45,119		21,400
Reservoir Chemical Technologies	(61,711)		37,800		(73,327)		31,979
Total segment operating profit	62,279		109,049		186,155		195,364
Corporate and other (1)	13,354		11,639		43,044		51,751
Interest expense, net	11,454		12,849		33,582		40,884
Income before income taxes	$	37,471	$	84,561	$	109,529	$	102,729

_______________________

(1)    Corporate and other includes costs not directly attributable or allocated to our reporting segments such as corporate executive management and other administrative functions, and the results attributable to our noncontrolling interest. Additionally, the sales and expenses related to the Cross Supply and Product Transfer Agreement with Ecolab Inc. (“Ecolab”) are included within Corporate and other.

XML

Revenue (Tables)

9 Months Ended

Sep. 30, 2022

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

Revenue disaggregated by geography was as follows:

	Three Months Ended September 30, 2022
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	228,007	$	192,914	$	47,645	$	19,756	$	19,651	$	507,973
Latin America	184,964		4,963		7		3,283		758		193,975
Middle East & Africa	77,162		15,567		1,562		8,314		1,358		103,963
Canada	75,334		18,922		4,614		334		49		99,253
Europe	50,206		2,776		5,774		1,102		3,584		63,442
Asia-Pacific	8,851		1,528		1,363		767		8,390		20,899
Australia	5,518		10,803		—		30		—		16,351
Other	13,562		244		—		1,899		—		15,705
Total revenue	$	643,604	$	247,717	$	60,965	$	35,485	$	33,790	$	1,021,561
	Three Months Ended September 30, 2021
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	163,184	$	158,534	$	37,716	$	26,332	$	26,890	$	412,656
Latin America	110,592		4,752		—		3,410		1,048		119,802
Middle East & Africa	66,584		14,243		1,582		4,958		1,467		88,834
Canada	68,907		14,922		3,697		662		43		88,231
Europe	47,891		731		4,459		930		3,529		57,540
Asia-Pacific	11,703		1,853		1,945		1,113		6,058		22,672
Australia	8,693		9,393		—		28		—		18,114
Other	10,116		45		16		759		—		10,936
Total revenue	$	487,670	$	204,473	$	49,415	$	38,192	$	39,035	$	818,785

	Nine Months Ended September 30, 2022
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	624,370	$	548,698	$	140,312	$	76,015	$	61,544	$	1,450,939
Latin America	409,109		16,324		7		10,094		2,388		437,922
Middle East & Africa	227,234		51,340		4,471		21,596		1,959		306,600
Canada	223,714		55,858		11,032		1,445		112		292,161
Europe	145,116		8,505		14,640		2,973		10,352		181,586
Asia-Pacific	26,852		3,983		5,180		2,721		27,105		65,841
Australia	16,321		25,386		15		229		—		41,951
Other	38,271		371		25		4,426		—		43,093
Total revenue	$	1,710,987	$	710,465	$	175,682	$	119,499	$	103,460	$	2,820,093
	Nine Months Ended September 30, 2021
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	469,900	$	426,246	$	93,515	$	61,530	$	83,132	$	1,134,323
Latin America	275,597		13,924		—		10,016		3,740		303,277
Middle East & Africa	191,167		38,346		3,744		17,554		8,534		259,345
Canada	193,838		42,204		9,510		1,768		325		247,645
Europe	131,545		4,504		9,236		3,420		9,476		158,181
Asia-Pacific	32,757		6,059		4,351		3,626		17,754		64,547
Australia	21,082		28,151		130		112		—		49,475
Other	31,204		57		1,512		3,279		—		36,052
Total revenue	$	1,347,090	$	559,491	$	121,998	$	101,305	$	122,961	$	2,252,845

______________________

(1)    Revenues associated with sales under the Cross Supply and Product Transfer Agreement with Ecolab are included within Corporate and other.

Schedule of Contract Balances

The beginning and ending contract asset and contract liability balances from contracts with customers were as follows:

(in thousands)	September 30, 2022		December 31, 2021
Contract assets	$	—	$	—
Contract liabilities - current	$	13,660	$	15,246

XML

Intangible Assets and Goodwill (Tables)

9 Months Ended

Sep. 30, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Finite-Lived Intangible Assets

The components of our definite- and indefinite-lived intangible assets were as follows:

	September 30, 2022						December 31, 2021
(in thousands)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Definite-lived intangible assets:
Customer relationships	$	581,504	$	395,810	$	185,694	$	593,242	$	365,773	$	227,469
Unpatented technologies	142,845		51,624		91,221		142,540		37,264		105,276
Favorable supply agreements	57,000		44,290		12,710		59,000		30,546		28,454
Trademarks	59,852		35,095		24,757		59,873		32,270		27,603
Patents	38,025		31,100		6,925		38,735		31,080		7,655
Other	5,242		5,193		49		5,390		5,177		213
	884,468		563,112		321,356		898,780		502,110		396,670
Indefinite-lived intangible assets:
Trademarks	3,600		—		3,600		3,600		—		3,600
In-process research and development	1,200		—		1,200		1,200		—		1,200
	4,800		—		4,800		4,800		—		4,800
Total	$	889,268	$	563,112	$	326,156	$	903,580	$	502,110	$	401,470

Schedule of Indefinite-Lived Intangible Assets

The components of our definite- and indefinite-lived intangible assets were as follows:

	September 30, 2022						December 31, 2021
(in thousands)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Definite-lived intangible assets:
Customer relationships	$	581,504	$	395,810	$	185,694	$	593,242	$	365,773	$	227,469
Unpatented technologies	142,845		51,624		91,221		142,540		37,264		105,276
Favorable supply agreements	57,000		44,290		12,710		59,000		30,546		28,454
Trademarks	59,852		35,095		24,757		59,873		32,270		27,603
Patents	38,025		31,100		6,925		38,735		31,080		7,655
Other	5,242		5,193		49		5,390		5,177		213
	884,468		563,112		321,356		898,780		502,110		396,670
Indefinite-lived intangible assets:
Trademarks	3,600		—		3,600		3,600		—		3,600
In-process research and development	1,200		—		1,200		1,200		—		1,200
	4,800		—		4,800		4,800		—		4,800
Total	$	889,268	$	563,112	$	326,156	$	903,580	$	502,110	$	401,470

Schedule of Goodwill

The carrying amount of goodwill, including changes therein, by reportable segment is below:

(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Total
December 31, 2021	$	356,638	$	205,467	$	101,136	$	39,626	$	702,867
Acquisition (1)	—		6,345		—		—		6,345
Allocated to disposal group (2)	(3,271)		—		—		—		(3,271)
Foreign currency translation	3,192		(665)		—		(8)		2,519
September 30, 2022	$	356,559	$	211,147	$	101,136	$	39,618	$	708,460

_______________________

(1) See Note 11—Acquisitions and Divestitures for additional information related to the acquisition of LSI completed during the first quarter of 2022.

(2) See Note 11—Acquisitions and Divestitures for additional information on the reclassification of assets and liabilities held for sale as part of the planned divestiture of our operations in Russia.

XML

Debt (Tables)

9 Months Ended

Sep. 30, 2022

Debt Disclosure [Abstract]

Schedule of Long-Term Debt

Long-term debt consisted of the following:

(in thousands)	September 30, 2022		December 31, 2021
2022 Revolving Credit Facility	$	45,000	$	—
2018 Term Loan Facility	—		140,000
2020 Term Loan Facility	—		496,725
2022 Term Loan Facility	625,000		—
6.375% Senior Notes due 2026	—		92,041
Total	670,000		728,766
Net unamortized discounts and issuance costs	(21,283)		(4,259)
Total long-term debt	648,717		724,507
Current portion of long-term debt (1)	(4,688)		(26,850)
Long-term debt, less current portion	$	644,029	$	697,657

_______________________

(1) Represents the mandatory amortization payments due within twelve months related to the 2022 Term Loan Facility as of September 30, 2022 and 2020 Term Loan Facility as of December 31, 2021.

XML

Restructuring and Other Related Charges (Tables)

9 Months Ended

Sep. 30, 2022

Restructuring and Related Activities [Abstract]

Schedule of Restructuring and Related Costs

The following table presents the restructuring and other related charges by segment as classified in our condensed consolidated statements of income.

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2022		2021		2022		2021
Segment restructuring charges (income):
Production Chemical Technologies	$	(335)	$	1,031	$	11,637	$	4,822
Production & Automation Technologies	4,282		947		260		4,903
Drilling Technologies	—		—		—		—
Reservoir Chemical Technologies	63,458		65		69,559		307
Corporate and other	2,350		44		3,403		86
Total	$	69,755	$	2,087	$	84,859	$	10,118
Statements of Income classification:
Cost of goods and services	$	66,488	$	802	$	67,496	$	4,708
Selling, general and administrative expense	3,267		1,285		17,363		5,410
Total	$	69,755	$	2,087	$	84,859	$	10,118

The following table details our restructuring accrual activities during the nine months ended September 30, 2022:

(in thousands)	Restructuring Accrual Balance
December 31, 2021	$	3,743
Restructuring charges	84,859
Asset sales	(13,235)
Payments	(13,771)
Other, including foreign currency translation	(66)
September 30, 2022	$	61,530

XML

Equity and Cash Incentive Programs (Tables)

9 Months Ended

Sep. 30, 2022

Share-Based Payment Arrangement, Noncash Expense [Abstract]

Schedule of Stock-Based Compensation Expense

Stock-based compensation expense relating to all stock-based incentive plans was as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2022		2021		2022		2021
Stock-based compensation expense	$	5,009	$	5,557	$	14,808	$	17,913
Tax benefit	(1,052)		(1,167)		(3,110)		(3,762)
Stock-based compensation expense, net of tax	$	3,957	$	4,390	$	11,698	$	14,151

Summary of Activity Related to Share-Based Awards

A summary of activity relating to our share-based awards for the nine months ended September 30, 2022 was as follows:

(in shares)	Stock-Settled Appreciation Rights	Performance Share Awards	Restricted Stock Units	Non-Qualified Stock Options
Outstanding at January 1, 2022	393,523	505,509	2,342,107	5,488,653
Granted	—	347,920	945,616	—
Forfeited / expired	(1,758)	(6,022)	(226,671)	(2,859)
Exercised / vested	—	(72,410)	(466,898)	(586,064)
Outstanding at September 30, 2022	391,765	774,997	2,594,154	4,899,730

XML

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2022

Stockholders' Equity Note [Abstract]

Schedule of Accumulated Other Comprehensive Loss

Accumulated other comprehensive loss consisted of the following:

(in thousands)	Foreign Currency Translation		Defined Pension and Other Post-Retirement Benefits		Cash Flow Hedges		Accumulated Other Comprehensive Loss
December 31, 2021	$	(19,430)	$	(3,476)	$	1,281	$	(21,625)
Other comprehensive loss before reclassifications, net of tax	(1,565)		—		(1,299)		(2,864)
Reclassification adjustment for net losses included in net income, net of tax	—		69		—		69
Other comprehensive loss, net of tax	(1,565)		69		(1,299)		(2,795)
March 31, 2022	$	(20,995)	$	(3,407)	$	(18)	$	(24,420)
Other comprehensive income before reclassifications, net of tax	21,169		—		(3,403)		17,766
Reclassification adjustment for net losses included in net income, net of tax	—		70		—		70
Other comprehensive income, net of tax	21,169		70		(3,403)		17,836
June 30, 2022	$	174	$	(3,337)	$	(3,421)	$	(6,584)
Other comprehensive income before reclassifications, net of tax	$	(47,067)	$	—	$	16,310	$	(30,757)
Reclassification adjustment for net losses included in net income, net of tax	$	—	$	68	$	—	$	68
Other comprehensive income, net of tax	(47,067)		68		16,310		(30,689)
September 30, 2022	$	(46,893)	$	(3,269)	$	12,889	$	(37,273)

(in thousands)	Foreign Currency Translation		Defined Pension and Other Post-Retirement Benefits		Cash Flow Hedges		Accumulated Other Comprehensive Loss
December 31, 2020	$	(14,965)	$	(13,470)	$	(2,320)	$	(30,755)
Other comprehensive income before reclassifications, net of tax	3,213		—		413		3,626
Reclassification adjustment for net losses included in net income, net of tax	—		167		—		167
Other comprehensive income, net of tax	3,213		167		413		3,793
March 31, 2021	$	(11,752)	$	(13,303)	$	(1,907)	$	(26,962)
Other comprehensive income (loss) before reclassifications, net of tax	8,332		—		(277)		8,055
Reclassification adjustment for net losses included in net income, net of tax	—		6,373		—		6,373
Other comprehensive income (loss), net of tax	8,332		6,373		(277)		14,428
June 30, 2021	$	(3,420)	$	(6,930)	$	(2,184)	$	(12,534)
Other comprehensive income (loss) before reclassifications, net of tax	(11,737)		—		3,218		(8,519)
Reclassification adjustment for net losses included in net income, net of tax	—		46		—		46
Other comprehensive income (loss), net of tax	(11,737)		46		3,218		(8,473)
September 30, 2021	$	(15,157)	$	(6,884)	$	1,034	$	(21,007)

Schedule of Reclassifications from Accumulated Other Comprehensive Loss

Reclassification adjustments from accumulated other comprehensive loss to net income (loss) related to defined pension and other post-retirement benefits consisted of the following:

	Three Months Ended September 30,				Nine Months Ended September 30,				Affected line items on the condensed consolidated statements of income (loss)
(in thousands)	2022		2021		2022		2021
Pensions and other post-retirement benefits:
Amortization of actuarial loss and other	$	68	$	46	$	207	$	6,586	Other expense (income), net
Total before tax	68		46		207		6,586		Income before income taxes
Tax benefit	—		—		—		—		Provision for income taxes
Net of tax	$	68	$	46	$	207	$	6,586	Net income

XML

Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2022

Earnings Per Share [Abstract]

Schedule of Earnings per Share

A reconciliation of the number of shares used for the basic and diluted earnings per share calculation was as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands, except per share data)	2022		2021		2022		2021
Net income attributable to ChampionX	$	23,068	$	56,828	$	87,112	$	69,850
Weighted-average number of shares outstanding	201,421		201,852		202,600		201,329
Dilutive effect of stock-based compensation	5,101		6,693		5,555		6,844
Total shares and dilutive securities	206,522		208,545		208,155		208,173
Earnings per share attributable to ChampionX:
Basic	$	0.11	$	0.28	$	0.43	$	0.35
Diluted	$	0.11	$	0.27	$	0.42	$	0.34

XML

Acquisitions and Divestitures (Tables)

9 Months Ended

Sep. 30, 2022

Business Combination and Asset Acquisition [Abstract]

Schedule of Major Class of Assets and Liabilities Held For Sale

The following table presents information related to the major classes of assets and liabilities of the CT Russia Business that were held for sale in our condensed consolidated balance sheet:

(in thousands)
Receivables	$	8,330
Inventory	6,638
Prepaid expenses and other current assets	3,078
Property, plant, and equipment	4,721
Goodwill	3,271
Intangible assets	6,927
Operating lease right-of-use assets	2,001
Loss on disposal group	(16,515)
Total assets held for sale	$	18,451
Accounts payable	$	2,168
Other current liabilities	3,933
Other noncurrent liabilities	3,257
Total liabilities held for sale	$	9,358

XML

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2022

Fair Value Disclosures [Abstract]

Schedule of Assets and Liabilities Measured on Recurring Basis

The carrying amount and the estimated fair value for assets and liabilities measured on a recurring basis are as follows:

		Carrying Amount
(in thousands)	Measurement Level	September 30, 2022		December 31, 2021
Assets
Foreign currency forward contracts	Level 2	$	17,074	$	4,081
Interest rate swaps	Level 2	8,885		—
Total		$	25,959	$	4,081
Liabilities
Foreign currency forward contracts	Level 2	$	11,989	$	3,773
Interest rate swaps	Level 2	133		—
Total		$	12,122	$	3,773

Schedule of Fair Value of Long-Term Debt

The carrying amount and the estimated fair value of long-term debt, including current maturities, held by the Company were:

	September 30, 2022				December 31, 2021
(in thousands)	Carrying Amount		Fair Value		Carrying Amount		Fair Value
2022 Revolving Credit Facility	$	45,000	$	45,000	$	—	$	—
2018 Term Loan Facility	$	—	$	—	$	140,000	$	138,950
2020 Term Loan Facility	$	—	$	—	$	496,725	$	502,313
2022 Term Loan Facility	$	625,000	$	609,375	$	—	$	—
6.375% Senior Notes due 2026	$	—	$	—	$	92,041	$	95,805

XML

Derivatives and Hedging Transactions (Tables)

9 Months Ended

Sep. 30, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Notional Values of Outstanding Derivatives

The following table summarizes the gross fair value of the Company’s outstanding derivatives and the lines in which they are presented on the condensed consolidated balance sheet.

	Derivative Assets				Derivative Liabilities
(in thousands)	September 30, 2022		December 31, 2021		September 30, 2022		December 31, 2021
Prepaid expenses and other current assets	$	20,027	$	4,081	$	—	$	—
Other non-current assets	5,932		—		—		—
Accrued expenses and other current liabilities	—		—		12,122		3,773
Other long-term liabilities	—		—		—		—
	$	25,959	$	4,081	$	12,122	$	3,773

The following table summarizes the notional values of the Company’s outstanding derivatives:

(in thousands)	September 30, 2022		December 31, 2021
Notional value of foreign currency forward contracts and interest rate swaps	$	953,246	$	704,190

Schedule of Derivative Instruments

The loss of all derivative instruments recognized is summarized below:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2022		2021		2022		2021
Loss (gain) reclassified from AOCI to income on cash flow hedges:
Cost of goods and services	$	(837)	$	1,447	$	(884)	$	3,219
Interest expense	585		—		585		—
Loss on derivatives not designated as hedging instruments:
Other (income) expense, net	1,167		955		6,578		2,417
Total loss of derivative instruments	$	915	$	2,402	$	6,279	$	5,636

XML

Inventories (Tables)

9 Months Ended

Sep. 30, 2022

Inventory, Net [Abstract]

Components of Inventory

Inventories consisted of the following:

(in thousands)	September 30, 2022		December 31, 2021
Raw materials	$	148,119	$	186,516
Work in progress	20,363		13,615
Finished goods	523,042		421,702
	691,524		621,833
Inventory reserve	(26,927)		(24,646)
LIFO adjustments (1)	(93,777)		(54,277)
Inventories, net	$	570,820	$	542,910

_______________________

(1) Represents the amount by which the current cost of LIFO inventories exceeded their carrying value.

XML

Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Segment revenue:
Revenue	$ 1,021,561	$ 818,785	$ 2,820,093	$ 2,252,845
Segment operating profit (loss):
Interest expense, net	11,454	12,849	33,582	40,884
Income before income taxes	37,471	84,561	109,529	102,729
Operating Segments
Segment operating profit (loss):
Income before income taxes	62,279	109,049	186,155	195,364
Operating Segments | Production Chemical Technologies
Segment revenue:
Revenue	643,604	487,670	1,710,987	1,347,090
Segment operating profit (loss):
Income before income taxes	86,649	45,696	143,518	109,924
Operating Segments | Production & Automation Technologies
Segment revenue:
Revenue	247,717	204,473	710,465	559,491
Segment operating profit (loss):
Income before income taxes	22,485	14,407	70,845	32,061
Operating Segments | Drilling Technologies
Segment revenue:
Revenue	60,965	49,415	175,682	121,998
Segment operating profit (loss):
Income before income taxes	14,856	11,146	45,119	21,400
Operating Segments | Reservoir Chemical Technologies
Segment revenue:
Revenue	35,485	38,192	119,499	101,305
Segment operating profit (loss):
Income before income taxes	(61,711)	37,800	(73,327)	31,979
Corporate and Other
Segment revenue:
Revenue	33,790	39,035	103,460	122,961
Segment operating profit (loss):
Income before income taxes	$ 13,354	$ 11,639	$ 43,044	$ 51,751

XML

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Total revenue	$ 1,021,561	$ 818,785	$ 2,820,093	$ 2,252,845
United States
Disaggregation of Revenue [Line Items]
Total revenue	507,973	412,656	1,450,939	1,134,323
Latin America
Disaggregation of Revenue [Line Items]
Total revenue	193,975	119,802	437,922	303,277
Middle East & Africa
Disaggregation of Revenue [Line Items]
Total revenue	103,963	88,834	306,600	259,345
Canada
Disaggregation of Revenue [Line Items]
Total revenue	99,253	88,231	292,161	247,645
Europe
Disaggregation of Revenue [Line Items]
Total revenue	63,442	57,540	181,586	158,181
Asia-Pacific
Disaggregation of Revenue [Line Items]
Total revenue	20,899	22,672	65,841	64,547
Australia
Disaggregation of Revenue [Line Items]
Total revenue	16,351	18,114	41,951	49,475
Other
Disaggregation of Revenue [Line Items]
Total revenue	15,705	10,936	43,093	36,052
Corporate and other
Disaggregation of Revenue [Line Items]
Total revenue	33,790	39,035	103,460	122,961
Corporate and other | United States
Disaggregation of Revenue [Line Items]
Total revenue	19,651	26,890	61,544	83,132
Corporate and other | Latin America
Disaggregation of Revenue [Line Items]
Total revenue	758	1,048	2,388	3,740
Corporate and other | Middle East & Africa
Disaggregation of Revenue [Line Items]
Total revenue	1,358	1,467	1,959	8,534
Corporate and other | Canada
Disaggregation of Revenue [Line Items]
Total revenue	49	43	112	325
Corporate and other | Europe
Disaggregation of Revenue [Line Items]
Total revenue	3,584	3,529	10,352	9,476
Corporate and other | Asia-Pacific
Disaggregation of Revenue [Line Items]
Total revenue	8,390	6,058	27,105	17,754
Corporate and other | Australia
Disaggregation of Revenue [Line Items]
Total revenue	0	0	0	0
Corporate and other | Other
Disaggregation of Revenue [Line Items]
Total revenue	0	0	0	0
Production Chemical Technologies | Operating Segments
Disaggregation of Revenue [Line Items]
Total revenue	643,604	487,670	1,710,987	1,347,090
Production Chemical Technologies | Operating Segments | United States
Disaggregation of Revenue [Line Items]
Total revenue	228,007	163,184	624,370	469,900
Production Chemical Technologies | Operating Segments | Latin America
Disaggregation of Revenue [Line Items]
Total revenue	184,964	110,592	409,109	275,597
Production Chemical Technologies | Operating Segments | Middle East & Africa
Disaggregation of Revenue [Line Items]
Total revenue	77,162	66,584	227,234	191,167
Production Chemical Technologies | Operating Segments | Canada
Disaggregation of Revenue [Line Items]
Total revenue	75,334	68,907	223,714	193,838
Production Chemical Technologies | Operating Segments | Europe
Disaggregation of Revenue [Line Items]
Total revenue	50,206	47,891	145,116	131,545
Production Chemical Technologies | Operating Segments | Asia-Pacific
Disaggregation of Revenue [Line Items]
Total revenue	8,851	11,703	26,852	32,757
Production Chemical Technologies | Operating Segments | Australia
Disaggregation of Revenue [Line Items]
Total revenue	5,518	8,693	16,321	21,082
Production Chemical Technologies | Operating Segments | Other
Disaggregation of Revenue [Line Items]
Total revenue	13,562	10,116	38,271	31,204
Production & Automation Technologies | Operating Segments
Disaggregation of Revenue [Line Items]
Total revenue	247,717	204,473	710,465	559,491
Production & Automation Technologies | Operating Segments | United States
Disaggregation of Revenue [Line Items]
Total revenue	192,914	158,534	548,698	426,246
Production & Automation Technologies | Operating Segments | Latin America
Disaggregation of Revenue [Line Items]
Total revenue	4,963	4,752	16,324	13,924
Production & Automation Technologies | Operating Segments | Middle East & Africa
Disaggregation of Revenue [Line Items]
Total revenue	15,567	14,243	51,340	38,346
Production & Automation Technologies | Operating Segments | Canada
Disaggregation of Revenue [Line Items]
Total revenue	18,922	14,922	55,858	42,204
Production & Automation Technologies | Operating Segments | Europe
Disaggregation of Revenue [Line Items]
Total revenue	2,776	731	8,505	4,504
Production & Automation Technologies | Operating Segments | Asia-Pacific
Disaggregation of Revenue [Line Items]
Total revenue	1,528	1,853	3,983	6,059
Production & Automation Technologies | Operating Segments | Australia
Disaggregation of Revenue [Line Items]
Total revenue	10,803	9,393	25,386	28,151
Production & Automation Technologies | Operating Segments | Other
Disaggregation of Revenue [Line Items]
Total revenue	244	45	371	57
Drilling Technologies | Operating Segments
Disaggregation of Revenue [Line Items]
Total revenue	60,965	49,415	175,682	121,998
Drilling Technologies | Operating Segments | United States
Disaggregation of Revenue [Line Items]
Total revenue	47,645	37,716	140,312	93,515
Drilling Technologies | Operating Segments | Latin America
Disaggregation of Revenue [Line Items]
Total revenue	7	0	7	0
Drilling Technologies | Operating Segments | Middle East & Africa
Disaggregation of Revenue [Line Items]
Total revenue	1,562	1,582	4,471	3,744
Drilling Technologies | Operating Segments | Canada
Disaggregation of Revenue [Line Items]
Total revenue	4,614	3,697	11,032	9,510
Drilling Technologies | Operating Segments | Europe
Disaggregation of Revenue [Line Items]
Total revenue	5,774	4,459	14,640	9,236
Drilling Technologies | Operating Segments | Asia-Pacific
Disaggregation of Revenue [Line Items]
Total revenue	1,363	1,945	5,180	4,351
Drilling Technologies | Operating Segments | Australia
Disaggregation of Revenue [Line Items]
Total revenue	0	0	15	130
Drilling Technologies | Operating Segments | Other
Disaggregation of Revenue [Line Items]
Total revenue	0	16	25	1,512
Reservoir Chemical Technologies | Operating Segments
Disaggregation of Revenue [Line Items]
Total revenue	35,485	38,192	119,499	101,305
Reservoir Chemical Technologies | Operating Segments | United States
Disaggregation of Revenue [Line Items]
Total revenue	19,756	26,332	76,015	61,530
Reservoir Chemical Technologies | Operating Segments | Latin America
Disaggregation of Revenue [Line Items]
Total revenue	3,283	3,410	10,094	10,016
Reservoir Chemical Technologies | Operating Segments | Middle East & Africa
Disaggregation of Revenue [Line Items]
Total revenue	8,314	4,958	21,596	17,554
Reservoir Chemical Technologies | Operating Segments | Canada
Disaggregation of Revenue [Line Items]
Total revenue	334	662	1,445	1,768
Reservoir Chemical Technologies | Operating Segments | Europe
Disaggregation of Revenue [Line Items]
Total revenue	1,102	930	2,973	3,420
Reservoir Chemical Technologies | Operating Segments | Asia-Pacific
Disaggregation of Revenue [Line Items]
Total revenue	767	1,113	2,721	3,626
Reservoir Chemical Technologies | Operating Segments | Australia
Disaggregation of Revenue [Line Items]
Total revenue	30	28	229	112
Reservoir Chemical Technologies | Operating Segments | Other
Disaggregation of Revenue [Line Items]
Total revenue	$ 1,899	$ 759	$ 4,426	$ 3,279

XML

Revenue - Contract Balances (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Contract assets	$ 0	$ 0
Contract liabilities - current	$ 13,660	$ 15,246

XML

Intangible Assets and Goodwill - Schedule of Intangibles (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 884,468	$ 898,780
Accumulated Amortization	563,112	502,110
Net Carrying Amount	321,356	396,670
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	4,800	4,800
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Intangible assets, gross	889,268	903,580
Accumulated Amortization	563,112	502,110
Intangible assets, net	326,156	401,470
Trademarks
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	3,600	3,600
In-process research and development
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	1,200	1,200
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	581,504	593,242
Accumulated Amortization	395,810	365,773
Net Carrying Amount	185,694	227,469
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	395,810	365,773
Unpatented technologies
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	142,845	142,540
Accumulated Amortization	51,624	37,264
Net Carrying Amount	91,221	105,276
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	51,624	37,264
Favorable supply agreements
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	57,000	59,000
Accumulated Amortization	44,290	30,546
Net Carrying Amount	12,710	28,454
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	44,290	30,546
Trademarks
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	59,852	59,873
Accumulated Amortization	35,095	32,270
Net Carrying Amount	24,757	27,603
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	35,095	32,270
Patents
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	38,025	38,735
Accumulated Amortization	31,100	31,080
Net Carrying Amount	6,925	7,655
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	31,100	31,080
Other
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	5,242	5,390
Accumulated Amortization	5,193	5,177
Net Carrying Amount	49	213
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	$ 5,193	$ 5,177

XML

Intangible Assets and Goodwill - Schedule of Goodwill (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 702,867
Acquisition	6,345
Allocated to disposal group	(3,271)
Foreign currency translation	2,519
Ending balance	708,460
Production Chemical Technologies
Goodwill [Roll Forward]
Beginning balance	356,638
Acquisition	0
Allocated to disposal group	(3,271)
Foreign currency translation	3,192
Ending balance	356,559
Production & Automation Technologies
Goodwill [Roll Forward]
Beginning balance	205,467
Acquisition	6,345
Allocated to disposal group	0
Foreign currency translation	(665)
Ending balance	211,147
Drilling Technologies
Goodwill [Roll Forward]
Beginning balance	101,136
Acquisition	0
Allocated to disposal group	0
Foreign currency translation	0
Ending balance	101,136
Reservoir Chemical Technologies
Goodwill [Roll Forward]
Beginning balance	39,626
Acquisition	0
Allocated to disposal group	0
Foreign currency translation	(8)
Ending balance	$ 39,618

XML

Debt - Long-term Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Long-term Debt and Lease Obligation	$ 670,000	$ 728,766
Net unamortized discounts and issuance costs	(21,283)	(4,259)
Total long-term debt	648,717	724,507
Current portion of long-term debt	(4,688)	(26,850)
Long-term debt, less current portion	644,029	697,657
Credit Facility | 2022 Revolving Credit Facility | Revolving Credit Facility
Debt Instrument [Line Items]
Long-term Debt and Lease Obligation	45,000	0
Term Loan Facility | 2018 Term Loan Facility
Debt Instrument [Line Items]
Long-term Debt and Lease Obligation	0	140,000
Term Loan Facility | 2020 Term Loan Facility
Debt Instrument [Line Items]
Long-term Debt and Lease Obligation	0	496,725
Term Loan Facility | 2022 Term Loan Facility
Debt Instrument [Line Items]
Long-term Debt and Lease Obligation	$ 625,000	$ 0
Senior Notes | 6.375% Senior Notes due 2026
Debt Instrument [Line Items]
Debt interest rate	6.375%	6.375%
Long-term Debt and Lease Obligation	$ 0	$ 92,041

XML

Debt - Narrative (Details) - USD ($)				9 Months Ended
	Jun. 29, 2022	Jun. 07, 2022	May 09, 2018	Sep. 30, 2022	Dec. 31, 2021	Jun. 03, 2020
Debt Instrument [Line Items]
Carrying Amount				$ 670,000,000	$ 728,766,000
Interest rate swaps | Designated as Hedging Instrument
Debt Instrument [Line Items]
Derivative instrument, term (in years)	5 years
Interest Rate Swap, First Three Years | Designated as Hedging Instrument
Debt Instrument [Line Items]
Notional value of foreign currency forward contracts and interest rate swaps	$ 300,000,000
Interest Rate Swap, Years Four And Five | Designated as Hedging Instrument
Debt Instrument [Line Items]
Notional value of foreign currency forward contracts and interest rate swaps	$ 150,000,000
Credit Agreement | Term Loan Facility
Debt Instrument [Line Items]
Debt instrument, term (in years)			7 years
2018 Term Loan Facility | Term Loan Facility
Debt Instrument [Line Items]
Principal amount of debt issued			$ 415,000,000
Carrying Amount				0	140,000,000
2020 Term Loan Facility | Term Loan Facility
Debt Instrument [Line Items]
Principal amount of debt issued						$ 537,000,000
Carrying Amount				0	496,725,000
2022 Term Loan Facility | Term Loan Facility
Debt Instrument [Line Items]
Debt instrument, term (in years)		7 years
Principal amount of debt issued		$ 625,000,000
Carrying Amount				625,000,000	0
Mandatory amortization payment, percent per annum		1.00%
2022 Revolving Credit Facility | Credit Facility | Revolving Credit Facility
Debt Instrument [Line Items]
Debt instrument, term (in years)		5 years
Maximum borrowing capacity		$ 700,000,000
Borrowings from lines of credit		135,000,000
Carrying Amount				$ 45,000,000	$ 0
2022 Revolving Credit Facility | Credit Facility | Letter of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 100,000,000
6.375% Senior Notes due 2026 | Senior Notes
Debt Instrument [Line Items]
Debt interest rate				6.375%	6.375%
Carrying Amount				$ 0	$ 92,041,000
Redemption price, percentage of principal amount of debt		103.188%
Aggregate principal amount repurchased		$ 92,000,000
Amount of principal debt repurchased		95,600,000
Accrued interest paid on repurchase		$ 600,000
Net loss from repurchases of debt				$ 3,900,000

XML

Commitments and Contingencies (Details) $ in Millions	9 Months Ended
	Sep. 30, 2022 USD ($) case location	Dec. 31, 2021 USD ($)	Dec. 31, 2019 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Outstanding letters of credit, surety bonds and guarantees	$ 73.0	$ 80.2
Number of locations participating in assessments and remediation | location	11
Accrued environmental liability	$ 6.1	$ 6.8	$ 2.0
Number of pending cases | case	2

XML

Restructuring and Other Related Charges - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 69,755	$ 2,087	$ 84,859	$ 10,118
Minimum
Restructuring Cost and Reserve [Line Items]
Contract termination liability, term (in years)			1 year
Maximum
Restructuring Cost and Reserve [Line Items]
Contract termination liability, term (in years)			8 years

XML

Restructuring and Other Related Charges - Schedule of Restructuring and Other Related Charges (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 69,755	$ 2,087	$ 84,859	$ 10,118
Cost of goods and services
Restructuring Cost and Reserve [Line Items]
Restructuring charges	66,488	802	67,496	4,708
Selling, general and administrative expense
Restructuring Cost and Reserve [Line Items]
Restructuring charges	3,267	1,285	17,363	5,410
Corporate and other
Restructuring Cost and Reserve [Line Items]
Restructuring charges	2,350	44	3,403	86
Production Chemical Technologies | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring charges	(335)	1,031	11,637	4,822
Production & Automation Technologies | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring charges	4,282	947	260	4,903
Drilling Technologies | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	0	0	0
Reservoir Chemical Technologies | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 63,458	$ 65	$ 69,559	$ 307

XML

Restructuring and Other Related Charges - Restructuring Reserve Rollforward (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($)
Restructuring Accrual Balance
Beginning balance	$ 3,743
Restructuring charges	84,859
Asset sales	(13,235)
Payments	(13,771)
Other, including foreign currency translation	(66)
Ending balance	$ 61,530

XML

Equity and Cash Incentive Programs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Stock-based compensation expense [Abstract]
Stock-based compensation expense	$ 5,009	$ 5,557	$ 14,808	$ 17,913
Tax benefit	(1,052)	(1,167)	(3,110)	(3,762)
Stock-based compensation expense, net of tax	$ 3,957	$ 4,390	$ 11,698	$ 14,151
Stock-Settled Appreciation Rights
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Outstanding, beginning balance (in shares)			393,523
Granted (in shares)			0
Forfeited / expired (in shares)			(1,758)
Exercised / vested (in shares)			0
Outstanding, ending balance (in shares)	391,765		391,765
Performance Share Awards
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Outstanding, beginning balance (in shares)			505,509
Granted (in shares)			347,920
Forfeited / expired (in shares)			(6,022)
Exercised / vested (in shares)			(72,410)
Outstanding, ending balance (in shares)	774,997		774,997
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Outstanding, beginning balance (in shares)			2,342,107
Granted (in shares)			945,616
Forfeited / expired (in shares)			(226,671)
Exercised / vested (in shares)			(466,898)
Outstanding, ending balance (in shares)	2,594,154		2,594,154
Non-Qualified Stock Options
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding, beginning balance (in shares)			5,488,653
Granted (in shares)			0
Forfeited / expired (in shares)			(2,859)
Exercised / vested (in shares)			(586,064)
Outstanding, ending balance (in shares)	4,899,730		4,899,730

XML

Stockholders' Equity - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands			3 Months Ended			9 Months Ended
	Aug. 11, 2022	Feb. 04, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2022	Oct. 24, 2022	Mar. 07, 2022
Class of Stock [Line Items]
Approved quarterly cash dividend (in dollars per share)		$ 0.075
Dividends declared to common shareholders (in dollars per share)	$ 0.075		$ 0.075	$ 0.075	$ 0.075
Dividends payable			$ 15,800			$ 15,800
Authorized amount of stock repurchase								$ 250,000
Repurchase and cancellation of common stock (in shares)			3,698,106			4,487,622
Weighted average price of common stock repurchased (in dollars per share)			$ 21.63			$ 22.28
Value of repurchased common stock			$ 80,074	$ 20,016		$ 100,100
Subsequent Event
Class of Stock [Line Items]
Authorized amount of stock repurchase							$ 750,000

XML

Stockholders' Equity - Schedule of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			$ 1,770,645				$ 1,770,645
Other comprehensive income	$ (30,689)	$ 17,836	(2,795)	$ (8,473)	$ 14,428	$ 3,793	(15,648)	$ 9,748
Ending balance	1,710,686						1,710,686
Accumulated Other Comprehensive Loss
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(6,584)	(24,420)	(21,625)	(12,534)	(26,962)	(30,755)	(21,625)	(30,755)
Other comprehensive income (loss) before reclassifications, net of tax	(30,757)	17,766	(2,864)	(8,519)	8,055	3,626
Reclassification adjustment for net losses included in net income, net of tax	68	70	69	46	6,373	167
Other comprehensive income	(30,689)	17,836	(2,795)	(8,473)	14,428	3,793
Ending balance	(37,273)	(6,584)	(24,420)	(21,007)	(12,534)	(26,962)	(37,273)	(21,007)
Foreign Currency Translation
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	174	(20,995)	(19,430)	(3,420)	(11,752)	(14,965)	(19,430)	(14,965)
Other comprehensive income (loss) before reclassifications, net of tax	(47,067)	21,169	(1,565)	(11,737)	8,332	3,213
Reclassification adjustment for net losses included in net income, net of tax	0	0	0	0	0	0
Other comprehensive income	(47,067)	21,169	(1,565)	(11,737)	8,332	3,213
Ending balance	(46,893)	174	(20,995)	(15,157)	(3,420)	(11,752)	(46,893)	(15,157)
Defined Pension and Other Post-Retirement Benefits
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(3,337)	(3,407)	(3,476)	(6,930)	(13,303)	(13,470)	(3,476)	(13,470)
Other comprehensive income (loss) before reclassifications, net of tax	0	0	0	0	0	0
Reclassification adjustment for net losses included in net income, net of tax	68	70	69	46	6,373	167
Other comprehensive income	68	70	69	46	6,373	167
Ending balance	(3,269)	(3,337)	(3,407)	(6,884)	(6,930)	(13,303)	(3,269)	(6,884)
Cash Flow Hedges
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(3,421)	(18)	1,281	(2,184)	(1,907)	(2,320)	1,281	(2,320)
Other comprehensive income (loss) before reclassifications, net of tax	16,310	(3,403)	(1,299)	3,218	(277)	413
Reclassification adjustment for net losses included in net income, net of tax	0	0	0	0	0	0
Other comprehensive income	16,310	(3,403)	(1,299)	3,218	(277)	413
Ending balance	$ 12,889	$ (3,421)	$ (18)	$ 1,034	$ (2,184)	$ (1,907)	$ 12,889	$ 1,034

XML

Stockholders' Equity - Reclassifications from Accumulated Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other expense (income), net	$ (6,118)			$ (36,876)			$ 27,483	$ (36,561)
Income before income taxes	(37,471)			(84,561)			(109,529)	(102,729)
Provision for income taxes	14,246			25,910			19,235	32,255
Net income	(23,225)	$ (28,896)	$ (38,173)	(58,651)	$ (7,786)	$ (4,037)	(90,294)	(70,474)
Amortization of actuarial loss and other | Reclassification from accumulated other comprehensive loss
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other expense (income), net	68			46			207	6,586
Accumulated defined benefit plans adjustment including portion attributable to noncontrolling interest | Reclassification from accumulated other comprehensive loss
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Income before income taxes	68			46			207	6,586
Provision for income taxes	0			0			0	0
Net income	$ 68			$ 46			$ 207	$ 6,586

XML

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Earnings Per Share [Abstract]
Net income attributable to ChampionX	$ 23,068	$ 56,828	$ 87,112	$ 69,850
Weighted-average number of shares outstanding (in shares)	201,421	201,852	202,600	201,329
Dilutive effect of stock-based compensation (in shares)	5,101	6,693	5,555	6,844
Total shares and dilutive securities (in shares)	206,522	208,545	208,155	208,173
Basic (in dollars per share)	$ 0.11	$ 0.28	$ 0.43	$ 0.35
Diluted (in dollars per share)	$ 0.11	$ 0.27	$ 0.42	$ 0.34
Number of antidilutive securities excluded (in shares)	400	500	400	600

XML

Acquisitions and Divestitures - Narrative (Details) - USD ($) $ in Thousands			3 Months Ended
	Feb. 23, 2023	Feb. 23, 2022	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Goodwill			$ 708,460		$ 702,867
Disposal Group, Held-for-sale, Not Discontinued Operations | CT Russia Business
Business Acquisition [Line Items]
Charge on divestiture			$ 6,400	$ 22,900
Leak Surveys, Inc.
Business Acquisition [Line Items]
Amount paid for acquisition		$ 3,200
Future payments contingent upon performance		2,500
Goodwill		$ 6,300
Leak Surveys, Inc. | Forecast
Business Acquisition [Line Items]
Amount paid for acquisition	$ 500

XML

Acquisitions and Divestitures - Schedule of Major Class of Assets and Liabilities Held For Sale (Details) - Disposal Group, Held-for-sale, Not Discontinued Operations - CT Russia Business $ in Thousands	Sep. 30, 2022 USD ($)
Business Acquisition [Line Items]
Receivables	$ 8,330
Inventory	6,638
Prepaid expenses and other current assets	3,078
Property, plant, and equipment	4,721
Goodwill	3,271
Intangible assets	6,927
Operating lease right-of-use assets	2,001
Loss on disposal group	(16,515)
Total assets held for sale	18,451
Accounts payable	2,168
Other current liabilities	3,933
Other noncurrent liabilities	3,257
Total liabilities held for sale	$ 9,358

XML

Fair Value Measurements (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Assets
Derivative assets	$ 25,959	$ 4,081
Liabilities
Derivative liabilities	12,122	3,773
Carrying Amount	670,000	728,766
Credit Facility | 2022 Revolving Credit Facility | Revolving Credit Facility
Liabilities
Carrying Amount	45,000	0
Fair Value	45,000	0
Term Loan Facility | 2018 Term Loan Facility
Liabilities
Carrying Amount	0	140,000
Term Loan Facility | 2020 Term Loan Facility
Liabilities
Carrying Amount	0	496,725
Term Loan Facility | 2022 Term Loan Facility
Liabilities
Carrying Amount	$ 625,000	$ 0
Senior Notes | 6.375% Senior Notes due 2026
Liabilities
Debt interest rate	6.375%	6.375%
Carrying Amount	$ 0	$ 92,041
Level 2 | Term Loan Facility | 2018 Term Loan Facility
Liabilities
Fair Value	0	138,950
Level 2 | Term Loan Facility | 2020 Term Loan Facility
Liabilities
Fair Value	0	502,313
Level 2 | Term Loan Facility | 2022 Term Loan Facility
Liabilities
Fair Value	609,375	0
Level 1 | Senior Notes | 6.375% Senior Notes due 2026
Liabilities
Fair Value	0	95,805
Fair Value, Recurring | Level 2
Assets
Derivative assets	25,959	4,081
Liabilities
Derivative liabilities	12,122	3,773
Foreign currency forward contracts | Fair Value, Recurring | Level 2
Assets
Derivative assets	17,074	4,081
Liabilities
Derivative liabilities	11,989	3,773
Interest rate swaps | Fair Value, Recurring | Level 2
Assets
Derivative assets	8,885	0
Liabilities
Derivative liabilities	$ 133	$ 0

XML

Derivatives and Hedging Transactions - Schedule of Fair Value of Derivative Instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Derivatives, Fair Value [Line Items]
Derivative Assets	$ 25,959	$ 4,081
Derivative Liabilities	12,122	3,773
Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Derivative Assets	20,027	4,081
Other non-current assets
Derivatives, Fair Value [Line Items]
Derivative Assets	5,932	0
Accrued expenses and other current liabilities
Derivatives, Fair Value [Line Items]
Derivative Liabilities	12,122	3,773
Other long-term liabilities
Derivatives, Fair Value [Line Items]
Derivative Liabilities	$ 0	$ 0

XML

Derivatives and Hedging Transactions - Schedule of Derivative Instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Foreign Exchange Forward And Interest Rate Swap
Derivative [Line Items]
Notional value under derivative instrument agreement	$ 953,246	$ 704,190

XML

Derivatives and Hedging Transactions - Schedule of Gain (Loss) on Derivative Instruments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Total loss of derivative instruments	$ 915	$ 2,402	$ 6,279	$ 5,636
Cost of goods and services | Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Total loss of derivative instruments	(837)	1,447	(884)	3,219
Interest expense | Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Total loss of derivative instruments	585	0	585	0
Other (income) expense, net | Not Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Total loss of derivative instruments	$ 1,167	$ 955	$ 6,578	$ 2,417

XML

Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Inventory, Net [Abstract]
Raw materials	$ 148,119	$ 186,516
Work in progress	20,363	13,615
Finished goods	523,042	421,702
Subtotal	691,524	621,833
Inventory reserve	(26,927)	(24,646)
LIFO adjustments	(93,777)	(54,277)
Inventories, net	$ 570,820	$ 542,910

XML

Accounts Receivable Facility (Details) - Accounts receivable held for sale under Accounts Receivable Facility - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Jun. 28, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Maximum accounts receivable that can be sold			$ 160.0
Accounts receivable sold	$ 101.2	$ 101.2
Accounts receivable outstanding	60.0	60.0
Loss on sale of trade receivable	$ 0.7	$ 0.7

XML

Cash Flow Information (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Supplemental Cash Flow Elements [Abstract]
Transfers from inventory	$ 32.1	$ 33.9